sartorius group annual report order intake sale revenue underlying ebitda million million financial schedule annual shareholder meeting goettingen germany april payment dividend april publication firstquarter figure april publication firsthalf figure july publication ninemonth figure october continuing continuing german equity forum frankfurt main germany november operation operation order intake publication preliminary figure fiscal january sale revenue annual press conference goettingen germany march key figure annual shareholder meeting goettingen germany april figure given million according publication firstquarter figure april ifrs unless otherwise specified restated order intake sale revenue earnings subject approval annual shareholder meeting order intake sale revenue underlying ebitda underlying ebitda sale revenue relevant net profit continuing operations contact relevant net profit research development cost petra kirchhoff andreas theisen financial data per share vice president director earnings per share continuing operations corporate communication ir investor relation per ordinary share phone phone per preference share petrakirchhoffsartoriuscom andreastheisensartoriuscom earnings per share per ordinary share per preference share dividend per ordinary share publication per preference share balance sheet published financial reporting system firesys balance sheet total sartorius ag michael konrad gmbh equity corporate communication frankfurt main germany equity ratio goettingen germany photography financials editorial deadline peter ginter capital expenditure excluding financial asset goodwill february lohmar germany capital expenditure sale amortization depreciation published net cash flow operating activity february net debt ratio net debt underlying ebitda total number employee december underlying adjusted extraordinary item noncontrolling interest adjusted extraordinary item well noncash amortization based normalized financial result translation original amount suggested supervisory board executive board sartorius ag continuing operation germanlanguage annual report including discontinued operation excluding tap biosystems excluding biohit mission sartorius leading international pharmaceutical laboratory equipment supplier wide array product help customer biopharmaceu tical industry manufacture innovative medication safely economically laboratory research quality assurance name sartorius synony mous premium lab instrument consumables service make sophisticated task easier efficient partner understand customer requirement last detail already working solution meet need today tomorrow seek systematically expand position applicationoriented technology group future well based clearcut strategy continue sustainably create value custo mers shareholder alike translate growth high profitability division glance sartorius globally operating company employee worldwide subsidiary based country business subdivided two division bioprocess solution offer integrated solution biopharmaceutical manufacture lab product service provides instrument consumables service laboratory report business development two division starting page provide insight strategy page bioprocess solution page key figure bioprocess solution fo cuses bioprocess business million δ pharmaceutical customer extensive product portfolio division help customer manufacture order intake medication vaccine safely efﬁciently major sale revenue goal optimize pharmaceutical production process primarily increasing deployment singleuse underlying ebitda product solution division global leader ﬁltration fermentation cell cultivation membrane sale chromatography ﬂuid management employees lab product service page key figure premium laboratory instrument consumables million δ excellent service lab product service division positioned broadbased laboratory supplier order intake concentrate laboratory research sale revenue quality assurance unit pharmaceutical biopharma ceutical company academic research institute underlying ebitda division serf customer chemical food industry sartoriusbrand laboratory product sale enable reliable efﬁcient analysis lab helping employees drive accelerate scientiﬁc progress division among market leader laboratory balance pipette lab consumables restated constant currency dec shareholder report executive board sartorius group executive committee report supervisory board sartorius share annual report contains statement concerning sartorius group future performance statement based assumption estimate although convinced forwardlooking statement realistic cannot guarantee actually apply assumption harbor risk uncertainty could lead actual result diverging substantially expected one planned update forwardlooking statement translation original germanlanguage annual report sartorius shall assume liability correctness translation original german annual report legally binding version furthermore sartorius reserve right responsible topicality correctness completeness quality information provided liability claim regarding damage caused use informa tion provided including kind information incomplete incorrect therefore rejected throughout annual report difference may apparent result rounding addition content combined group consolidated financial management report statement note structure management group statement proﬁt loss comprehensive income strategy goal statement financial position macroeconomic environment condition sector statement cash flow assessment economic position statement change equity group business development note financial statement net worth financial position note statement proﬁt loss business development bioprocess solution note statement financial position business development lab product service disclosure discontinued operation declaration executive board annual financial statement sartorius ag independent auditor report opportunity risk report executive board supervisory board forecast report report material event description key feature internal control risk management system supplementary information explanatory report executive board glossary corporate governance report index remuneration report local presence worldwide address sustainability report sustainability sartorius sustainable corporate management ecological sustainability contributing society gri g index leerseite dummy shareholder report executive board dear shareholder business partner fiscal yet another successful year expected phaseout nonstrategic sartorius met extent even exceeded product line still continued noticeable im sale earnings target addition imple pact business lab product service mented important element longterm strategy supply premium laboratory instrument lab con sartorius growth initiative two core sumables especially first three quarter division made strong headway long momentum picking yearend division grew planned sale smallest group division industrial achieving underlying ebitda margin technology completed effect year end business found strong new consolidated order intake whole owner japanese minebea group offer jumped sale revenue climbed good potential synergy promising growth plan million euro achieved increase looking beyond also well track underlying ebitda margin multiyear infrastructure project previous year system production capacity based positive development supervisory let u briefly review key business figure board executive board submit proposal context refer continuing annual shareholder meeting april operation word sartorius group raise dividend per preference share two division bioprocess solution lab per ordinary share connection product service also pleased report share price increased double digit based performance growth engine driving overall dynamic per past fiscal year formance largest division bioprocess solution focus singleuse product beyond continue execute manufacture biopharmaceuticals gain sartorius agenda provides roadmap sale revenue underlying ebitda creating profitable growth strategic core margin division expanded product business important element generate segment region two acquisition substantial organic sale growth plan achieve tap biosystems cell culture medium business gaining market share north america also showed exceptionally positive development also expanding overproportionally asia acquiring majority stake u startup allpure moreover potential division technology additionally extended portfolio acquire suitable company add complemen another innovative group singleuse product tary product product range make u even attractive customer regarding dear shareholder customer business partner profitability striving continue successful would like express appreciation performance past year increase trust often extending back many year underlying ebitda margin step step open dialogue time cordially invite continue u road success line strong business prospect innovative highly profitable technology set ambitious target well specifically group plan increase sale revenue constant currency around underlying ebitda margin sincerely division region expected contribute development general economic condition trend bio process solution division highly stable scarcely dependent business cycle degree uncertainty currently surround projection lab division however due economic imponder ables key market especially european dr joachim kreuzburg union china russia ceo executive board chairman besides focusing strategic operational tar get described implement multi year investment project therefore expect investment ratio slightly longterm average coming year current year thus plan invest sum equal approximately sale primarily expand production capacity various site combine two largest plant headquarters goettingen germany point would like sincerely thank staff made possible u achieve strong result fiscal based expertise motivation dedication sartorius group executive committee group executive committee gec consists member executive board sartorius ag member executive committee subgroup sartorius stedim biotech additional top manager appointed executive board necessary gec key management committee sartorius group serf coordinate control global business activity function gecs activity supplement executive board sartorius ag board director sartorius stedim biotech sa lay groundwork board legally binding decisionmaking joachim kreuzburg chairman corporate strategy legal compliance communication ceo sartorius ag chairman board director ceo sartorius stedim biotech sa sartorius year oscarwerner reif research development member board director sartorius stedim biotech sa sartorius year jörg pﬁrrmann finance human resource information technology member executive board sartorius ag sartorius year volker niebel procurement production supply chain management business process management member board director sartorius stedim biotech sa sartorius year reinhard vogt marketing sale service business development bioprocess solution division member executive board sartorius ag member board director sartorius stedim biotech sa sartorius year michael melingo marketing sale service business development lab product service division sartorius since april report supervisory board dear shareholder summarize opinion supervisory board latter board matter regular conference look back upon another successful fiscal primarily revolved around development sale year sartorius company succeeded yet revenue earnings employment group growing region expanding earn financial situation company affiliate ings despite facing challenging market situation strategic project area besides reaching financial target sartorius also made strategic headway growth meeting february supervisory initiative designed strengthen core business board fully discussed annual consolidated consistently pursued shortly year end financial statement fiscal endorsed company implemented important component based report given audit commit longterm strategic approach signing agreement tee independent auditor present sell industrial weighing technology division item agenda moreover con ferred upon approved agenda along fiscal supervisory board intensively dealt proposed resolution annual sharehold situation prospect company er meeting proposal appropriation advised executive board performed task annual profit addition resolved adjust execu assigned german corporate law company tive board remuneration prior decision article association executive board kept u intensively reviewed whether compensation informed providing regular prompt detailed line usual market condition report written verbal relevant level paid peer company place corporate planning strategic development issue within area company based ex progress business division situation ecutive task committee prior report prepared fur group including risk situation risk manage thermore executive board informed u ment internal control system compli status negotiation contemplated acquisition ance company significant transaction startup company allpure well discussed depth executive task com result employee survey conducted mittee audit committee respectively responsible end well full supervisory board basis report provided executive board various strategic project focus following thorough review executive board meeting april receiving thorough report proposed resolution voted information executive board approved extent vote required acquisition allpure addition executive board provided overview operational cooperation supervisory board measure designed support strong growth executive board always characterized openness bioprocess solution division fluid management constructive dialogue trust area reported status investment project progress focus supervisory board conference meeting september obtained information project strategy various sale initi reporting year supervisory board convened atives lab product service division four ordinary meeting executive board executive board additionally gave detailed status also attended provided meeting concern report sartorius strategy based report ascertained group track next supervisory board meeting february especially view organic growth target item agenda dealt earnings development moreover compliance system company risk management system current place sartorius presented discussed risk situation determined discernible risk could jeopardize future exist meeting december supervisory ence group furthermore examined board thoroughly dealt planned sale result efficiency review work industrial technology division minebea group consented transaction decided extend dr joachim kreuzburgs appointment activity report committee chairman ceo executive board ahead time another five year november four committee support work supervisory supervisory board pleased gained board prepare topic dealt dr kreuzburg term thanks full supervisory board individual case executive task committee successful negotia take decision lieu full board far tions held meeting well supervisory permitted committee chairman reported regularly board agreed commission law office hengeler supervisory board detail mueller whose partner prof gerd krieger member committee work supervisory board draft resolution voted next annual shareholder executive task committee met meeting authorization use company average rate nine time reporting year share finance acquisition remunera conferred intensively various strategic measure tion component executive board member company among sale industrial recommendation audit committee also technology division addition committee dealt agreed conclude new longterm syndicated loan matter involving executive board pre agreement based upon sartorius replaced pared decision latter remuneration consolidated two existing loan ahead schedule well extension contract addition also approved budget submitted current executive board chairman ceo com executive board mittee also received information progress project rollout groupwide erp system topic corporate governance item thoroughly discussed succession planning top agenda discussed detail manager consultation decided upon wording declaration compliance accordance year review audit committee held german corporate governance code declaration five meeting committee prepared full confirms sartorius complies recommen supervisory board conference endorsement dations current code full extent approval consolidated annual financial state additionally dealt process retendering ments fiscal discussed quarterly external auditor review financial statement firsthalf financial report focus company initiated audit com monitoring effectiveness group mittee due new eu audit reform regulation wide risk management internal control system decision auditor recommend annual well well inhouse auditing compliance shareholder meeting scheduled made committee also conferred subject shareholder report supervisory board group financing particularly consolidation two meeting february endorsed finan separate loan agreement term new cial statement sartorius ag group rec syndicated loan contract signed december ommendation audit committee annual beyond item committee reviewed financial statement thus approved supervisory internal audit department report indi board executive board submit proposal cate material discrepancy business transac annual shareholder meeting april tions also considered department plan shareholder paid dividend per pref upcoming month respect audit erence share per ordinary share annual financial statement fiscal com retained profit mittee confirmed independence auditor conferred detail selection auditor recommend annual shareholder meeting composition supervisory board appointment commissioning appointed auditor executive board perform audit review well defining monitoring audit procedure focal point fiscal personnel change audit focus reporting year supervisory board february mr gerd tender offer audit fiscal uwe boguslawski employee representative vice audit committee monitored supervisory board chairman supervisory board left board fulfillment obligation following thorough reaching retirement age behalf entire consultation result tender offer board would like thank mr boguslawski committee recommended suggest supervisory many year valuable service upon recommendation board meeting february german metalworker union ig metall kpmg ag auditing company proposed appoint local court appointed mr manfred zaffke succeed ment annual shareholder meeting member supervisory board effective march mr zaffke elected super nomination committee meet past visory board vice chairman member year conciliation committee pursuant sec various committee change tion subsection german codetermination membership executive board reporting law mitbestg likewise convened year position held dr joachim kreuzburg executive board chairman ceo extended ahead time term five year audit annual consolidated november financial statement supervisory board would like thank execu annual consolidated financial statement tive board employee across globe prepared executive board fiscal great commitment successful hard work management report sartorius ag fiscal year ended addition supervisory reviewed independent auditing company board express appreciation shareholder deloitte touche gmbh wirtschaftsprüfungsgesell confidence shown yet schaft based hanover germany company company commissioned audit committee supervisory board pursuant resolution passed munich february annual shareholder meeting april independent auditor issued unqualified audit supervisory board certificate attended audit committee meet ing february supervisory meeting february reported essential result audit sufficient time allotted discussion issue auditor written formation audit report sent super visory board member time discussed detail meeting mentioned basis prof dr dres hc arnold picot examination annual sartorius ag consolidated financial statement sartorius ag chairman management report group management port supervisory board concurred result audit conducted deloitte touche shareholder sartorius share sartorius share share market state high volatility doubledigit increase sartorius share price reporting year german dax share index reporting year sartorius share performed showed volatile performance whole well yet sartorius ordinary share thus rose index supported primarily expansionist ecb closing yearend com policy first half year geopolitical panys preference share gained reporting tension worsening economic prospect fueled year closing uncertainty consequence leading german stock index fell annual low point sartorius ordinary share hit low october driven liquidity dax reached beginning reporting period january alltime high point december year company preference share reached low end index point represented october ordinary overall gain compared year earlier preference share peaked december german technology index tecdax ord prf respectively sartorius also belongs rose period much dynamically dax closing criterion admission tecdax freefloat point december market capitalization turnover last twelve month frankfurt stock exchange yearend sartorius preference share ranked th based criterion market capitalization th stockexchange turnover criterion shareholder sartorius share fact share isin de ordinary share de preference share designated sponsor oddo seydler bank ag hsbc trinkaus burkhardt ag market segment prime standard index tecdax cdax prime share index technology share index nisax stock exchange xetra frankfurt hanover duesseldorf munich berlin hamburg bremen stuttgart number share nopar individual share certificate calculated par value per share ordinary share preference share share outstanding ordinary share preference share trading volume share price development change preference share xetra yearend closing price ordinary share xetra yearend closing price market capitalization million average daily trading volume preference share average daily trading volume ordinary share trading volume preference share million trading volume ordinary share million total trading volume million tecdax dax without treasury share source bloomberg deutsche börse ag shareholder sartorius share sartorius share january december preference ordinary share share ordinary share preference share sartorius share comparison dax tecdax nasdaq biotechnology index january december preference ordinary dax nasdaqshare tecdax biotechnology index share tecdax preference share ordinary share dax nasdaq biotechnology index shareholder sartorius share market capitalization trading volume research coverage institute date recommended market capitalization sartorius ordinary deutsche bank january hold preference share billion december dz bank january buy compared prioryear figure billion equates increase nord lb january hold oddo seydler january buy average number preference share traded daily berenberg january buy frankfurt stock exchange xetra trading commerzbank january buy floor decreased reporting year hsbc trinkaus burckhardt october buy share among reason decline cheuvreux july hold increase trading alternative security plat form corresponding trading volume sartorius dividend preference share million sartorius group applies dividend policy intended average number ordinary share traded daily ensure shareholder adequately rewarded relative previous year due company success line policy endeavor low free float principle distribute underlying net profit see page definition investor relation activity supervisory board executive board submit proposal annual shareholder meeting sartorius investor relation activity focus main april paying dividend previous taining ongoing open dialogue shareholder year per preference share previous potential investor financial analyst year per ordinary share fiscal besides providing quarterly firsthalf annual dividend report well holding quarterly telephone confer ences also regularly published press release pre senting significant company business development material event reporting year moreover management team available capital market participant site goettingen germany aubagne france conference roadshows conducted financial market cen ters london paris frankfurt main new york hold oneonone meeting first capital market day hosted september goettingen also provided indepth view group strategy busi ness model positioning division well future business potential information publication company preference share ordinary share share provided website wwwsartoriuscom amount suggested supervisory board executive board sartorius ag analyst would increase total profit distributed assessment recommendation financial million million total analyst serve important foundation profit distributed based relevant net result decision private institutional investor would compared year earlier acquiring share reporting year maintained based yearend share price ongoing dialogue eight institution total sartorius preference ordinary share would give dividend yield share class pre vious year treasury share held company entitled dividend payment shareholder sartorius share shareholder structure recent information available u company biorad laboratory inc hold around sartorius ag issued capital comprises million company ordinary share according current ordinary share number preference information remaining portion comprising around share calculated par value per ordinary share free float share good ordinary share held sartorius family management around company preference share executor approximately owned directly free float roughly held treasury share member family approximately held corporation treasury share corporation according shareholder structure ordinary share shareholder structure preference share administered executor treasury share biorad laboratory inc free float treasury share member family free float key figure sartorius share ordinary share reporting date high low preference share reporting date high low market capitalization million dividend per ordinary share dividend per preference share total dividend million payout ratio dividend yield per ordinary share dividend yield per preference share xetra daily closing price without treasury share amount suggested supervisory board executive board sartorius ag calculated basis number share entitled dividend based relevant net profit net profit adjusted extraordinary item noncash amortization based normalized financial result including corresponding tax effect relation closing price year concerned shareholder sartorius share combined group management report group management report structure management group structure management group group legal structure change group portfolio sartorius globally operating company subsidiary consolidated financial statement include country parent company parent company sartorius ag major affiliate sartorius group sartorius ag holding sartorius ag controlling interest pur company control group direct indirect suant ifrs affiliate sartorius ag headquartered goettingen germany listed franfurt stock exchange april sartorius stedim biotech acquired majority stake allpure technology llc startup sartorius stedim biotech run legally independ company headquartered new oxford pennsylvania ent subgroup focus especially biopro usa specializes singleuse product aspetic cess business december sartorius ag sampling biopharmaceutical application com held approximately share around plements product portfolio bioprocess solu voting right parent company sarto tions division allpure initially consolidated rius stedim biotech sa listed paris reporting date transaction april bourse sartorius stedim biotech sa headquartered aubagne southern france december sartorius concluded contract japanese minebea group partner sale manufacturing company development bank japan sell industrial laboratory business operated legally owned technology division additional information given rule sartorius ag crossdivisional report material event page controlling administrative function finance human resource combined service company group management report structure management group organization management group financial controlling key performance indicator sartorius group consistently organized func tion worldwide accordingly controlled sartorius group managed using number key core operating function performance indicator also decisive determination variable remuneration compo sale industrial weighing operation nent executive board manager previously mentioned sartorius operating business conducted two division bioprocess solu key management parameter sartorius u tions lab product service division measure development volume currency combine respective business cu adjusted growth order intake sale revenue tomer group field application share certain infrastructure central service based key profitability measure ebitda adjusted organization described sartorius suitable extraordinary item ie underlying ebitda structure place meet prerequisite corresponding margin beyond indicator ebit flexible successful development relevant net profit year net profit earn group ings per share reported group central management entity sartorius important indicator ratio net debt group executive committee gec currently underlying ebitda membership six member executive board sartorius ag executive member addition following financial nonfinancial board director sartorius stedim biotech sa indicator reported regular basis one senior manager crossdivisional responsibility capex ratio equity ratio functional responsibility also assigned global net working capital level across site region senior man net cash flow operating activity agement tier immediately beneath gec imple number employee menting group various strategy project local level responsibility national rule annual financial forecast pub affiliate management body local compa lished management beginning fiscal year ny manage organization accordance group division refers develop applicable statutory provision article associa ment sale revenue underlying ebitda tion rule procedure keeping expected capex ratio well directional forecast principle corporate governance apply ratio net debt underlying ebitda addi throughout sartorius group worldwide tionally indicated group sale revenue order intake mostly similar level sartorius due structure generally show considerable timing difference subject similar growth assumption reason order intake usually budgeted separately component financial forecast group management report strategy goal strategy goal sartorius group business organized according two business sartorius focus particular division bioprocess solution lab product singleuse product represent around three service division setup strategy follows quarter division sale revenue cu tomers singleuse product innovative alter native conventional reusable stainless steel system bioprocess solution provide considerable cost time saving reduce risk contamination sartorius bioprocess solution division sartorius extensive portfolio singleuse technology leading international supplier product industry technology manufacture medication vaccine biological basis socalled biopharma product division address attractive ceuticals market aboveaverage growth potential sale distribution activity carried globally part strategy total solution provider field force customer manufacturing offer biopharmaceutical industry product process validated respective authority portfolio cover nearly step production product quality assurance supply essential process encompass cell culture medium seed fermentation cultivation various bioreactor size see leading market position division cell propagation well range technology process filtration fluid management fermentation equipment filter aseptic bag membrane chromatography good stepping cell harvesting purification concentration stone sustained dynamic profitable growth way final filling future besides realizing organic growth poten tial division also plan continue expanding complementary acquisition alliance upstream bioprocessing downstream bioprocessing medium seed production cell removal capture polishing viral formulation preparation fermentation fermentation clariﬁcation clearance final fill service evaluation optimization engineering design implementation technical service group management report strategy goal lab product service assurance research laboratory reason nonstrategic product line phased lab product service division focus past two year research quality assurance laboratory pharma ceutical biopharmaceutical company lab product service sell product academic research institute division additionally three distribution channel specialized dealer serf customer chemical food beverage distributor direct sale ebusiness industry product portfolio cover instrument distributor channel long wellestablished consumables laboratory require instance direct sale ebusiness channel sample preparation use standard applica expanded strengthen division market position tions laboratory instrument lab balance pipette laboratory water system contribute doubledigit share market sartorius around division sale revenue wellknown laboratory brand premium seg consumables product microbiological ment based company history market posi test pipette tip service account tions differ quite considerably depending total sale region product group however back ground see significant potential lab prod beginning three formerly separate ucts service division grow organically due activity comprised laboratory weighing busi economy scale growth projected ness laboratory consumables unit liquid accompanied increase margin beyond handling entity combined one business target division aim expand offering subsequently division product portfolio complementary laboratory product streamlined focus application quality alliance acquisition lab instrument lab consumables service portfolio product revenue revenue distribution channel lab distributor direct sale ebusiness segment customer clinical diagnostics pharma biotech academia chemical food beverage group management report strategy goal strategic planning sartorius sartorius aim grow sustainably profitably future well group thus plan generate sale revenue around billion approxi mately twothirds growth achieved organically around one third acquisition moreover sartorius plan increase underlying ebitda margin around sartorius executed strategic plan developed im plementing number initiative related regional growth product portfolio infrastructure view organic growth continued im provement profitability track achieve goal however sale revenue contributed acquisition substantially depends availability appropriate takeover target regionally north america focus sartorius growth strategy manufacture biopharmaceuti cals laboratory product north america world largest market sartorius still belowaverage market share region also usa home market vast majority competitor gain market share strengthened capa city primarily sale distribution service enhanced sale process second regional focus asia especially china india market tremendous po tential growing higherthanaverage rate participate momentum best possible way sartorius considerably invested sale infra structure region well addition acquisition primarily focused comple mentary technology product contribute future growth past year success fully expanded wide array product service several small mediumsized acquisition make business process efficient sartorius globally introducing new erp system already use group headquarters goettingen germany moreover continuously expanding capacity manufacturing site goettingen combining plant site still located separate area one location part multiyear project time extending local produc tion capacity group management report macroeconomic environment condition sector macroeconomic environment condition sector two division sartorius group operate reporting year pace expansion germany sector different economic sensitivity bio france slowed relative first half attaining process solution division active environment respectively italian economy largely unaffected economic fluctuation continued shrink lab product service division contrast conduct business activity also sector fueled strong private consumption rising dependent economic development vestment uk economy grew political crisis ukraine associated sanction led macroeconomic environment stagnation russian economy global economy expanded rate economic growth asia nearly prior previous year according international year level momentum chinese economy slowed monetary fund imf view overall weak start slightly reporting period gain year pace expansion slightly less recorded following growth previous year rate originally forecasted contrast momentum indian economy im proved due rising export investment econo gained compared japan economic global development gdp performance rose reporting year gross domestic product region source international monetary fund global euro area u japan asia following sluggish start mainly weather induced u economy performed robustly latter course year balance growth u thus asia china india asean indonesia malaysia previous year level driven primarily rising gov philippine thailand vietnam ernment spending besides strong private consumption source international monetary fund national economy europe showed quite uneven development reporting year euro zone continued affected consequence financial crisis overall high sovereign debt member nation comparably high unem ployment rate negative impact yet contracting several year eurozone economy however record slight increase group management report macroeconomic environment condition sector exchange rate trend pharmerging market continued expand dynamically whole reporting period growth important currency sartorius group besides market driven expansion state euro include especially u dollar well healthcare higher private spending currency like chinese yuan indian rupee growth regional pharma market exchange rate euro u dollar impacted reporting year continuing weak economy europe robust economic devel opment usa result european single currency sharply depreciated course year hitting annual low u dollar december interest rate trend year review average interest rate dropped new historic low european central europe united state japan pharmerging bank cut base rate two step reporting year markets record low month euribor rate rate interest fixedterm deposit denominated euro interbank business still low level december china brazil russia india algeria argentina columbia egypt relative previous year indonesia mexico nigeria pakistan poland romania saudi arabia south africa thailand turkey ukraine venezuela vietnam source international monetary fund world economic outlook october bloomberg ecb deeuriborrateseu source ims health sector condition continued aboveaverage growth biotechnology market key customer sartorius group serf biopharmaceutical pharmaceutical global market pharmaceutical manufactured dustries public research institute chem using biotech method grew overproportionately ical food sector accordingly trend reporting year around outperforming specific sector considerably influence business global pharmaceutical market attributable development sartorius group mainly launch many new biopharmaceuticals past year expanded indication existing medicine proportion sale revenue strong growth pharmaceutical market accounted biologically produced medication risen continuously past year international market research institute ims health stood around currently therapeutic estimate global pharmaceutical market protein play important role treat grown around compared gain ment condition including diabetes chronic anemia still make largest category active pharmaceutical ingredient manufactured using bio significant acceleration growth primarily tech method monoclonal antibody also con attributed comparably low number patent tinuing gain importance used expiration developed market many new instance treatment cancer hiv auto medical drug approved addition introduction immune disease multiple sclerosis rheu government health insurance usa matism according study conducted boston positive impact consulting group monoclonal antibody undergoing clinical development phase iiii significantly prioryear figure adjusted discount rebate considered group management report macroeconomic environment condition sector strong trend towards singleuse system competitive position biopharmaceutical production competitive environment varies two compared classic procedure biotechnological core division production process vastly complex costintensive reason manufacturer bioprocess solution division operates total supplier intensively working develop solution provider covering core process step efficient production technology singleuse product biopharmaceutical manufacture hold leading playing crucial role effort require global position key technological field offering significantly less capital expenditure moreover extensive portfolio singleuse technology reduce cost cleaning validation minimize sector division main competitor include downtime beyond advantage singleuse product emd millipore pall general electric thermo fisher provide considerable flexibility help accelerate time market thanks particular cost efficiency lab product service division positioned singleuse product already well established premium provider product along excellent many process step service serf research quality assur ance laboratory across many industry product range cover laboratory balance pipette well continued soft demand wide array consumables name exam public research sector ples segment division rank among leading provider worldwide main competitor proportion demand laboratory prod include mettler toledo thermo fisher emd millipore ucts come public research sector many pall eppendorf country research budget declining result excessive public debt according frost source boston consulting group medizinische biotechnologie sullivan demand public research sector deutschland medical biotechnology germany reporting year slightly prioryear level ims global outlook medicine evaluate pharma world preview june frost sullivan midyear report forecast analysis global market laboratory chemical sector moderate growth product vci quartalsbericht q cefic chemical industry benefit general economic recovery june industry expert estimate chemical industry europe made moderate progress increas ing production according european chemical industry council cefic attribut ed particular rise demand auto motive industry addition stabilization building sector positive effect north america asia also saw increasing demand chemical product group management report assessment economic position assessment economic position sartorius fiscal industrial technology division discontinued operation sartorius enjoyed another year strong progress fiscal achieving case exceeding december contract sale financial target set management begin dustrial technology division concluded ning year moreover sartorius focused minebea group partner development bank portfolio envisaged sartorius strategic japan accordance ifrs division plan sale industrial technology consequently reported consolidated financial smallest group division two remaining statement group management report dis division bioprocess solution lab product continued operation mean order intake service sharpened strategic focus sale revenue earnings asset liability including core customer biopharmaceutical industry borrowing cash flow industrial technolo laboratory respectively bioprocess solution gy division shown separately financial product range gained another innovative strand reporting original statement profit loss acquisition majority stake accordingly restated line ifrs allpure technology contrast statement financial position restated given industrial technology division included group guidance published section discontinued operation page beginning year accordingly also retained provides information business development following comparison financial target industrial technology fiscal actual performance subsequent part group management report however report continu ing operation accordance presentation consolidated financial statement note sartorius grew considerably yet sale revenue rose constant currency thus slightly exceeding forecast range announced beginning year profit margin based underlying ebitda rose slightly forecast approximately facilitate future growth sartorius expanded capaci tie several production facility invested system reporting year capex ratio rela tive sale revenue amounted well line range forecasted beginning year group financial position remained broadly un changed stable equity ratio thus remained comfortable level ratio net debt underlying ebitda last twelve month following thus developed slightly better fore casted start year application irfs minor effect particular division result comparison respective forecast provided chapter division group management report group business development group business development sartorius group business development presented regarding division performance bioprocess solu continuing operation ie division tions division major growth driver bioprocess solution product service reporting year achieving doubledigit gain division order intake climbed million sale revenue surged million order intake sale revenue division organic growth around mean acquisition excluded rate business performance sartorius group change constant currency positive whole year review significant doubledigit gain reported order intake sale revenue growth sale revenue order intake rose million unless otherwise specified million period group sale revenue increased million rate change constant currency order intake sale revenue million group bioprocess lab product solution service restated order intake sale revenue growth growth sale revenue million restated group bioprocess solution lab product service constant currency sale revenue division bioprocess solution reporting year lab product service division received order amounting million relative million year ago equal lab product service increase division sale revenue rose million million rate change constant currency information business development group division given page et seq bioprocess solution division page et seq lab product service division group management report group business development sale revenue region group sale revenue region million unless otherwise specified europe north america asia pacific market europe north asia acc customer location america pacific market europe region account around acc customer location sartorius group business thus highest restated sale share sale revenue high base previous year bioprocess solu tions division reported doubledigit sale gain sale revenue growth growth sale revenue lab product service million division slightly prioryear level group primarily due phaseout non europe strategic product rate change constant north america currency asia pacific market north america represented approximately group revenue reporting year grew acc customer location dynamically recording gain fueled constant currency division bioprocess solution division reported surge sale partly induced acquisition addition business ex panded also organically significant pace driven strong demand product segment sale revenue lab product service likewise increased sharply rate change constant currency asia pacific region account around consolidated sale saw doubledigit gain year review key growth driver bioprocess solution division boosted sale revenue performance driven large equipment order strong demand singleuse product given weak market environment especially beginning year lab product service division reported sale growth rate change constant currency group management report group business development development cost earnings already mentioned industrial technology division reported discontinued operation net reporting year cost sale profit tax activity million million rise primarily due previous year level increase production volume complete consolidation medium business higher reporting year net profit attributable share depreciation related expansion production holder sartorius ag million relative capacity cost sale ratio relative million year earlier noncontrolling interest year ago stood million million essen tially reflected share sartorius stedim biotech sa functional cost sartorius group developed held sartorius group fiscal follows selling distribution cost rose underproportionately relative sale revenue million ratio selling statement profit loss distribution cost sale revenue com million pared previous year sale revenue cost sale expense research development rose reporting year group division whole gross profit sale rd cost increased million selling distribution cost equates sale revenue compared research development cost prior year general administrative expense operating income expense concerning general administrative expense earnings interest ported increase million tax ebit primarily attributed recent acquisition relation financial income sale revenue general administrative expense financial expense relative previous year financial result profit tax fiscal balance operating income income tax expense million relative million profit tax year earlier continuing operation profit tax overall group operating expense rose year discontinued operation year accordingly ebit increased overproportion net profit period ately respect sale revenue attributable million group ebit margin equity holder sartorius ag noncontrolling interest significant change financial result restated according ifrs million relative million especially reflects valuation effect hedging instrument connection refinancing syndicated loan effect amounted approximately million reporting year income tax totaled million million company tax rate year group management report group business development underlying ebitda relevant net profit sartorius group u underlying ebitda earnings relevant net profit attributable shareholder interest tax depreciation amortization sartorius ag million million adjusted extraordinary item key prof year ago figure calculated adjusting itability indicator information extraordinary extraordinary item eliminating noncash amortization item provided page fair value adjustment hedging instrument based normalized financial result well reconciliation ebit underlying ebitda corresponding tax effect item million respective underlying earnings per ordinary share amounted year earlier ebit per preference share euro extraordinary item euro year ago amortization depreciation underlying ebitda million restated ebit extraordinary item amortization fiscal sartorius group increased earn normalized financial result ings overproportionately yet underlying ebitda normalized income tax thus rose million group respec tive underlying ebitda margin improved underlying earnings noncontrolling interest underlying earnings tax underlying underlying noncontrolling interest ebitda ebitda margin underlying earnings per share million per ordinary share group per preference share bioprocess solution relevant net profit non lab product service controlling interest underlying earnings per share per ordinary share bioprocess solution division increased per preference share lying ebitda million million overproportionate increase relative restated financial result excluding fair value adjustment hedging sale revenue driven economy scale instrument nonperiodic expense income division margin rose lab underlying income tax based underlying profit product service division reported underlying tax noncash amortization ebitda million v million year ago including discontinued operation division margin remained pre vious year level mainly induced sale information earnings development extraordinary item group division given consolidated ebit including extraordinary item page et seq et seq million million mainly related integration tap biosystems severance payment various crossdivisional project depreciation amortization reached million million group respective ebit margin previous year group management report group business development underlying earnings per share research development spending research development rd across sartorius group amounted reporting year million represents yearonyear increase million ratio rd cost sale revenue stood development investment significanty increased reporting period driven successful completion several larger project amounted million compared million equates share group total rd expense depreciation related capitalized development cost amounted preference share million reporting year million ordinary share adjusted extraordinary item noncash amortization based research development activity aim normalized financial result including corresponding providing innovative product solution tax effect help customer run production lab oper including discontinued operation ations efficiently term time cost endeavor expand range product continuously via research development appropriation profit integrating technology alliance supervisory board executive board sartorius operates strategic property right policy submit proposal annual shareholder meeting across division protect expertise en april raise dividend fiscal tail systematic program detect infringement according proposal dividend set right plus review based cost benefit crease year ago per preference approach determine specific individual right share year earlier per ordi need maintained nary share total amount disbursed proposal would thus rise million filed total application property right million issued patent trademark also result past application previ ous year balance sheet date total patent trademark portfolio information provided section covering individual division beginning page et seq et seq group management report group business development capital expenditure employee increased capital expenditure considerably following number employee include staff reporting year planned million member apart vocational trainee intern em million ployees extended leaf absence par ticipating early retirement plan number fiscal substantial part capital ex recorded head count meaning employ penditures related investment expansion ee counted regardless whether work full production capacity particular filter part time manufacture goettingen site december sartorius group em completed preparation international ployed people continuing business seg rollout new erp system reporting year ments previous year began implementation site usa employee british company tap biosystems sartorius acquired end moreover sartorius started multiyear project staff member sartorius recent acquisition consolidate expand headquarters allpure technology included first time goettingen fiscal reporting employee growth bioprocess solution lab product service continuing operation discontinued operation total group restated excluding tap biosystems yearend majority total group workforce employed bioprocess solution division worked lab product service division division reported gain respective workforce headcount increase respectively employee central administrative function reported according continuing division performed task group management report group business development employee region number employee function show production unit accounted largest share group total workforce head count increased primarily resulted sartorius ex panded personnel capacity french puerto rican manufacturing site response sustained strong demand singleuse product addition majority staff tap biosystems acquired previous year work production good quarter total group workforce em ployed marketing sale function part sale initiative sartorius strengthened sale team region led increase head count compared prior year europe north asia percentage gain number employee america pacific market highest research development unit area bioprocess solution division hired new staff end reporting year continuing operation workforce employed administrative unit restated include finance human resource among unit functional area recorded lowest rate increase gain head count increased three core region reporting year yearend around twothirds employee age total workforce employed europe head count grew gain ger number number man group site employ total year staff north america recorded highest staff year crease number people employed year asia pacific region end fiscal year year rose representing total group year workforce yearend year employee function restated sartorius group employed men woman december meaning men make total workforce woman half employee age aver age employee age across entire workforce reporting period virtually unchanged year year production marketing research administration sale development continuing operation restated group management report group business development new hire attrition rate average seniority absenteeism new hire departures attrition rate average seniority year absence rate restated departure companydriven dismissal layoff recorded first time group whole number people leaving company percentage average head count including expired fixed term contract contract terminated either employee employer retirement reason employee leaving company attrition rate express number people leaving company percentage average head count fell group reporting year previous year attrition rate generally varies region region also true sartorius german site rate typically low stood previous year country high average attrition rate china india sartorius suc cessfully lowered rate various employee retention motivation activity result attrition rate asia dropped considerably fiscal year review absence rate proportion planned work ing time worked due general absence decreased reporting year across group even average time missed per employee due illness dropped day fiscal detailed information sartorius employer human resource strategy people development please see chapter sustainable corporate management starting page group management report net worth financial position net worth financial position cash flow consolidated statement financial position reporting year net cash flow operating accordance ifrs prioryear statement activity sartorius group rose financial position required adjusted con million million especially due cerning disclosure asset liability dis positive development earnings cash continued operation material impact inflow discontinued operation accounted discontinuation described following million million balance sheet total sartorius group rose planned investment higher million million reporting previous year net cash outflow investing date december figure includes asset activity increased million million liability million million investment activity focused spectively discontinued industrial technology expansion production capacity various site division amount disclosed current rollout new system measure related item combination two separate plant one group headquarters goettingen germany noncurrent asset slightly rose million discontinued operation accounted investment million increase mainly attributed million following million year expansion production capacity group discontinued operation asset originally ported noncurrent item million cash outflow related acquisition amounted year ended december disclosed cur million takeover majority stake rent asset allpure technology figure significantly amount million prior year current asset increased million sartorius acquired lonza cell culture million inter alia due change medium business tap biosystems disclosure mentioned thus sartorius group financed investment acquisition entirely operating cash flow key figure working capital previous year day rate turnover inventory cash flow statement inventory x summary sale revenue million rate turnover receivables net cash flow operating activity trade receivables x discontinued operation sale revenue net cash flow investing activity acquisition rate turnover net working capital discontinued operation net working capital x net cash flow financing activity sale revenue discontinued operation cash cash equivalent restated sum inventory trade receivables less trade gross debt payable net debt including pro forma sale revenue tap biosystems group management report net worth financial position key balance sheet figure gross debt comprised liability bank including note loan schuldscheindarlehen finance lease stood million slightly equity ratio prioryear figure million net equity balance sheet total debt defined gross debt less cash cash equiva lent slightly decreased million million longtermcapitalto fixedassets ratio longterm capital ratio longterm capital fixed asset margin fixed asset ally increased reporting date relative december equity increased driven earnings million million equity ratio sartorius group rose noncurrent liability year year million million group dis continued operation liability originally reported noncurrent item million year ended december disclosed current liability current liability rose million million reporting year figure includes liability totaling million discontinued operation sartorius group balance sheet structure asset equity liability noncurrent equity asset noncurrent current liability asset current liability group management report net worth financial position financing treasury ratio net debt underlying ebitda financing sartorius group consists various element largely renewed reporting year benefit attractive market environ ment increase flexibility major pillar financing syndicated credit line million concluded december maturity term five year new financing arrangement sartorius replaced two syndicated credit line ahead schedule consolidated financing within group additional component company financing underlying note loan schuldscheindarlehen placed including discontinued operation volume million maturity five ten year consequence global business activity addition several longterm loan totaling around sartorius group exposed fluctuation foreign million available expand production exchange rate main foreign currency include capacity among project u dollar japanese yen british pound using global manufacturing network production beyond component diverse working facility north america uk china india capital guaranteed credit line totaling approxi among place sartorius compensate mately million factoring program majority currency fluctuation natural hedging volume million generally hedge approximately twothirds sartorius group financed longterm well remaining net currency exposure period diversified basis financing component comprise year suitable currency transaction instrument fixed variable interest rate variable interestrate bank loan hedged increase general interest rate level ratio net debt underlying ebitda decreased december year earlier ratio ratio include discontin ued operation sartorius group business development bioprocess solution signiﬁcant growth across product range region performance slightly stronger expected organic growth acquisitionled sale increase earnings margin due economy scale key figure sale revenue region according customer location europe million δ order intake north america sale revenue mn underlying ebitda sale asia paciﬁc employees market product biopharmaceutical manufacture singleuse bag fermentation storage scaleup level filter sterilization biopharmaceutical medium culture medium buffer cell cultivation membrane chromatography singleuse bioreactor system safe efﬁcient cell cultivation process puriﬁcation bioprocesses l restated constant currency dec group management report business development bioprocess solution order intake sale revenue bioprocess solution sale revenue region million unless otherwise specified bioprocess solution division increased order intake reporting year million constant currency compared high prior year base bioprocess solution order intake sale revenue million europe north asia america pacific market acc customer location order intake sale revenue sale revenue growth growth million bioprocess solution europe sale revenue rose period north america constant currency million thus surpassing asia pacific range predicted beginning market year organic growth around exceeded expectation driven product line also acc customer location recent acquisition cell culture medium busi constant currency ness tap biosystems developed dynamically reporting period performed better anticipated beginning year main region reported doubledigit gain sale revenue especially europe north america acquisition mentioned contributed signifi cantly growth europe region generating highest sale accounting around division revenue reported increase sale revenue million north america represented division sale revenue registered highest growth dynamic report ing period sale region significantly increased million asia pacific accounted around total sale recording gain million rate change constant currency group management report business development bioprocess solution earnings acquisition strengthen product range earnings bioprocess solution division advanced acquisition british company tap biosystems significantly reporting period based strong end added two smallvolume singleuse growth sale revenue due economy scale un bioreactor system process development applica derlying ebitda increased overproportionally tions product range innovative system million division respective margin rose enable customer perform large number thus slightly exceeding guidance cell culture experiment simultaneously providing around communicated outset year quick costeffective way determine optimal development condition cell culture al bioprocess solution underlying ebitda low u begin working customer ebitda margin early stage process development underlying ebitda product range gained new sampling system underlying ebitda margin acquisition majority stake u startup allpure technology allpure system restated based singleuse technology allows sample taken bioreactor sterile closed environ ment technology replaces traditional reusable division recorded extraordinary item sampling system pose greater risk con million reporting year relative tamination million year ago extensive range service product sale sophisticated manufacturing process employed bioprocess solution division provides product customer subject strict regulation cover virtually step biopharmaceutical production quality control quality assurance compliance process medium cell cultivation bioreactors regulation subject regular check various size cell propagation filter purifying relevant authority offer extensive range cell material system storage transport service encompassing validation consulting activ intermediate finished product offering com ities well equipment installation maintenance plemented range service including consulting repair help customer comply applicable validation applicationspecific package regulatory requirement division launched new generation existing product line reporting year added several sale distribution activity expanded completely new product notably area fluid management fermentation bioprocess solution division market product portfolio exclusively direct channel maintains team field sale representative new generation singleuse bag also global key account management team coordinate support sale distribution activ together cooperation partner developed ities key account reporting year sartorius new polyethylene film based launched began introduce new global crm system pro new singleuse bag fermentation application vide support sale distribution activi reporting year one main benefit tie also stepped sale distribution activity new film interact cell asia reporting year connection terial stable cell growth ensured new implementation strategy film combine robustness flexibility new application center opened shanghai exam time meaning also used large ple allows presentation key product volume cultivation fermentation storage process plus demonstration variety different applica e wide range application another ad tions customer vantage customer single film material validated pave way significant reduction validation time cost group management report business development bioprocess solution research development production supply chain management research development activity encompass bioprocess solution division operates well inhouse development area core developed global production network plant technology well integration product europe north america asia largest produc alliance partner university tion site located germany france puerto industry rico sartorius also manufacturing operation switzerland uk tunisia india inhouse research development sartorius focus particular following technology area production site generally serf membrane core component center competence particular technology type filter product several base technology group largest plant goettingen example con broad spectrum application bioprocesses like centrates chiefly production membrane singleuse container sensor well control filter aubagne mohamdia site primarily technology eg fermentation moreover manufacture singleuse bag plant yauco sup extensive expertise bioprocess application ply membrane filter singleuse bag principally development u market guxhagen site specializes bioreactors system bioprocess applica regional perspective largest rd site tions collaborates closely bangalore site located goettingen additional key rd mainly manufacture stainless steel unit activity aubagne guxhagen bangalore royston system overall research development activity becoming increasingly international production capacity expanded one rd priority reporting year develop additional application new polyeth sartorius expanded production capacity various ylene film thus continued effort bring site reporting year response dynamic new film market area storage freeze growth bioprocess business thus new bag thaw application production system commissioned yauco aubagne mohamdia plant sartorius installed connection acquisition allpure technol new casting machine production filter ogies began work reporting year develop membrane goettingen site reporting new standardized product taking sample year scheduled commissioned bioreactors production capacity also expanded bangalore plant fermentation also collaborating industrial university partner development new control technol ogies manufacturing process active medical central distribution center ingredient socalled process analytical tool sartorius joint venture partner built new spending research development biopro highly automated logistics center goettingen cess solution division amounted million site reporting year facility handle product reporting year corresponding ratio rd shipping well supplying production unit cost sale revenue compared goettingen plant sartorius intends implement prior year central distribution center asian market future based suzhou site china business development lab product service development sale revenue earnings impacted portfolio cleaning new product featuring userfriendliness data management focus direct sale key account ebusiness key figure sale revenue region according customer location europe million δ north america order intake sale revenue mn underlying ebitda asia paciﬁc sale employees market product laboratory quality assurance research laboratory balance lab water system reliable convenient singleuse bag system weighing process storage puriﬁed water lightest smallest innovative membrane electronic pipette transfer agar system market microbiological testing mass comparators climate module automatically measure environmental parameter restated constant currency dec group management report business development lab product service order intake sale revenue lab product service sale revenue region million unless otherwise specified reporting year order intake lab product service division rose constant currency million million phaseout nonstrategic product merchandise article laboratory balance lowend basic segment marginal impact order intake lab product service order intake sale revenue million europe north asia america pacific market acc customer location restated sale revenue growth growth million order intake sale revenue lab product service europe north america restated asia pacific market contrast portfolio adjustment mentioned acc customer location continued deferred impact sale constant currency percentage point expected accordingly sale revenue reporting period rose constant currency million million thus lower end growth forecast europe region contributing highest share sale revenue sale revenue quite reach high prioryear level discontinuation nonstrategic product still noticeable impact sale year review asia pacific account around business lab product service division sale revenue grew figure affected weak market environment beginning year particularly china north america generated approximately division revenue sale revenue climbed significantly strong demand laboratory instrument well consumable product service contributed growth rate change constant currency group management report business development lab product service earnings product sale reporting period lab product service lab product service division extensive range division achieved underlying ebitda million premium laboratory instrument consumables relative million year ago development service make attractive partner research essentially due moderate expansion sale quality assurance laboratory industrial revenue result portfolio cleaning accordingly academic sector division consolidated division underlying ebitda margin range past two year phasing compared year earlier thus reached nonstrategic product line portfolio guidance adjusted toward middle year also streamlined brand strategy based actual sale progress margin origi nally projected reach approximately division sell product three channel sale distribution specialized lab product service underlying ebitda laboratory dealer already well established ebitda margin direct sale ebusiness activity expanded underlying ebitda underlying ebitda margin userfriendly operating concept restated sartorius develops refines product helping laboratory work efficiently comply reporting year extraordinary item amounted official regulatory requirement automated data million million management play essential role context new generation electronic pipette example consequently record measurement result mainte nance history entry similar data la boratories regulatory sector submit regular verification pipette integrated common laboratory information system measurement result automatically availa ble centrally new device moreover eliminate certain manual hence errorprone step alto gether new device typically equipped intui tive user guidance assistance system make operation easier efficient even less suscep tible error service competitive edge sartorius offer wide range service covering entire life cycle product device installa tion commissioning verification calibration regular maintenance repair service limited sartorius instrument include device manufacturer well extensive range interest many customer looking mini mize number service provider use duce complexity cost impetus growth service business come sector like pharmaceutical industry quality standard high regulatory requirement increasing group management report business development lab product service sartorius opened two additional calibration lab research development pipette laboratory balance india singapore reporting year well commissioned new lab division core area technical expertise application laboratory shanghai customer include weighing technology mechatronics soft test product take training course ware development laboratory instrument manufac turing well membrane technology injection molding process consumables additional com expanding direct sale ebusiness plementary expertise technology liquid handling come aboard result acquisition sartorius enjoys strong presence lab equip division rd team centrally located ment market overall doubledigit market share goettingen site rd activity company instance historical reason share acquired kept original site still vary considerably product group approach brings sartorius benefit collaboration region situation present significant potential across technology site growth existing portfolio division accordingly launched series multiyear product development priority sartorius initiative addressing different area fiscal year ended included standardized intuitive user interface laboratory equipment associated past two year sartorius integrated new concept already implemented bal sale service team formerly separate busi ances moisture analyzer laboratory water purifi ness activity trained sale staff promoting cation system design work entire product range company also began instrument progress field particular rolling new crm system covering region interest include data management process auto division provide access uniform data mation example activity area include base sale team ongoing development qapps special program customerspecific guide lab staff lab division effort build direct sale key weighing process send correspond account benefiting substantially pharma ing data laboratory management system ceutical biotech sector close customer relationship established contact developed sartorius collaborates closely industrial bioprocess solution division major research insti academic technology partner addition pursuing tutions also served directly field sale staff mem rd fraunhofer application center bers relieved number administrative plasma photonics joined extensive research duty enabling focus closely contact network germany reporting year sartorius customer also involved member smartlab working group design laboratory future sartorius building ebusiness activity presented lab technology trade fair labvolu enhancing quantity quality product tion sartorius stepping collaboration information provides electronic channel international partner notably universi well boosting electronic sale expansion tie china ebusiness intended primarily simplify order ing process lab distributor help u reach cu sartorius invested million rd lab tomers directly served sale operation product service division reporting year million rd ratio increased year ago group management report business development lab product service production supply chain management lab product service division operates plant germany china finland uk u plant also serve center competence conse quently tend focus one product group small set product group laboratory balance manu factured goettingen beijing example pipette made helsinki souzhou site kit microbiological test produced stonehouse membranebased product manufactured goettingen capacity expanded sartorius invested creating additional production capacity number site reporting year new machinery enhanced process pipette tip manufacturing place since summer kajaani plant finland addition construction new laboratory instru ment production facility began october goettingen site two plant separate site goettingen combined new building part sartorius campus project calibration center prototype manufacturing unit training workshop also integrated sartorius invested efficient logistics like bioprocess solution division lab product service u logistics center sartorius along joint venture partner built goettingen shipping product supplying manufacturing oper ations future division deliver product customer asia centrally distribution hub suzhou china group management report discontinued operation discontinued operation industrial technology order intake sale revenue industrial weighing division leading supplier following weak start fiscal industrial industrial weighing control equipment focus technology division recorded positive performance ing premium segment pharmaceutical year progressed order intake thus increased food industry sartorius decided ex million million growth sale amine option including sale business revenue slightly less dynamic due timing effect high investment would necessary related completion contract whole sale ensure sustained positive development revenue industrial technology division rose division especially outside europe reporting million million thus year business therefore carved legal reached lower end guidance range ly independent subgroup december rate change constant currency signed contract sell industrial technology division accordingly business reported europe region contributing highest share discontinued operation requirement ifrs around division sale revenue international financial reporting standard strong prioryear base sale reve nue asia pacific accounted around key figure industrial technology industrial technology business million reporting year previous year figure attributable soft demand particularly order intake beginning year review business expanded sale revenue briskly north america generated around underlying ebitda division total sale region sale reve sale revenue nue surged rate change constant employee dec currency restated earnings reporting year industrial technology divi sion signficantly increased earnings positive product mix effect primarily contributing result therefore division underlying ebitda surged million million earnings margin improved accordingly higher forecast group management report annual financial statement sartorius ag note based hgb annual financial statement sartorius ag note based hgb retained profit sartorius ag key reference earnings value payment dividend shareholder whereas sartorius group financial statement sale revenue sartorius ag consists essentially drawn according international financial cost transfer affiliated company within group reporting standard ifrs annual financial management service rendered statement sartorius ag prepared applying rule regulation german commercial item operating expense includes consult code hgb ing expense million related contract sell industrial technology division management report sartorius ag signed reporting year among expense group management report fiscal com bined hgb annual financial statement income investment million relative sartorius ag combined management report million concern dividend paid published simultaneously german federal french subsidiary sartorius stedim biotech sa gazette bundesanzeiger well sartorius mechatronics th based hamburg germany profit loss transfer agreement sartorius lab holding gmbh sartorius corporate business operation corporate strategy administration gmbh resulted receipt profit corporate management oversight million compared million overview business development sartorius ag exercised function net worth financial position strategic groupleading management holding entity sartorius group since beginning fiscal balance sheet total sartorius ag rose refer connection explanatory million reporting year million remark concerning business operation corporate increase primarily attributed con strategy corporate management oversight well clusion new syndicated loan agreement part overview business development presented agreement sartorius ag taken page et seq combined management report financing entire group since transaction sartorius ag group borrowed fund also transferred company sartorius stedim biotech subgroup internal group loan agreement cash pooling account balance sheet structure sartorius ag reflects function management holding entity sartorius group fixed asset consist essentially financial asset reporting year amounted million previous year million accordingly fixed asset account balance sheet total previous year equity ratio decreased due increase balance sheet total previous year group management report annual financial statement sartorius ag note based hgb statement profit loss sartorius ag based total cost accounting method according section subsection hgb k sale revenue operating income employee benefit expense depreciation amortization operating expense income investment profit received profit loss transfer agreement loss accepted profit loss transfer agreement earnings interest tax interest similar income interest similar expense profit tax income tax expense tax net profit period profit brought forward retained profit incl net profit period hgb german commercial code group management report annual financial statement sartorius ag note based hgb balance sheet sartorius ag according hgb k asset dec dec fixed asset property plant equipment ii financial asset b current asset trade receivables ii cash hand deposit bank c prepaid expense equity liability dec dec equity subscribed capital nominal value treasury share issued capital ii capital reserve iii earnings reserve iv retained profit incl net profit period b provision c liability deferred tax liability hgb german commercial code group management report annual financial statement sartorius ag note based hgb proposal appropriation profit risk opportunity executive board submit proposal opportunity risk affecting business annual shareholder meeting appropriate development sartorius ag management retained profit reported holding entity essentially equivalent sartorius ag year ended december sartorius group sartorius ag share risk follows investment subsidiary exposed proportion extent investment expedient feasible adopted countermeasure arranged balance sheet measure payment dividend reporting year cover discernible risk within per ordinary share sartorius ag potential damage net payment dividend worth financial position profitability per preference share unappropriated profit carried forward detailed opportunity risk report sartorius group provided page de scription internal control risk management system page research development detailed information research develop report material event ment activity sartorius group division given page et seq et seq please refer page read report material event sartorius ag sartorius group employee forecast report sartorius ag employ staff disclosed pursuant section hgb earnings trend sartorius ag depend substantially progress subsidiary hence sartorius group development sartorius group business discussed forecast report page group management report opportunity risk report opportunity risk report every business activity entail opportunity risk planning medium longerterm opportunity managed skill tracked systematically part strategic planning done go long way determining future devel status opportunity management permanent opment company shareholder value manag fixture corporate management system mean ing risk opportunity sartorius aim identify also feature discussion decision use business opportunity systematically well making process toplevel management recognize evaluate risk early stage executive board supervisory board take measure counter possible unrealistic expect risk management eliminate key area opportunity presented risk rather approach intentionally appropriate reference made relevant section take certain measure risk business activity group management report order avoid order successful unlocking opportunity repetition risk presented section however endeavor important keep risk specific risk represent opportunity event contained within acceptable limit control develop opposite positive direction carefully reason discus opportunity section specific risk opportunity end sartorius single unit tasked identifying chapter managing opportunity risk instead pre fers make function integral component groupwide planning control system described area opportunity internal control system compliance department responsible development supplier pharmaceutical laboratory group risk management system including industry sartorius operates futureoriented organization respective reporting process highgrowth sector significant opportunity generated various market technology trend described detail section entitled managing opportunity sector condition outlook sector page et seq page et seq opportunity management center analysis target market sector environment well assessment rank company one glob assessment trend give strong al market leader many subsegments product indication future business opportunity area believe high quality product identification potential development strong brand recognition established customer context one key role relevant manag relationship give u strong opportunity continue er initially take place local rather extending market leadership corresponding central level marketfacing function division strategy growth opportunity strategic marketing product management initiative based discussed section individual division play leading role respect strategy bioprocess solution division central business development unit additionally begin page section support area market monitoring data strategy lab product service division analysis implementation strategic project start page part strategy review member group strict management process cost provides executive committee regularly meet manag opportunity increase profitability key er operational responsibility business target area respect include continued en development unit discus short medium hancements procurement chain ongoing longterm opportunity potential various busi effort optimize production present ness area subsequent step prioritizing page opportunity evaluating business management perspective deriving strategic measure opportunity discussed context allocating resource proceed accordance presentation specific risk opportunity begin standardized decisionmaking process applies ning page throughout group opportunity short term nature considered annual budget group management report opportunity risk report risk management urgent reporting procedure place ensure new emerging significant risk opportunity management overall responsi net worth financial position profitability bility maintenance effective risk man identified estimated involving million agement system ensuring comprehensive higher executive board sartorius ag receives consistent management material risk rest necessary detail without undue delay executive board coordinating developing system responsibility central internal control system compliance department super risk classification visory board sartorius ag monitor effective ness risk management system first level risk management relates four preparatory work necessary per main risk category defined sartorius external risk formed audit committee furthermore operating risk financial risk corporate govern carrying statutory audit mandate ance risk annual financial statement consolidated financial statement independent auditor examine wheth second level consists additional subcategories er early warning system place capable within main category legal risk pro prompt identification risk could put fu duction risk receivables risk organizational risk ture company jeopardy process also includes allocation functional category example supply chain sale distri risk management system risk reporting bution human resource accordance group structural organization heart risk management system sartorius group risk management handbook categorize risk according scale applies throughout entire group organization implication also perform specific evalua handbook includes definition frame tion risk assigned value work structural organization process risk maximum impact time risk analysis porting monitoring control word record maximum risk without consider effectiveness risk management system based ing probability occurrence effect risk internationally recognized coso standard mitigation measure also number source contain stipulation handling risk including article association rule procedure specific risk opportunity group company internal guideline groupwide risk reporting system form corner general macroeconomic risk stone internal risk communication object opportunity make possible address risk structured con tinuous manner document accordance nature various business area mean relevant statutory regulatory requirement sartorius whole insulated certain extent full force wider cyclical effect prescribed reporting process requires head macroeconomic effect little bearing central department managing director progress bioprocess solution division group company review risk situation within particularly relevant lab product service area responsibility ongoing basis division represent risk latter growth report finding every quarter new organiza context economic development prove tional unit joining consolidated group company positive expected turn additionally successively integrated reporting process stimulate stronger growth lab product service involves evaluating specific risk probability occurrence scale potential impact well ability foresee mitigate direct reporting case central risk management unit indirect effect risk broader sense example whenever defined threshold breached currency crisis natural disaster associated damage commercially significant critical infra structure limited group management report opportunity risk report risk discussed section consider production risk opportunity probability occurrence low medium ing case occurrence significant manufacture large proportion sartorius group whole individual product belong core area technical group company expertise involve high level vertical integra tion example include filter laboratory balance product reusable fermenters bio supply chain risk opportunity reactor manufactured collaboration sup plier production risk supply chain extends way procure transferred external third party manu ment production sale distribution problem facture product also bear associated within sequence consequential effect risk capacity bottleneck overcapacity production including delay delivery global supply chain downtime excessive reject rate high level management system instituted throughout tiedup working capital contain reduce production process prevent problem risk planning production capacity carefully using largely minimizes associated risk analyzing versatile machine semiautomated individual work controlling operation involved strongly station flextime work schedule continu international alignment organization open ously monitoring production process moreover whole series opportunity various risk global manufacturing network enables u compensate opportunity encountered within supply capacity bottleneck shifting production chain explained detail regional plant regard probability occurrence concerning procurement risk opportunity risk described low risk happen occur significant individual group purchase wide range raw material compo company nents part service supplier conse quently exposed risk unexpected delivery consider opportunity various pro bottleneck price increase global supply duction facility able concentrate specific chain management system reduces risk ena production technology result enhance bling u monitor supervise procurement activi production operation greater efficiency tie moreover conduct regular supplier review ternational production network also make possible also use early warning system continued capitalize cost advantage offered indi increase number framework agreement con vidual site furthermore continuous improvement cluded safeguard supply supplier strate production simplifying process increas gically important raw material fiscal ing level automation help drive efficiency addition always maintain reserve inventory even higher strategic raw material work alternative supplier possible sale distribution risk opportunity present see low probability occurrence risk described risk happen occur use variety channel sell distribute likely limited significance product around world potential risk entailed sartorius group unexpected change demand structure growing price pressure noncompliance supply opportunity arise area procurement agreement concluded customer employ growth enables u increase order quanti targeted market analysis identify emerging demand tie thereby strengthen position trend individual segment early supplier increased globalization supplier pool time respond appropriately technical innova hold prospect purchasing favorable tions focus less pricesensitive sale term moreover also possibility market product validated production expanded purchasing activity international process biopharmaceutical industry reduce market leading u identify supplier special exposure risk growing price pressure product technical expertise could eventually minimized risk exposure area logis enhance competitive edge tic recent year setting using central warehouse optimize distribution logistics group management report opportunity risk report area well probability risk occur quality requirement growing ring low medium according estimate stringent time least result regulato case occurrence significant ry pressure actually regard first fore sartorius group whole individual risk opportunity open group company new market prospect also challenging quality de mands represent considerable barrier entry opportunity arise area sale distribu potential new competitor provide stimulus tion increasing breadth product range technical innovation actively bioprocess lab segment put u respond position sell new product existing customer business relationship estab lished long term global presence rd risk opportunity provide opportunity moreover ongoing project strengthen direct sale especially lab devote considerable share resource segment also promise enhance sale prospect research development potential risk area may arise development result diverge market need exceeding planned development dead quality risk opportunity line unintentional transfer knowhow com petitors advanced project management intensive customer use sartorius product wide range rd controlling early involvement custom critical production process including manu er development process substantially limit facture pharmaceutical food chemical rd risk patent continuous tracking research development laboratory main technology competitor relevant u secure risk encountered area noncompliance technology position agreed quality criterion lead loss customer may made liable reason see low probability pre compensation claim employ rigorous quality sent risk described might occur check stateoftheart production method case could significant process cleanroom technology ensure sartorius group whole product satisfy stringent quality requirement manufacturing method pro hand rd sphere also offer num cesses subject constant review con ber potential opportunity intensive collabora tinuous improvement process moreover tion partner rank among global market refined appropriately requirement evolve leader field open opportunity successful completion host annual audit u jointly develop innovative product customer accreditation iso especially high level innovation area iso together document high level quality membrane technology well weighing technology achieved sartorius product process irrespec turn expertise specialist put u tive measure also maintain significant forefront global research development insurance coverage product liability risk present u opportunity turn tech sartorius established traceability system nical knowledge potential sale even enables u recall entire production batch imme stronger position market diately necessary minimize adverse conse quences event defect discovered product customer risk opportunity consider probability occurrence sartorius source key customer pharma risk described low case ceutical chemical food industry occurrence significant sartorius group search educational institution public whole individual group company sector customer usually relatively large organization existence time strong credit rating busi ness area highly diversified customer base group whole dependent individual key account significant degree factoring program additionally place keep group management report opportunity risk report risk exposure trade receivables customer acquisition risk opportunity constant low level work continuously improve receivables management nature acquisition provide many opportunity sale growth extension product portfo present see low probability lio development new market contrast risk associated customer might occur purchase sale company part company case occurrence would likely lim entail number inherent risk incorrect ited significance sartorius group whole valuation assumption insufficient usage antici individual group company pated synergy effect prevent risk take various measure particular acquisition process performing standard due diligence competitive risk opportunity review addition involve external consultant expert purchase sale process early sartorius leading competitive position possible especially focus drafting transaction market competitor larger contract adequately counter risk u share status globally operating especially clause assuring specific characteristic company example include emd millipore pall contractual warranty guarantee provision mettlertoledo serve large number cu well agreement mechanism adjustment tomers highly regulated sector like pharma purchase price liability clause immediately ceutical food industry technology acquisition taken place integration barrier market entry substantially high phase initiated potential risk regard risk new competitor emerging low likewise detected early possible prevented furthermore global presence significantly miti minimized taking appropriate counteraction gate regional risk consider probability occurrence change competitive environment example risk described low case consolidation market pose opportu occurrence significant sartorius group nities risk sector find whole individual group company ongoing process change sartorius remains active participant made acquisition continuously recent year reinforce market personnel risk opportunity position open new potential synergy innovative technology group sartorius employ consider probability occurrence large number highly qualified people possible risk described low case scarcity required specialist represents oppor occurrence likely limited significance tunity well risk instance company sartorius group however cannot entirely ruled prof particularly good training retain risk might significant individual ing staff counter threat demo group company graphic change losing employee especially key position offering performance related remuneration model targeted continuing professional development option attractive social benefit continuous education training junior staff member within organization interesting people development opportunity success measure apparent low attri tion rate recent year many year sen iority people accumulate average employment contract certain case contain clause prohibiting move direct competitor reason regard probability risk occuring low risk happen occur likely limited importance sartorius group whole group management report opportunity risk report financial risk opportunity anticipated net currency exposure foreign currency level make policy hedge global nature sartorius group operation exposure advance following mean business activity inevitably ex month hedging transaction set one group posed financial risk significant staff monitored another separate group aside risk associated group accounting exchange rate risk interest rate risk liquidity risk described addressed interest rate risk opportunity detail note consolidated financial statement vice versa financial risk concluded fixed interest agreement notably exchange rate risk interest rate risk portion outstanding loan eliminate risk balanced opportunity approximately equal posed variable interest payment however magnitude financial instrument outstanding reporting date subject interest based market rate consider probability occurrence almost twothirds currently covered risk described following low risk happen interest rate swap interest rate risk opportu occur significant sartorius group nities apply remainder monitor interest whole individual group company rate trend interest rate exposure constantly facility arrange additional hedging transaction consider necessary eco risk associated group accounting nomically advisable individual loan except general typical risk inherent accounting process specific risk concerning group liquidity risk opportunity accounting discernible typical accounting error connection example incorrect discre sartorius group actively manages liquidity central tionary decision measurement asset ly order check minimize liquidity risk liability use various common standardized optimize liquidity management within organization control mechanism integrated accounting use various long shortterm financial instru process ensures error recognized ments purpose corrected early stage syndicated credit facility place far sartorius ag sartorius stedim biotech subgroup exchange rate risk opportunity refinanced ahead schedule december based highly attractive market condition pre generate around half consolidated sale reve vailing time financing structure nue foreign currency twothirds total converted holding company group revenue u dollar currency pegged wide financing sartorius ag subsidiary financed u dollar positively negatively impacted primarily financing contract within group currency effect especially converting cur rencies balance sheet item profit loss item shortterm liquidity procurement also employ respectively largely compensate general risk various measure addition credit line resulting impact individual foreign curren accessed repaid short notice cies taken number measure besides number bilateral credit line place smaller hedging currency global production network scale individual group company furthermore thus enables u offset lion share sale reve use cash pooling agreement selected group nues received foreign currency within group company primary tool manage liquidity cost likewise incurred foreign currency within group example manufacture many product north american market locally therefore disadvantaged way competition regulatory risk u rival continuously monitor exchange rate net currency exposure ie propor role supplier biopharmaceutical indus tion foreign currency sale revenue try health care provider mean sartorius main settled cost use also affected underlying development derivative financial instrument notably spot area possibility regulatory authority fda forward swap transaction basis current emea adopting restrictive approach group management report opportunity risk report approval new medication remains principal opportunity especially relation efficiency gain source risk context move would standardization harmonization business reduce number new pharmaceutical product process worldwide marketed would consequently downgrade future prospect sartorius medium term believe low probability occurrence risk mentioned case occurrence significant sartorius group environmental risk whole sartorius established environmental manage ment system encompasses integrated process risk division cover whole series environmen tally relevant regulation minimize environmental legal dispute proceeding could risk management system certified substantial negative impact group result compliance iso company relatively allowance made balance sheet large manufacturing site respective company cover cost potential proceeding organizational unit ensure particular site law regulation relating environmental protection observed technical insurance possibility limiting environmental risk identi fied ongoing basis taken insurance policy cover wide range risk possible economically advisa assess probability occurrence environ ble insurance policy include coverage mental risk low case occur liability business interruption transport material rence significant group company pecuniary damage risk provide com affected prehensive coverage legal cost independent department working conjunction external insurance broker regularly review nature risk opportunity extent insurance protection make adjustment necessary besides risk already described sartorius group exposed potential risk area sult pronounced dependence system assessment overall risk situation risk since errorfree operation essential outlook smooth functioning company business pro cesses reduce security risk continuously expedient feasible adopted countermeas enhancing implementing security guideline ures arranged balance sheet measure policy rule measure based reporting year cover discernible risk within requirement iso standard sartorius group potential damage german federal office information security bsi net worth financial situation profitability standard furthermore company existing application system checked potential judge probability occurrence risk risk regular external internal audit presented low case appropriate measure taken minimize risk occurrence significant sartorius group identified continuous alignment strategy whole individual group company business strategy tracking new technical development use advanced hardware thorough analysis entire risk situation software minimize risk inherent operation according current review discernible system environment new erp system risk present could jeopardize continued commissioned sartorius goettingen group existence group headquarters successively rolled group site around world starting similarly based current review conducting project continued focus discernible risk could jeopardize future controlling risk involved maintain existence group ing precautionary backup system implementa tion new system brings whole series group management report forecast report forecast report future macroeconomic environment japan expect another year moderate expansion economic output according imf based forecast provided imf global indicates growth rate economy gain momentum growth forecast based large part anticipated economic progress u future exchange interest rate trend positive outlook imf caution subject though high level risk least connection expert assessment suggest another year geopolitical tension low base rate additional measure provision liquidity bond repurchase pro gram euro zone example also forecasted gdp growth rate mooted forecast eurous dollar exchange rate course range euro u dollar euro u dollar source international monetary fund world economic outlook october reuters forex poll november outlook sector global euro area u japan asia strong growth prospect pharmaceutical asia china india asean indonesia malaysia philippine industry thailand vietnam future global pharmaceutical industry source international monetary fund driven large part constantly expanding aging global population increasing access imf expects rate economic growth healthcare emerging developing country u pick strongly general increase prevalence lifestyle fueled continued expansionary chronic disease new medication especially monetary policy ongoing recovery u targeting condition currently difficult real estate market treat also fuel significant growth expiry patent austerity measure cut healthcare euro zone expected register minor gain spending particular industrialized country economist predicting moderate growth hand tend slow future growth imf predicts even industry expansionary monetary policy adopted euro zone slight positive impact ger market researcher ims health forecasting many expected see growth overall growth global economic activity france forecast pick pharmaceutical industry period increase compared italy saw economic output contract expected register growth imf forecast asia region suggests growth compared prior year helped part development china economy expected expand growth economy india forecast increase group management report forecast report u pharmaceutical market expected emerging country still driving growth post solid growth expansion pharmerging market contrast u pharmaceutical market world largest remain average around per expected register growth annum period rapid growth average period driven demographic trend expansion driven principally continuous also notably rising level state investment rollout state health insurance demographic change healthcare system increased private spending price increase especially among fastexpanding middle class thus share global pharmaceutical market accounted pharmerging market likely moderate growth europe japan increase next five year approxi mately growth european japanese pharmaceutical market likely remain moderate next year continuing austerity measure impact respective healthcare system pronounced longterm trend deliver better average growth biopharmaceutical industry global trend pharma market sector trend q aging population q average growth q patent expiry western country q increasing cost pressure eg q increasing population due healthcare reform improved access health care biopharma market developing economy q growing number chronic q average growth trend toward biotech civilization disease q continued market penetration approved indication technology trend singleuse technology q label expansion q higher yield efﬁciencies q doubledigit growth q personalized medicine cell cultivation q highest growth innovative q biosimilars q availability innovative segment eg bioreactors singleuse technology ﬂuid management q strong pipeline eg mabs q higher ﬂexibility change manufacturing system multipurpose source ims global use medicine outlook evaluate pharma world preview outlook june bioplan th annual report april biotech sector still growing faster medication vaccine manufactured using biotech market whole method expected rise today figure around approximately peri expert forecast suggest biopharma segment od pharmaceutical market enjoying particularly strong growth year continue continued exceptional growth driven outperform market whole going forward part biopharmaceuticals already gained proportion sale revenue accounted approval increasing market penetration group management report forecast report expanding range indication part whole series patent ims health report segment persistently strong research develop sale come known biosimilars ment pipeline proportion new development biobetters likely swell based biological manufacturing process partic u billion ularly high around expert expect biotechnology market whole expiry patent significant factor tradi grow around average tional market likely increasing effect growth biotechnology market noting expiry biopharma growth market proportion global pharmaceutical sale revenue rx otc area biotechnology conventional production technology compared biotech share within top product bn bn bn biotechnology conventional unclassified split biotech n avg bn conv n avg bn source evaluate pharma world preview outlook june publicsector research demand stabilizes slight growth chemical industry ongoing widespread reduction national budget european chemical industry council cefic ex likely affect overall level demand pects chemical industry europe expand public sector however according following moderate increase frost sullivan important u market likely production slightly lower growth stabilize current year thus global demand attributed tailingoff inventorybuilding activity public sector may broadly flat source ims global use medicine outlook ims searching terra firma biosimilars nonoriginal biologics market evaluate pharma preview june bioplan th annual report april midyear report forecast analysis global market laboratory product cefic chemical industry benefit general economic recovery june group management report forecast report outlook sartorius division outlook incorporates potential op bioprocess solution division forecast portunities risk outlined annual report sale revenue full year rise signifi following forecast provided assump cantly assuming trend toward biomanufac tion economic activity relevant sector turing pharmaceutical increasing utilization trend develop described singleuse technology continue see page et seq accordingly project sale revenue increase relative strong com sartorius group parative base prior year also plan crease division underlying ebitda margin management expects sartorius group around figure constant currency achieve significantly profitable growth year well thus anticipate fullyear sale lab product service division serf sector grow group underlying ebitda whose dependency economic cycle varies therefore margin increase around figure division partly depends general develop constant currency ment economy due strained public budget geopolitical risk outlook europe sur moreover planning invest around rounded exceptionally high level uncertainty sale revenue investment include lab product service division expect multiyear project consolidate extend sale increase approximately group headquarters goettingen well expand whole assuming economic momentum pick production capacity continue international slightly see page view profitability rollout new erp system striving achieve underlying ebitda margin around figure constant currency regard financial position forecast end ratio net debt underlying ebitda remain level year end provided target mentioned earlier achieved proceeds sale industrial technology help contribute decrease without possible change product portfolio considered group management report report material event report material event sale industrial technology divsion japanese minebea co ltd partner development bank japan inc completed february become economically effec tive january cash proceeds resulting transaction total approximately million group management report description key feature internal control risk management system description key feature internal control risk management system relation group accounting process sec statement group bookkeeping external tion subsection section subsection reporting includes operational risk manage german commercial code hgb ment involves activity transfer risk insurance company coverage damage liability risk arrangement definition element internal control suitable hedge limit currency interest rate risk risk management system sartorius group monitoring system operated sartorius group early groupwide detection risk internal control system sartorius ag potential jeopardize company continued exist sartorius group encompasses principle ence defined section subsection procedure measure adopted ensure organi german stock corporation law aktg efficacy zational implementation management decision early risk detection system sartorius main priority system relates sartorius ag group adapts promptly response relevant group accounting process make sure change circumstance assessed independ accounting effective costefficient formally ent group auditor accordance section correct complies pertinent legal subsection german commercial code hgb provision regular system review also carried verify system remains functional effective internal control system sartorius ag sartorius group consists combination pro cessintegrated nonprocessintegrated monitor use system ing measure processintegrated safeguarding measure subdivided turn organizational transaction relevance accounting measure four eye principle double recorded individual financial statement verification access restriction relation subsidiary sartorius ag using software system control measure manual target actual used worldwide process preparing check programmed plausibility check consolidated financial statement sartorius ag software used supervisory board case group company add supplementary information specifically audit committee sartorius ag individual financial statement create stand internal control system compliance unit ardized reporting package submitted group auditing department involved group company consolidated reporting sartorius group internal control system system sartorius ag consolidated financial state nonprocessintegrated audit activity ments prepared using consolidation rou tine consolidated reporting system independent group auditor auditing developed sartorius ag authority also play role control environment supplemented manual adaptation inhouse sartorius group nonprocess auditor independent group auditor sarto integrated audit activity particular review rius ag regularly verify reporting package consolidated financial statement inde submitted consolidated reporting system concur pendent group auditor audit indivi individual company financial statement dual financial statement sartorius group audit based case consol company included consolidated financial idation procedure necessary prepare consolidat statement constitute key nonprocessintegrated ed financial statement sartorius ag monitoring measure relation group consolidation investment elimination inter accounting process company payable receivables elimination intercompany revenue expense performed finance unit represents another important element using documented consolidated reporting internal control system analysis system component sartorius ag consolidated monthly report subsidiary financial statement including detail presented note developed using consolidated risk management system concentrate con reporting system also provides wide range text group accounting primarily risk mi analysis option group management report description key feature internal control risk management system key supervision control activity ensure sartorius group accounting rule also govern proper reliable group accounting specific formal requirement placed consolidated financial statement include mandatory use internal control system measure designed standardized complete reporting package maintain proper reliable group accounting ensure group accounting department assist local unit transaction recorded full timely resolving complex accounting issue measur manner accordance applicable provision ing fair value ensure consistent accurate law article association addition porting consolidated financial statement measure ensure inventory taken properly asset liability recognized scope regulation group level also extends assessed reported appropriately consolidated central definition measurement rule para financial statement meter among factor additional data presentation external information note employee involved accounting process group management report also prepared aggre meet qualitative standard receive regular training gated group level duty responsibility clearly assigned dif ferent specialized unit company regional unit specific control activity performed ensure segregation duty foureyes principle proper reliable group accounting encompass ie review two individual strictly imple analysis applicable correction indi mented complex evaluation actuarial report vidual financial statement submitted sartorius company valuation purchase price allocation group company line report authored assigned specialized service provider involve independent auditor reporting package contain specially qualified inhouse staff ing error identified corrected group level basis large number control mechanism example control activity performed ensure already incorporated consolidated reporting proper reliable accounting include analysis system impairment test conducted centrally situation development reference specific specific cashgenerating unit known cgus key indicator separation administrative ex group perspective ensure consistent ecutive settlement approval function reduces standardized evaluation criterion applied possibility fraud organizational measure also intended record company groupwide manual company internal control system restructuring step change nature focusing company business process operation individual business area promptly drafted involving group financial auditor accurately group accounting finally internal contribute toward strengthening control system also ensures change ternal control ic system based current rule sartorius group economic legal environment manual combine icsrelevant requirement mapped new amended legal provision business process define one stand applied group accounting ardized document first time supple mented appropriate control necessary sartorius group accounting principle govern standard recognition measurement principle german nongerman company included qualifying statement sartorius consolidated financial statement addition general recognition principle internal control risk management system method rule applied statement finan enables complete recording processing evalu cial position statement profit loss note group ation companyrelated matter basis management report statement cash flow organizational control monitoring structure segment report established compli defined sartorius group well ance eu legislation primarily accurate presentation group accounting ifrs german commercial law group management report description key feature internal control risk management system particular decision based personal judgment erro neous control criminal act circumstance impair efficacy reliability ternal control risk management system place cannot ruled however even application throughout group system adopted cannot provide absolute assurance accurate complete timely recording matter group accounting statement made relate solely subsidiary included consolidated financial statement sartorius ag whose financial business policy sartorius ag directly indirectly determine order obtain benefit activity group management report explanatory report executive board explanatory report executive board disclosure pursuant section subsec according mandatory announcement dated april tions section subsection german biorad laboratory inc alfred nobel drive commercial code hgb hercules california usa voting right biorad laboratory gmbh heidemannstr composition issued capital limitation munich germany ascribed according sec voting right tion subsection sentence german security trading act wphg hold sartorius ag capital stock total vote voting right sartorius ag comprises par value individual bearer share ordinary share appointment dismissal executive board nonvoting preference share member amendment article share certificate represents calculated proportion association issued capital executive board member sartorius ag nomi right obligation associated share nated appointed well dismissed ac governed provision german stock cordance section et seq german stock corporation law aktiengesetz abbreviated aktg corporation law aktg section according company article association german codetermination law mitbestimmungsgesetz preference share entitled dividend payment abbreviated mitbestg amendment sartorius ag higher dividend payment ordinary article association regulated section share amount equal preference german stock corporation law aktg share calculated proportion issued capital ie two euro cent per share case dividend power executive board issue share entitlement shall least preference share calculated proportion issued capital ie subject approval supervisory board four euro cent per share apart case pro executive board authorized sell treasury share vided section german stock held corporation including selling corporation law aktg preference share non channel stock exchange voting however grant right tendering offer shareholder proportion every shareholder entitled participation company provided share offered within scope acquiring com company hold ordinary share panies shareholding company return preference share entitle circumstance preemptive right company membership right shareholder excluded direct indirect equity ownership exceeding material agreement clause regulating voting right event change control community heir consisting mr u baro sartorius ag two material agreement containing resident munich germany mr c franken resident clause regulating possible event change bovenden germany mr franken resident control one syndicated loan agreement concluded riemerling germany mr kc franken resident current volume million goettingen germany mr k sartoriusherbst term december note resident northeim germany hold voting per loan schuldscheindarlehen placed centage approximately sartorius ag volume million maturity term five vote according list attendee ten year respective clause customary annual shareholder meeting april market give participating lender op decedent horst sartorius ordered tion extraordinary termination event executed appointed executor prof change control dr dres hc arnold picot resident gauting germany exercise specified voting right circumstance beyond disclosure made pursuant discretion defined section subsection subsection subsection sentence german security trading hgb exist known act wertpapierhandelsgesetz abbreviated wphg group management report corporate governance report corporate governance report executive supervisory body sartorius ag remark concerning corporate governance guided action principle trans parent responsible corporate governance reporting year executive board executive board supervisory board report supervisory board dealt issue raised corporate governance pursuant article revised version german corporate governance german corporate governance code code dated june change code essentially referred model table management board member remuneration declaration executive board implemented full extent furthermore su supervisory board sartorius ag concerning pervisory board reviewed whether compensation recommendation government executive board member appropriate commission german corporate taking account level compensation governance code pursuant paid peer company compensation place german stock corporation law aktiengesetz within area company supervisory board determined executive board member executive board supervisory board declare remuneration appropriate full compliance achieved recommen dations made government commission target composition supervisory german corporate governance code published board defined continue apply german federal ministry justice official section electronic german federal gazette elektronischer woman make less bundesanzeiger amended june supervisory board since last year declaration compliance issued independent member shall account less sartorius ag complied recommendation supervisory board valid version government commission german corporate governance code full extent aim selecting candidate international experience international background goettingen december considered previously making appoint ments supervisory board supervisory board executive board upper age limit time election taken consideration may waived exceptional case provided reservation suitability person pro posed election expedient interest company spite age limit prof dr dres hc dr joachim kreuzburg exceeded arnold picot company already meet target target proportion woman supervisory board somewhat higher proportion woman management position within sartorius group corporate governance statement accordance section german commercial code hgb following present detail concerning mode operation executive board supervisory board governance measure employed company accordance section german commercial code hgb group management report corporate governance report mode operation executive board interest aim creating sustainable value supervisory board executive board provides supervisory board regular prompt detailed report writ sartorius ag company german law founded ten oral relevant corporate planning dual management system executive strategic development issue progress board supervisory board group business significant transaction dis independent competency cussed depth full supervisory board ac cordance rule procedure executive supervisory board comprises twelve member board rule procedure executive board defined german codetermination law mitbe additionally define legal transaction may stimmungsgesetz equal number share effected without approval supervisory holder representative employee representative board executive board supervisory board supervisory board monitor advises execu work closely together spirit mutual trust tive board management company detail management supervision company member supervisory board provided chapter executive board supervisory board page shareholder shareholder meeting supervisory board established four committee sartorius ag shareholder exercise right executive task committee audit committee company shareholder meeting shareholder conciliation committee nomination meeting held least year within first committee executive task committee audit eight month fiscal year shareholder committee conciliation committee four meeting decides matter member equal number shareholder responsible law representative employee representative executive task committee audit committee hold shareholder register due time may attend regular meeting conciliation committee shareholder meeting shareholder una nomination committee meet necessary ble participate shareholder meeting person may arrange vote cast bank executive task committee carry preparatory shareholder union proxy ap work resolution issue addressed pointed sartorius ag bound follow meeting supervisory board also look instruction issued different proxy preparation appointment including choice muneration employment contract condition member executive board audit committee assist supervisory board performance risk management supervisory function chairperson audit committee independent member supervi conscientious management commercial risk key sory board detailed knowledge extensive principle good corporate governance sartorius ag experience application accounting standard group disposal enterprisewide internal control system pro companyspecific reporting control system fessional practice conciliation committee meet designed facilitate recording assessment majority required connection appoint management commercial risk system ment member body authorized repre developed adapted continuously condition sent company legal purpose reached evolve executive board notifies supervisory nomination committee comprises representative board regularly existing risk development shareholder function propose audit committee concerned particular suitable candidate supervisory board monitoring following accounting process latter election proposal submitted annual including reporting efficacy internal con shareholder meeting information trol system risk management internal auditing individual meeting held reporting year system compliance independent statutory supervisory board committee given audit detail risk management presented report supervisory board page risk opportunity report executive board sartorius ag currently consists three member board full responsibility action managing company latter group management report corporate governance report transparency statement prepared executive board au dited independent auditor elected sartorius ag place great importance disclosing annual shareholder meeting approved consistent complete information promptly infor supervisory board mation economic position group new development consequently released regularly agreed independent auditor without delay becomes known order inform notify supervisory board directly participant capital market interested potential disqualification bias issue mate member public large annual report rial finding incident identified audit firsthalf financial report quarterly report also encompasses corporate governance published within timeframes specified porting duty pursuant section german purpose current development material event stock corporation law aktiengesetz publicized press release appropriate ad hoc announcement information usually made available german english simultaneously code conduct published via suitable medium internet central corporate culture sartorius ag chief recurring event publication understanding always conduct business annual shareholder meeting annual report sustainable manner compatible pertinent interim report listed financial cal economic environmental social imperative endar may viewed time group uniform code conduct applies across entire website group order ensure action con sistent throughout organization code conduct applies equally group share trading activity supervisory people whether member executive executive board member board managing director manager employee establishes defined standard formulated help user receive report applicable successfully navigate ethical legal challenge mandatory disclosure requirement purchase everyday operation interest employ sale share sartorius ag related financial ee company breach code instrument made member executive conduct investigated internal con board supervisory board person trol system compliance department established management responsibility related party purpose cause eliminated supervisory board chairman prof dr dres hc arnold information given sustainability picot hold approximately ordinary report pp et seq company internet share issued company capacity execu website wwwsartoriuscom tor estate horst sartorius otherwise member executive board supervisory board holding share financial instrument subject mandatory reporting requirement supervisory board executive board directly indirectly exceeds share issued company accounting independent statutory audit consolidated financial statement consolidat ed interim financial statement prepared ac cordance international financial reporting standard ifrs applied within eu annual financial statement sartorius ag prepared accordance german commercial law german commercial code hgb con solidated financial statement annual financial group management report remuneration report remuneration report main feature remuneration plan consolidated net profit hand executive board multiyear component depend value monetary sum ascribed executive board mem ber beginning year general fixed remuneration full supervisory board responsible establish consolidated net profit ing remuneration paid member execu tive board sartorius ag total value subordinate target basis assessment remuneration executive board member reflects consolidated net profit noncontrolling scope responsibility executive board terest excluding amortization impairment value member concerned executive board member intangible asset due business combination personal performance company economic situa pursuant ifrs target achievement assessing tion sustainable progress addition extent annual variable remuneration particular year amount remuneration typical review based average taken considered taking account peer company period three fiscal year beginning partic remuneration structure place area ular year review smooth amount company similar company remuneration paid partial payment amounting comprised fixed variable component target achievement first fiscal year reviewed annually ensure remains respective average period effected appropriate variable remuneration component payment result partial payment paid addition fixed base salary represent offset remuneration component fixed approximately half total remuneration exclud variable total target achievement ing pension commitment fringe benefit determined third fiscal year average case target achievement period cap component provided well variable remuneration phantom stock plan variable portion remuneration contains issue shadow share called phantom component paid annually deter stock executive board member treated mined multiyear performance assessment owner certain number share sartori category component making one u ag without however entitled receive half target achievement possible dividend development value phan tom stock linked development sarto annually paid variable remuneration rius share increase decrease share price taken account later value portion variable remuneration paid phantom stock assessed based share price annually based following weighted compo time equivalent paid provided nents sale revenue order intake underlying ebitda associated condition met phantom stock ratio net debt ebitda minimum target cannot traded entail share sub achievement required component scription right amount paid depends degree target achieved supervisory according sartorius phantom stock plan board defines setting individual subordinate executive board member credited beginning target cap provided variable component every year phantom stock unit valued paid agreed monetary sum value phantom stock paid entire annual tranche b variable remuneration based multiyear assessment payment requested earliest period four year later eight year one hand weighted component determined multiyear assessment depend degree executive board member entitled receive target achieved supervisory board payment phantom stock unit share defines setting subordinate target constituted price time payment request appre group management report remuneration report ciated least per year relative time old age invalidity well form phantom stock assigned share price survivor benefit surviving spouse child performed tecdax comparative index decedent phantom stock plan rule subsequent change parameter used comparative stock valuation member turned shall considered amount paid capped maximum regular age limit member shall auto time share price time phantom stock matically entitled receive benefit assigned based case actual annual tranche concerned remuneration component assignment phantom stock payment monetary equivalent depend mean value cal remuneration system provides supervisory culated average price class board sartorius ag discretion may grant sartorius ag share closing auction xetra executive board member special compensation based trading frankfurt stock exchange last member exceptional performance day trading previous year last day trading prior submission payment request serf compensate shortterm early termination executive board duty fluctuation share price event early termination executive payment phantom stock blocked four board duty employment contract executive week preceding scheduled publication date board member provide severance capped quarterly preliminary yearend result maximum two annual salary day trading stock exchange following actual publication quarterly preliminary year end result blackout period intended fringe benefit prevent executive board member profiting insider knowledge beyond remuneration component stated member executive board entitled use company car reclaim expense incurred pension commitment business travel covered accident insur ance insurance fringe benefit according company remuneration policy insurance provides application deductible executive board member sartorius ag receive excess amount required law performancerelated benefit commitment defined benefit plan reappointed first time addition including basic pension sharebased payment commitment provide executive board member make contribution variable earn rule remuneration policy executive board ings company match contribution member provide transfer sartorius bonus amount executive board member may ag share compensation member exception choose receive defined benefit form policy rule made december dr retirement pension old age onetime kreuzburg granted entitlement receive payment cover member retirement pension sharebased remuneration due third extension old age invalidity well form survi appointment member executive vors benefit surviving spouse child board chairman ceo please refer decedent section chapter beyond commitment executive board member additionally entitled former company pen sion scheme receive performancebased retirement benefit based salary german federal civil servant classified grade salary class b ministry official according federal civil service remuneration act bundesbesoldungsgesetz benefit paid form retirement pension group management report remuneration report remuneration executive board subject holding period end member reporting year november dr kreuzburg leave company prior november total remuneration active service request entitlement granted said share provided executive board member totaled transfer shall lapse entirety dr kreuzburg k relative k aggre leaf company november gate total k accounted nonperformance november request half related component k k entitlement granted said share shall lapse performancerelated component k share already transferred entitle performancerelated component include ments lapsed shall returned company transfer share agreed december remuneration component included granted dr kreuzburg actually possible total remuneration fair value grant date grant november earliest share respective fair value derived therefore yet granted furthermore number share granted price part pension commitment executive class share grant date amount board member pension service cost totaling k considering agreed condition k reporting year expensed following amount resulting december k prior year spread employee benefit expense full vesting period plan fiscal amount according executive board remuneration policy k accordingly recognized employee nonperformancerelated component paid benefit expense resulting grant share year granted variable remuneration com ponents based annual performance assessment determined consolidated annual financial statement approved therefore accounted paid following year variable remuneration component based multiyear per formance assessment accrue period lasting three least four year thus paid two earliest three year respective reporting year ended minimum target achievement cap provided variable remuneration component third term dr kreuzburg member executive board chairman ceo expire november resolution supervisory board december dr kreuzburg reap pointed member executive board chairman ceo term november november due dr kreuzburgs excel lent performance developing company since start tenure executive board november company wished continue successful cooperation despite alternative offer made new remuneration agreement therefore provides ordinary share preference share company shall transferred supplementary compensation component dr kreuzburg sharebased payment subject rule ifrs deemed granted upon resolution approved supervisory board december follow ing basic structure agreed upon transfer share granted shall effected time determined dr kreuzburg earlier november however share granted shall group management report remuneration report total remuneration executive board pursuant subsec german commercial code hgb executive board total dr joachim kreuzburg jörg pfirrmann reinhard vogt k fixed remuneration fringe benefits fixed remuneration annually paid variable remuneration variable remuneration multiyear component consolidated net profit years phantom stock plan years share granted variable remuneration total remuneration amount contributed insurance totaling k k included refer executive body company sartorius group allocated individual insurees recognized amount corresponds actual target achievement recognized amount corresponds actual target achievement plan fiscal year ended ie consolidated net profit consolidated net profit fair value grant date share granted dr kreuzburg fiscal derived number share granted ordinary share preference share respective price stock exchange grant date resp due sharebased payment arrangement expected dividend included measurement share part remuneration component based consolidated net profit three consecutive fiscal year executive board member receives partial compensation payment respective target achievement first fiscal year review total target achievement deter mined third fiscal year final payment effected deducting particular partial payment already made amount partial payment made total end reporting year shown follows k k balance jan fiscal year partial payment deducted partial payment effected balance dec fiscal year group management report remuneration report disclosure sharebased payment k k employee benefit expense recognized profit executive board total loss connection sharebased payment phantom stock unit shown follows share granted dr joachim kreuzburg phantom stock unit share granted jörg pfirrmann phantom stock unit share granted reinhard vogt phantom stock unit share granted disclosure phantom stock unit fair value granted fair value jan year fair value number end yearend change phantom price particular dec dec paid value stock unit assignment year fiscal fiscal status k k k k k dr joachim kreuzburg paid tranche tranche exercisable tranche exercisable tranche exercisable sum tranche previous year tranche exercisable total sum tranche jörg pfirrmann paid tranche tranche exercisable tranche exercisable tranche exercisable sum tranche previous year tranche exercisable total sum tranche reinhard vogt paid tranche tranche exercisable tranche exercisable tranche exercisable sum tranche previous year tranche exercisable total sum tranche group management report remuneration report pension commitment retirement plan executive board member furthermore earlier pension agreement granted provides old age disability pension dr kreuzburg provides receive monthly dr kreuzburg old age pension pension basic salary german federal messrs pfirrmann vogt cover pension civil servant classified grade salary class b benefit contribution amounting one percent ministry official according federal civil service pensionable income pensionable remuneration act bundesbesoldungsgesetz bonus paid reinsurance policy benefit respective version applicable full year contribution dr kreuzburg service full pension vested messrs pfirrmann vogt respective full pension reached year pensionable income equal fixed remuner arrangement pension surviving dependent ation executive board member elect convert basically provide widow pension portion salary accrued retirement benefit orphan pension child amounting paying contribution reinsurance pension policy sartorius match paying correspond ing additional benefit contribution reporting projected pension payment present value date amount matched company pension obligation past service cost shown pensionable bonus earned dr kreuzburg following table earned messrs pfirrmann vogt pensionable bonus comprised respective oneyear variable remuneration respective multiyear remuneration based consolidated net profit amount retirement benefit sartorius pay later executive board member surviving dependent dependent turity payment insurance policy accrued maturity date including policyholder bonus earned insurance company executive board member acquire right reinsurance policy sartorius shall solely vested right time projected pension present value obligation ifrs current service cost ifrs payment k pa dr joachim kreuzburg jörg pfirrmann reinhard vogt total group management report remuneration report disclosure required german tainable maximum minimum remuneration corporate governance code dcgk variable remuneration component line requirement dcgk lit june following table show benefit granted year including fringe benefit dr joachim kreuzburg jörg pfirrmann reinhard vogt benefit granted k min max min max min max fixed remuneration fringe benefits total annually paid variable remuneration variable remuneration multiyear component consolidated net profit consolidated net profit phantom stock plan holding period phantom stock plan holding period share granted total postemployment benefit total remuneration recognized amount target achievement fair value grant date inflow various remuneration component reporting year shown following table dr joachim kreuzburg jörg pfirrmann reinhard vogt benefit received k fixed remuneration fringe benefits total annually paid variable remuneration variable remuneration multiyear component consolidated net profit consolidated net profit phantom stock plan holding period phantom stock plan holding period share granted total postemployment benefit total remuneration amount equal actual target achievement paid transferred fiscal year group management report remuneration report main feature remuneration plan supervisory board k k prof dr dres hc arnold picot remuneration supervisory board member defined chairman article association sartorius ag comprises total remuneration fixed remuneration meeting attendance fee reim fixed remuneration bursement outofpocket expense member serving compensation committee work chairperson vice chairperson supervisory board meeting attendance fee receive higher fixed remuneration remuneration sartorius weighing technology gmbh goettingen total remuneration sartorius member chairperson supervisory board commit stedim biotech subgroup tee entitled receive additional annual fixed remuneration sartorius stedim amount meeting attendance fee reim biotech gmbh goettingen bursement outofpocket expense amount remuneration sartorius stedim apply relation nomination committee biotech sa aubagne committee pursuant section subsection german codetermination law mitbestg k k remuneration dr dirk basting supervisory board member total remuneration fixed remuneration meeting attendance fee k k remuneration supervisory board member total remuneration k k fixed remuneration annette becker compensation committee work total remuneration meeting attendance fee fixed remuneration remuneration sartorius weighing technology gmbh goettingen meeting attendance fee total remuneration sartorius stedim biotech subgroup remuneration sartorius stedim biotech gmbh goettingen k k remuneration sartorius stedim biotech sa aubagne uwe bretthauer total remuneration fixed remuneration compensation committee work meeting attendance fee k k michael dohrmann total remuneration fixed remuneration meeting attendance fee group management report remuneration report k k k k dr lothar kappich manfred zaffke march total remuneration vice chairman fixed remuneration total remuneration meeting attendance fee fixed remuneration compensation committee work meeting attendance fee k k petra kirchhoff k k total remuneration fixed remuneration gerduwe boguslawski feb meeting attendance fee total remuneration fixed remuneration performancerelated remuneration meeting attendance fee k k karoline kleinschmidt employee representative declared donate total remuneration supervisory board remuneration foundation han fixed remuneration böckler stiftung according guideline german trade union association meeting attendance fee beyond supervisory board remuneration employee representative employee within k k sartorius group receive compensation prof dr gerd krieger related service supervisory board total remuneration fixed remuneration compensation committee work remuneration former managing director meeting attendance fee k k remuneration former managing k k director prof dr thomas scheper remuneration former managing director member executive total remuneration board well surviving fixed remuneration dependent meeting attendance fee retirement benefit pension obligation former managing director member executive board well surviving dependent k k prof dr klaus trützschler total remuneration fixed remuneration compensation committee work meeting attendance fee group management report remuneration report sustainability report sustainability report sustainability sartorius sustainability sartorius sustainability one core value based sustainable approach important corporate culture sartorius founded primary u comply legal ethical standard manu commercial mission offer attractive product facture product environmentally responsible solution customer entail way consider environmental impact highly innovative achieving maintaining developing product innovation similarly hr strategic operational excellence sus policy aim protect right interest em tainably believe mean taking broadbased ployees actively utilize develop poten longterm view business includes social tial global workforce sartorius help shape ecological consideration take responsibil regional environment around site worldwide ities toward various stakeholder seriously employer customer believe longterm relation deliver benefit party involved sartorius elected make defined relevant performance indicator sustainability responsibility chief executive supplementary financial indicator used officer recognition overarching importance assessing impact commercial activity company economy environment employee society indicator designed great care ensure incorporate far dimension sustainability possible expectation demand important stakeholder customer employee sup plier investor community operate society whole survey employee economic customer regular meeting investor f method use track stakeholder eo success u loyee co e v l p mp view priority l e ntia glo acti l te ian ba po ce able corpo sartorius conduct reporting activity line tain ra u anagement guideline global reporting initiative gri e ensure transparency facilitate ready compari e u c tio n l ctiv p r ti n son sustainability report published annually r ese rc h n ble ctio n c n r cie part group annual report reporting period l ai g c b ili produ u st fiscal year unless otherwise indicated em ibu ti na l ty n g ec ployeerelated data cover sartorius company f sus including discontinued operation indus oci r oje trial technology data include p n pr al c f ica l io f e n r l g ovum employee u startup allpure acquired ar ra st f h e e c inn r r u c ius tu duc environmental indicator encompass sit e r e pro production company unless otherwise indicated coverage rate based total head count amount data gathered internal ly addition data consumption used provided utility company report externally audited sustainability report sustainable corporate management sustainable corporate management compliance legal ethical standard global compact company categorically reject form forced compulsory child labor explicitly activity based corporate value sus expects supplier act integrity tainability openness enjoyment value dealing competitor supplier customer govern interact customer business aim work trusting partnership relevant partner investor every day well employee representative body work together within company time corporate value guide u direction remuneration paid sartorius regular work intend develop company ing hour overtime compensation hour future worked excess contract regular work schedule either meet additional variable remuner sartorius conduct business compliance ation component applies exceeds industry standard legal regulation individual country andor legal minimum wage level vari globally accepted ethical standard action follow able component linked progress principle responsible corporate governance company attainment personal target de control focused sustainable value added fined employee line manager annual cludes compliance legal groupinternal regu target agreement lations consideration stakeholder interest transparent corporate communication appropriate risk management proper accounting auditing employee survey confirms key issue sartorius complies stipulation recom mendations german corporate governance global employee survey conducted yielded code recent version published june aboveaverage score whole sartorius information topic given spondents especially satisfied role corporate governance report page task manager nature cooperation within company finding also sartorius operates global compliance system intend confirmed continuing professional development ed ensure member executive body opportunity advancement important manager employee comply legal regula employee topic therefore one tions code internal guideline systematically focal point hr activity reporting year raise awareness relevant compliance issue among people prevent misconduct financial loss damage image internal control sys applying different perspective tems compliance department responsible inter nal auditing corporate security environmental workforce reflects diversity market management data protection risk management anti business region customer served interna corruption export control tional operation take care assembling team ensure different perspective experi sartorius code conduct sartorius anti ences contributed people combine productively corruption code set expand minimum similarly aim achieve mix nationality standard legally compliant ethical behavior gender age group filling management sartorius code conduct help employee act vacancy december ethically accordance law daily group employee employed outside germany work provision specific rule conduct represents yearonyear increase percent counter corruption binding employee age point half company manager employee around globe complete train originated outside germany proportion woman ing course deal ethically legally total workforce decreased slightly problematic situation whistleblower portal proportion woman hold telephone hotline enable employee supplier cu ing post two tier management immediately tomers partner report dubious conduct executive board increased worldwide regard making management sartorius adheres principle united nation team even international increasing universal declaration human right interna proportion woman managerial position tional labor organization ilo united nation significant priority medium term sustainability report sustainable corporate management sartorius employed people reporting period finding developing talented young staff registered disabled germany france sartorius enjoys reputation attractive employer evidenced among indicator large number applicant respond job adver developing potential tisements provide extensive range infor employee worldwide mation company applicant career section website employee attach great importance continuing professional development offering sartorius offer young people rigorous initial profes corresponding program wide range field sional training germany group provides train many year made particular effort ing education total different make international strand hr development profession eight workstudy program sartorius work even stronger improved training availa total trainee student em ble locally south american site example ployment december reporting date set electronic platform internal job yearonyear increase eight people advertisement site usa globally male female two trainee disability developing structured talent management system previous year large proportion trainee improving support option help employee entered continuing employment company working outside field away successfully completing final examination home site temporarily permanently con tinue professional personal development sartorius run foreign exchange program trainee enable interest gaining interna annual performance review held em tional experience spend number week ployee manager provide forum discus specific group site another country part training development opportunity well target per option offered addition standard tech formance sartorius conduct annual performance nical program promising young individual sartori review worldwide line set criterion u also opportunity prepare specific future role highly practical work sartorius fill management vacancy within study program natural science business rank help junior manager build administration management skill specific project directly related company business sartorius company regularly avail eu funding pro also provides separate development program gram including marie curie scheme young experienced management staff designed refer scientist leonardo da vinci scheme inter ence management guideline program national vocational education enable intern help strengthen common management culture take part variety training initiative intern aubagne site example opportunity particularly rd scientist engineer sartorius attend master business administration offer structured expert career path complement course offered kedge business school mar traditional management career program seille alliance enhances visibility expert internally externally build staff loyalty reporting international sartorius scholarship program year together expert introduced meanwhile support talented student graduate refinement program scientific technical discipline finan cially also provision mentor sartorius college offer employee diverse within organization technically range training continuing personal develop personally program intended attract appro ment opportunity number different language priately qualified young people global help improve linguistic methodological skill growth market organization enhance specialist course targeted onthejob training international project activity sartorius pa essential skill expertise sustainability report sustainable corporate management certified vocational training workstudy freedom flexibility work program sartorius germany sartorius set employee demanding task del vocational study program offered german chamber egates responsibility early stage also commerce industry ihk give freedom arrange daily work recognized profession commerce recognition desire flexible working event manager arrangement allow better balance industrial business administrator work family life working time model give office management assistant employee german site option arrange application specialist working hour flexibly example system integration specialist flextime parttime work teleworking sartorius warehouse logistics specialist group people employee part warehouse operator time employment reporting year recognized profession natural science germany represents increase per skilled chemistry technician centage point figure sartorius al physic laboratory assistant ready garnered number award family chemical laboratory assistant friendly policy recognized profession skilled trade skilled technical job mechatronics engineer electronics technician automation technology culture open dialog electronics technician equipment system milling machine operator sartorius seek maintain culture open industrial mechatronics engineer constructive dialog employee share construction technician formation financial progress strategic skilled machine plant operator plant technician objective change within company technical product designer promptly regularly internal notice news certified production technician letter employee magazine machine tool technician process technician specific relationship employee workstudy program employer vary region region bachelor art business administration sartorius always work together relevant bachelor engineering electrical electronic employee representative body spirit mutual engineering information technology confidence involvement employee man bachelor engineering physical engineering technology agement operational level germany governed bachelor engineering precision machinery provision including german codetermination bachelor engineering production technology law mitbestg german work constitution bachelor science biotechnology bachelor science information technology act betrvg employee germany represented bachelor science business information management system total twelve work council work agreement concluded german site cover matter health incentive system apply good employee health protection safety sartorius operates corporate health management policy covering physical psychosocial element health order enhance employee performance motivation reduce cost associated illness special action day sport opportunity held different site raise health awareness among employee senior manager ger many access annual medical checkup selected partner clinic advisory travel service introduced assist sartorius employee business trip international deployment event medi cal emergency accident security threat example sustainability report sustainable corporate management sartorius strives improve working condition strong cooperation supplier continuously bring reduction job related medical condition risk health poten sartorius maintains broad product range pur tial cause industrial accident company also chase correspondingly diverse range material provides regular employee training occupational use manufacturing operation service provider health safety environmental protection supplier contribute value creation continuously adapt job safety work organization expect supplier service provider comply condition line applicable law regula internationally recognized social environ tions example provision guidance mental standard respect law uphold issued german occupational health safety tenet fair competition formalized agency corresponding requirement code conduct supplier service provider sartorius stand accident recorded sartorius worldwide ardized procurement channel worldwide reporting year led day missed great contract awarded transparent process majority accident minor nature complies current regulation reporting date company recorded workrelated accident largest production site goettingen sartorius total approximately supplier previous year occurred com service provider worldwide cost purchase pany premise rather employee com consumed purchased service amounted mute home work review reporting year million equates effectiveness accident prevention measure sale revenue please refer note regularly reference accident analysis statement financial position page sartorius operates high level vertical integration accident statistic material change workrelated accident day missed due accident accident rate accident severity workrelated accident per million working hour number day lost due work accident per million working hour sustainability report ecological sustainability ecological sustainability sustainable manufacturing sustainable product sartorius supply product pharmaceutical food key longterm financial success sartorius chemical manufacturer research de design manufacturing process conserve velopment laboratory high level product quality source offer customer product delivery reliability critical customer efficient safe also provide environmental strictly regulated industry company em benefit planning operation look ploy rigorous quality check advanced manufac yond immediate use resource turing method process ensure stand entire life cycle product including used intended product comply customer process supplier also required requirement highly regulated sector con meet specification green approach cerned pose risk health safety tracea sartorius seek grow business without bility system make possible recall entire commensurate increase consumption natural production batch immediately event defect resource made formal objective discovered product various level specific environmental risk requiring provision emission monitoring accordance set identified reporting year greenhouse gas protocol sartorius recording greenhouse gas emission high standard quality line greenhouse gas ghg protocol since environmental protection accordingly considers report co equivalent coeq emission co sartorius certified internationally recog gas relevance climate change nized standard quality iso environ currently report direct emission relevance cli mental protection iso two management mate change caused production site scope system ensure comply quality require energy indirect emission arise course ments manufacture product power generation external energy supplier prudent use resource avoid scope greenhouse gas emission environmental risk tagelswangen employ associated manufacture precursor around people one manufactur product distribution operation scope ing site certified compliance moment assessed main production site iso quality standard iso environmen singleuse bag aubagne considering tal management system introduced three phased integration scope greenhouse gas company goettingen hamburg beijing emission bangalore site pipette production site kajaani finland suzhou china operate energy management system specified iso singleuse product manufacturing operation goettingen nearby guxhagen site manufacture equipment system biopharmaceutical production energy man agement system first certified rele vant local organizational unit ensure compliance applicable law regulation international site sartorius established working group incor porating representative number different country improve harmonize process across three area action environment health safety sustainability report ecological sustainability greenhouse gas emission sartorius group efficient use energy developed follows sartorius adapting negative consequence energy consumption greenhouse gas climate change endeavoring reduce green house gas emission associated business op erations energy efficiency one main area total energy consumption mwh targeting connection accounting ap electricity strom proximately total energy consumption natural gas largest site goettingen play key role effort fuels adoption advanced technology including energy source energyefficient combined heat power chp plant total greenhouse gas emission compressed air center controlling production coeq equipment brought reduction annual carbon scope dioxide emission around metric ton intelli scope gent control system pave way annual energy key indicator saving mwh second chp plant coeq emission per employee cut emission additional metric coeq emission per sale revenue ton carbon dioxide year came online tmio measure enabled u break link diesel generator tween consumption output goettingen site coeq calculated hawk university applied science result overall energy consumption art goettingen using gabi analytical software increased much slower rate sale revenue package greenhouse gas emission last year energy management sys scope emission excluding fuel consumption vehicle pool tem make possible identify additional energy saving potential specific area scope emission consumption electricity account almost company total continue improve existing production process emission represent main source emission building international site order relevance climate change sartorius reduce resource consumption increasing pro quarter attributed largely combustion portion renewable energy source energy mix fossil fuel scope key aspect effort especially new build solar energy meet around total scope emission aubagne site energy requirement yauco site example assessed according bilan carbone method guxhagen tagelswangen site developed french environment energy photovoltaic plant make use geo management agency ademe result thermal energy recent year analyzed show business workrelated travel employee account around sartorius supply various market directly environmental footprint raw production facility case work mini terials obtained sartorius supplier make mize business travel example making greater approximately significant use videoconferencing measure source co include freight transport avoid emissionsgenerating transport operation packaging site drawn plan ac staff travel tion reduce co emission based finding minimizing water consumption solvent emission occur principally filter production goettingen yauco site rinsing process follow precipitation amounted metric ton reporting year bath procedure filter membrane production share total carbon figure relevance largest consumer water sartorius modern cast term greenhouse gas emission taken ing machine help make water use efficient account calculating coeq measure possible sartorius operates waste water treatment plant company premise goettin gen bangalore beijing site interest sustainable water management new building sustainability report ecological sustainability yauco consumes around less fresh water ever leaving premise enables u simultane conventional factory thanks part intelligent ously close material cycle minimize transport concept use rain water requirement reduce water consumption volume waste water produced thanks result water consumption research development moreover able reduce relative quantity sol vent required membrane manufacture total water consumption water consumption per employee switched delivery polypropylene waste water use manufacture injectionmolded component biochemical oxygen demand bod metric ton required singleuse product sack silo reduce consumption polythene packaging contaminated waste water excludes waste water sanitary facility sartorius little scope use recycled plastic due safety regulation applying product however use small amount material return recyclable material certain functional component balance instance sartorius endeavor reduce waste volume employ waste separation system help ensure recyclable material recycled reduce environmentally compatible infrastructure proportion waste sent landfill development waste sartorius new build plant expansion com pleted comply local legislation regulation land use production facility utilize dedicated total quantity waste metric ton industrial area away nature conservation area waste reuserecycling green space maintain extensive green space metric ton within site avoiding unnecessary artificial waste disposal ground covering prevent water entering soil metric ton generally believe activity material quantity waste per employee impact biodiversity remain acutely aware metric ton special sensitivity biodiversity hot spot recycling rate tunisia puerto rico site located however take care act accordingly yauco site example expanded become sartorius applies relevant regulation environ main production logistics facility mentally compatible reuse recycling force north american market meet stringent u around world electronic product standard sustainable environmentallycompatible balance laboratory equipment en resourcefriendly construction production sures material heavy precious metal building yauco actually achieved platinum status recovered reuse rather landfilled leed u certification system green sartorius site germany using elec building making sartorius first pharmaceutical tronic signature system hazardous waste item industry supplier world receive award example caustic solution oil since advanced building technology often exceeds ensures generation disposal hazardous requirement national environmental protection waste product documented digitally regulation site traced full proportion waste count hazardous waste recorded germany corresponding figure metric ton avoidance environmentally problematic material organic solvent sartorius need manufac turing membrane filter cartridge recovered sartorius employ material management system recycled goettingen facility account check raw material used ensure solvent use solvent reprocessing comply applicable environmental plant site solvent used recovered health safety regulation pertinent regulation fed back production operation without context include directive restriction sustainability report ecological sustainability use certain hazardous substance electrical ucts example requires around less water electronic equipment rohs regulation less energy equivalent process using registration evaluation authorisation predominantly reusable solution using singleuse striction chemical reach europe well solution make smaller production unit similar standard around world safety data ducing manufacturing space required sheet product safety notice instruction consequently shrinking energy material consump user manual reliably inform customer hazard tion well research confirmed ous material contained product cannot energy consumption associated sterilization replaced steadily reducing amount cleaning material process based singleuse leadcontaining solder used production elec product around half conventional processes tronic component circuit board time sartorius able implement corresponding although singleuse product clear environmen rohs regulation full u tal benefit term energy water consumption leadfree solder use generate waste however consistent reuse recycling significantly im sartorius classified three raw material type prove environmental performance ultrapure plas critical manufacture product chemical tic use manufacture various singleuse product production filter membrane plastic contain around energy pure singleuse product stainless steel reusable crude oil thus valuable secondary raw mate bioreactors system began phased introduc rial high energy content polymer example tion indicator boughtin raw material mean reused fuel heat sartorius procured metric ton chemical power generation reporting year metric ton cor responding figure plastic report integrated solution sartorius flexact prod first time metric ton uct line combine fundamental environmental advantage singleuse technology bene fit lower material consumption due reduced sustainable product innovation need permanently installed system versatile central control unit example used effort improve environmental performance number different biopharmaceutical process product production method begin early development stage aim increase use technical refinement membrane filter renewable raw material reduce packaging enabled sartorius slash consumption ultrapure whenever done without compromising water wetting rinsing membrane safety functionality sartorius also collaborates improved filter waste less highlyvaluable industrial academic partner connec protein solution due significantly lower tion currently exploring possibility including absorption enabling pharmaceutical manufacturer sourcing polymer membrane capsule simultaneously reduce resource consumption con renewable recycled raw material siderably obtain higher yield sartorius process monitoring control technol highperformance product improve customer ogy also reduces material consumption help environmental footprint prevent defective batch sartorius service analyzes customer process round identifies area singleuse product becoming increasingly wide harboring potential economic environmental im spread manufacture innovative effective provements pharmaceutical essentially due economic advantage offer singleuse product source sinclair lindsay l etal environmental impact also completely eliminate resourceintensive disposable technology biopharm int november httpwwwbiopharmservicescomdocsenvironmentimpactdis cleaning process ultrapure water associated posablespdf rawlings b pora h environmental impact wastewater processing required conventional singleuse reusable bioprocess system bioprocess int steel glass equipment study confirm single february use product made plastic far superior com plex reusable system consumption energy water chemical product life cycle typical industrial manufacturing process monoclo nal antibody using predominantly singleuse prod sustainability report contributing society contributing society business operation many positive effect goettingen group headquarters site progress city community longstanding member local logistics network based great majority measurement valley business association home sartorius many year often one alliance small midsize measurement technology largest private employer customer company established boost local economy area especially main manufacturing site also involved local climate protection initia consequently play significant role increasing tive reduce co emission collaborate growth purchasing power sartorius part goettingens georgaugust university industri ners actively involved shaping economic al partner several goettingen high school social environment around site company also feature among sponsor internationally help make region operates renowned goettingen handel festival city liter attractive current future employee alike aturherbst fall literature festival men team providing financial support project sphere local basketball club bg göttingen currently education culture social affair sport play germany top division also made dona tion support local childrens cancer charity social outreach activity targeting area beyond elternhilfe für da krebskranke kind home region concentrate field linked core business promoting research education yauco sartorius supporting public school supporting event scientific community remain university many year award around chief priority scholarship annually pupil student low income family also sponsored equipment sport group charity performance support contributing regional economic development breast cancer research many sartorius production facility among goettingen guxhagen aubagne yauco alliance research site located small mediumsized city educational institution community rank important employer region group headquarters site university promoting academic excellence interdisciplinary city goettingen example largest private communication key aspect longterm alli employer area employee ances research educational institution company also major force local economy florenz sartorius prize created recognize rural region surrounding nearby guxhagen standing academic achievement awarded twice aubagne yauco mediumsized city year best class faculty economic population around provide attractive science goettingens georgaugust university job people respectively site also sartorius provides financial support around support additional job local service provider outstanding student seven different university supplier every year involvement german federal government deutschlandstipendium local subsidiary involved alongside repre national scholarship program also support sentatives political industrial social sphere international graduate school metrology initiative make region competitive brunswick germany concentrate connection issue directly indirectly affect company operation sartorius site aubagne many year infrastructure logistics environmental protection collaborating highlyregarded school uni education make priority longterm coopera versities including école nationale supérieure de tion reliable partnership maintain open technologie de biomolécules bordeaux support constructive dialog various local stake education training biotechnology engineer holder group notify promptly full business administrator help young graduate activity development touching upon area make start career sartorius also award two concern several example goettingen scholarship every year hong kong especially yauco presented highachieving young geologist biologist sustainability report contributing society chemist university hong kong chinese university hong kong hong kong university science technology french muscular dystrophy association afm téléthon charity working several year received christmas donation sartorius used help fund research rare nervous system muscle disorder development gene stem cell therapy company also provided laboratory equipment worth support goettingen experi mental laboratory young people xlab supporting event scientific community sartorius regularly take part symposium conven tions annual conference event scientific community primarily involving bioprocess industry addition maintaining longterm alliance scientific institution supported international regional annual conference usbased parenteral drug association pda interna tional society pharmaceutical engineering ispe example ispe independent notfor profit association dedicated employee education information sharing across pharmaceutical industry worldwide sartorius also involved symposium presented chinese academy inspection quarantine caiq whose area expertise include quality assurance lab sustainability report gri g index gri g index gri g indicator description page supplementary detail general standard disclosure strategy analysis g executive board statement concerning relevance httpwwwsartoriusenenkonzern sustainability sartorius uebersartoriuscorporatesocial g description key impact risk responsibility opportunity organizational profile g name organization g primary brand product service g location organization headquarters g nature ownership legal form g market served g scale organization g employee profile total number employee g percentage total employee covered collective bargaining agreement g description supply chain g significant change reporting period regarding organization size structure ownership supply chain g precautionary principle g commitment voluntary initiative g active membership identified material aspect boundary g entity included g definition report content g material aspect g aspect boundary within organization g aspect boundary outside organization g restatement reporting relevant g change scope aspect boundary relevant stakeholder engagement g list stakeholder g selection stakeholder g stakeholder engagement g result stakeholder engagement sustainability report gri g index report profile g reporting period g previous report g reporting cycle g contact point question regarding report back cover content g gri content index g external assurance externally audited governance g governance structure governance body responsibility economic environmental social performance ethic integrity g code conduct specific standard disclosure category economic gen energy consumption within organization gen energy consumption outside organization gen reduction energy consumption gen percentage total volume water recycled reused gen direct greenhouse gas emission scope gen energy indirect greenhouse gas emission scope gen indirect greenhouse gas emission scope determined gen total water discharge quality destination gen total weight waste disposal method gen hazardous waste gen impact mitigation environmental impact product service gen percentage product sold packaging determined material reclaimed gen significant environmental impact transport operation category social gla total number new hire employee turnover gla minimum notice period regarding operational change gla health safety topic covered agreement trade union gla program skill management lifelong learning gla diversity equal opportunity ghr child labor ghr forced compulsory labor ghr supplier human right assessment gso anticorruption policy gso compliance gso supplier assessment impact society category economic gec economic performance gec indirect economic impact consolidated financial statement note consolidated financial statement note statement profit loss comprehensive income statement profit loss comprehensive income note k k sale revenue cost sale gross profit sale selling distribution expense research development expense general administrative expense operating income expense earnings interest tax ebit financial income financial expense financial result profit tax income tax profit tax continuing operation profit tax discontinued operation net profit period attributable equity holder sartorius ag noncontrolling interest earnings per ordinary share basic diluted continuing operation discontinued operation earnings per preference share basic diluted continuing operation discontinued operation consolidated financial statement note statement profit loss comprehensive income statement comprehensive income k k net profit period cash flow hedges income tax cash flow hedge net investment foreign operation income tax net investment foreign operation currency translation difference item may reclassified profit loss net tax actuarial gain loss defined benefit obligation income tax actuarial gain loss item reclassified profit loss net tax comprehensive income tax total comprehensive income attributable equity holder sartorius ag noncontrolling interest amount reclassified statement profit loss listed section note consolidated financial statement integral part statement consolidated financial statement note statement financial position statement financial position note dec dec k k noncurrent asset goodwill intangible asset property plant equipment financial asset asset deferred tax asset current asset inventory trade receivables financial asset current tax asset asset cash cash equivalent asset classified held sale note dec dec k k equity equity attributable sartorius ag shareholder issued capital capital reserve reserve retained earnings noncontrolling interest noncurrent liability pension provision provision loan borrowing finance lease liability financial liability deferred tax liability current liability provision trade payable loan borrowing finance lease liability financial liability current tax liability liability liability associated asset classified held sale yearearlier figure restated final purchase price allocation acquisition tap biosystems section consolidated financial statement note statement cash flow statement cash flow k k profit tax financial result earnings interest tax ebit depreciation amortization intangible tangible asset increase decrease provision income tax paid gross cash flow operating activity increase decrease receivables increase decrease inventory increase decrease liability net cash flow operating activity net cash flow operating activity continuing operation net cash flow operating activity discontinued operation capital expenditure proceeds disposal fixed asset payment net cash flow investing activity payment acquisition consolidated subsidiary business operation net cash acquired net cash flow investing activity acquisition net cash flow investing activity continuing operation net cash flow investing activity discontinued operation interest received interest paid financial charge dividend paid shareholder sartorius ag noncontrolling interest gross cash flow financing activity change noncontrolling interest loan borrowing raised loan borrowing repaid net cash flow financing activity net cash flow financing activity continuing operation net cash flow financing activity discontinued operation net increase decrease cash cash equivalent cash cash equivalent beginning period net effect currency translation cash cash equivalent less cash cash equivalent discontinued operation cash cash equivalent end period consolidated financial statement note statement change equity statement change equity equity attribut foreign able cash flow currency sartorius non issued capital hedging pension retained translation ag share controlling total k capital reserve reserve reserve earnings reserve holder interest equity balance jan net profit period comprehensive income tax total comprehensive income dividend change equity balance dec jan net profit period comprehensive income tax total comprehensive income sharebased payment dividend purchase price liability forward non controlling interest change non controlling interest change equity balance dec dividend paid per share follows per share total per share total k k dividend ordinary share dividend preference share consolidated financial statement note note financial statement note financial statement general information consolidated financial statement prepared euro unless otherwise specified amount sartorius ag listed joint stock corporation estab disclosed thousand euro abbreviated k lished according german law highest case sum figure given level parent company sartorius group report may precisely equal stated total corporation recorded german commercial percentage may exact due rounding register district court goettingen hrb headquartered weender landstrasse executive board scheduled submit consol goettingen federal republic germany idated financial statement february supervisory board sartorius group organizes business two divi sion bioprocess solution lab product ser sale industrial technlologies division vice bioprocess solution division sartorius leading international supplier product sartorius ag signed contract december technology manufacture medication japanese minebea group partner vaccine biological basis socalled biopharma development bank japan inc sell industrial ceuticals part total solution provider strate technology division intec latter gy bioprocess solution division offer biopharmaceutical industry product portfolio group sale important milestone cover nearly process step industry manu mediumterm strategy focus two core facture encompass cell culture medium division bioprocess solution lab product cultivation cell bioreactors various size cell service offer higher growth earnings po propagation different technology filter tential intec unlock potential however bag cell harvesting purification concen high degree focus investment tration way filling required proceeds sale intec divi sion strengthen financing potential lab product service division focus labor expansion core business atories research quality assurance sector pharmaceutical biopharmaceutical company pending sale intec division resulted academic research institute serf cu application ifrs noncurrent asset held tomers chemical food industry divi sale discontinued operation thus sion portfolio cover instrument consumables disclosure intec division discontinued oper laboratory use example sample prepara ation therefore expense income tion standard application industrial operation disclosed item profit tax technology division formerly industrial weighing discontinued operation asset liability classified asset held sale since attributable operation reported item december see also section asset held sale liability associated asset classified held sale respectively compliance subsection ger statement financial position disclosure man commercial code hgb conjunction art note financial statement accordingly refer regulation ec europe continuing operation unless otherwise specified parliament council dated july oj prioryear disclosure statement profit l p consolidated financial statement loss correspondingly adjusted line sartorius group year ended december rule ifrs contrast amount reported prepared according ifrs ifric statement financial position reclassified standard interpretation international accounting standard board iasb required applied european union available following site httpeceuropaeuinternal_marketaccountingias index_enhtm consolidated financial statement note note financial statement effect new revised firsttime application ifrs financial reporting standard result material impact special purpose entity associate jointly controlled compared yearearlier consolidated financial entity ifrs led disclosure con statement following new amended accounting solidated financial statement see section standard obligatorily applied first time following revised accounting standard inter pretations generally required applied ifrs consolidated financial statement first time result material im pact consolidated financial statement ifrs joint arrangement amendment ia financial instrument ifrs disclosure interest entity presentation offsetting financial asset financial liability amendment ia separate financial statement amendment ifrs transition amendment ia investment associate amendment ia recoverable amount joint venture disclosure nonfinancial asset ifrs contains new definition term amendment ia novation derivative control must considered determining continuation hedge accounting company included consolidated finan cial statement ifrs establishes rule standard interpretation revision financial reporting entity interest amendment following page yet ap arrangement controlled jointly ie joint plied consolidated financial statement arrangement ifrs combine disclosure obliga reporting year yet adopted tions interest subsidiary joint arrangement eu application obligatory associate unconsolidated structured entity one standard consolidated financial statement note note financial statement applicable endorsement financial standard interpretation title year eu commission standard amendment ia employee contribution february yes annual improvement ifrss various cycle issued dec february yes annual improvement ifrss various cycle issued dec january yes investment entity applying amendment ifrs ifrs ia consolidation exception january sale contribution asset amendment ifrs ia investor associate joint venture january accounting acquisition interest amendment ifrs joint operation january ifrs regulatory defferral account january amendment ia disclosure initiative january amendment ia ia agriculture bearer plant january clarification acceptable method amendment ia ia depreciation amortization january equity method separate financial amendment ia statement january annual improvement ifrss various cycle issued sep january ifrs revenue contract customer january ifrs financial instrument january interpretation ifric levy june yes application mandatory adopted eu commission standard require earlier compulsory application process measuring potential impact scope consolidated financial statement standard interpretation consolidated financial statement sartorius group pro consolidated financial statement sartorius ag gress according current audit review status include annual financial statement major group anticipate overall significant im company controlled directly indirectly pact consolidated account arising sartorius ag term ifrs consolidated fi application new amended standard nancial statement controlling interest exists following criterion met presently firsttime application planned reporting period standard interpreta power ie investor must existing right tions amendment enter force give current ability direct relevant activity investee respect latter return significant accounting policy exposure right variable return investee basis preparation ability use power way significantly consolidated financial statement group affect investees return based principle historical cost acquisi tion construction production exception investees included consolidated finan item disclosed fair value financial asset cial statement time sartorius ag held trading available sale derivative subsidiary acquire control longer included time control transferred entity outside group consolidated financial statement note note financial statement subsidiary included basis annual certain defined loan granted longterm basis financial statement reporting period group applies principle net investment parent company using uniform group recognition foreign operation foreign currency translation measurement method difference resulting loan recognized comprehensive income according ia intragroup asset liability equity income expense cash flow relating transaction exchange rate major currency tween member group eliminated full euro considered follows consolidation yearend exchange average annual rate exchange rate business combination usd business combination measured according gbp acquisition method identifiable asset acquired chf group well liability contingent liabili jpy tie assumed recorded fair value date inr combination cny significant acquisition purchase price alloca tion generally carried assistance independent thirdparty valuation specialist sale revenue valuation based information available acquisition date revenue derived selling product rendering service recognized sale expense directly related business combination operational revenue recognized operat reported profit period ing income sale recognized statement profit loss significant risk reward ownership good transferred foreign currency translation customer company retains neither continuing managerial effective control good sold subsidiary annual financial statement prepared amount revenue cost incurred foreign currency translated pursuant incurred measured reliably sufficiently ia effect change foreign exchange probable economic benefit associated rate accordance concept functional transaction flow company currency foreign subsidiary regarded inde pendent subdivision sartorius group item statement financial position translated functional cost exchange rate reporting date income expense item converted average rate general operating expense assigned translation difference resulting use dif individual function according functional area ferent exchange rate item statement corresponding profit cost center expense financial position statement profit loss relating crossfunctional initiative project recognized comprehensive income assigned respective functional cost based shareholder equity appropriate allocation principle individual financial statement consoli item cost sale report cost product dated company transaction foreign currency sold acquisition cost merchandise sold translated functional currency com besides directly imputable expense raw pany exchange rate date transac material supply employee benefit expense tion monetary asset liability denominated energy expense cost sale also includes foreign currency translated closing rate overhead allocated manufac reporting date gain loss foreign currency turing area corresponding depreciation transaction recognized profit loss amortization consolidated financial statement note note financial statement selling distribution expense pertain par income tax ticular cost sale marketing organi zation distribution advertising market research current income tax determined based respective local taxable income period local research development cost comprise cost tax rule addition current income tax may research product process development insofar clude adjustment uncertain tax payment tax capitalized amortization capital refund period yet assessed ized development cost also indicated item deferred tax asset liability determined based item general administrative expense primarily temporary difference carrying comprises employee benefit expense cost amount tax base asset liability material general administrative area including difference consolidation addition loss carryforwards tax credit considered profit loss item cannot allocated measurement based tax rate expected one functional area mentioned recognized effective period asset realized operating income expense essen liability settled change deferred tax asset tially include effect currency translation dis liability reflected income tax except posal fixed asset allowance trade receivables change recognized comprehensive income extraordinary expense income grant relat directly equity ed expense recognized income reasonable assurance condition principle tax rate tax rule used tached grant complied enacted substantively enacted grant received reporting date deferred tax asset recognized extent probable taxable profit level relevant tax authority available borrowing cost utilization deductible temporary differ ences loss carried forward borrowing cost expensed incurred unless directly attributable acquisition construc tion production qualifying asset goodwill fore part cost asset asset deemed qualified asset period least month goodwill represents future economic benefit required ensure intended arising asset acquired business combination state ready use sale individually identified separately recognized according ia goodwill acquired business combination may amortized rather must tested annually impairment soon indication asset impairment purpose impairment testing goodwill must allocated acquirer cashgenerating unit cgus cgu represents lowest level within entity goodwill monitored internal management purpose may larger segment consolidated financial statement note note financial statement intangible asset amortization intangible asset based fol lowing period useful life intangible asset acquired stated cost less accumulated regular amortization calculated software year according straightline method useful life customer relationship technology year intangible asset period capitalized development expense year asset expected contribute directly indirectly year cash flow entity brand name indefinite period cost incurred within scope development new product method capitalized internally property plant equipment generated intangible asset following criterion met item property plant equipment reported cost subject depreciation depreciated technical feasibility completing intangible scheduled straightline method applied asset available use sale depreciation reported consolidated financial statement intention complete intangible asset use sell grant related asset generally deducted cost asset ability use sell intangible asset depreciation fixed asset based following demonstration intangible asset period useful life generate probable future economic benefit building year availability adequate technical financial machinery year resource complete development factory office equipment year use sell intangible asset ability measure reliably expenditure impairment intangible tangible asset tributable intangible asset devel opment book value carrying amount property plant equipment intangible asset examined capitalized development cost essentially cover whether indication asset might cost allocated staff involved rd impaired pursuant ia impairment asset raw material supply outside service indication asset impaired directly attributable overhead recoverable amount asset estimated recoverable amount asset cashgenerating internally generated intangible asset may unit higher fair value less cost sell capitalized development cost recognized asset cgu value use event expense period incurred individual asset recoverable amount cannot cost research activity reported expense estimated recoverable amount asset cash period incurred generating unit cgu estimated estimated recoverable amount asset cgu go book value carrying amount carrying amount must reduced recoverable amount cause asset impairment removed book value asset cgu credited newly estimated recoverable amount however book value increase limited value asset cgu would asset impairment loss would assessed previous financial year consolidated financial statement note note financial statement lease inventory must evaluated lower amount cost net realizable value net realizable lease considered agreement whereby lessor value represents estimated selling price conveys lessee return payment series ordinary course business less estimated cost payment right use asset agreed completion estimated cost necessary period time according ia lease classi marketing sale distribution inventory fied either operating lease finance lease risk exist risk reduced shelf life finance lease lease transfer substantially result storage period limited usability invento risk reward incidental ownership ries marked accordingly asset lease designated operating lease trade receivables group lessee finance lease amount equal fair value leased asset lower trade receivables reported present value minimum lease payment discernible risk covered book value trade recognized asset statement financial receivables receivables approximate position simultaneously recognized financial fair value considering maturity date credit liability inception lease mini risk determining recoverability trade receiv mum lease payment essentially consist finance ables group considers change credit charge reduction outstanding liability quality date credit originally granted leased asset depreciated straightline basis reporting date period expected useful life shorter lease term construction contract group lessor finance lease sale revenue equal net investment lease lease construction contract contract specifically nego receivable recognized leasing rate group tiated construction asset combina receives also apportioned finance tion asset closely interrelated charge reduction liability according interdependent term design technology effective interest method function ultimate purpose use outcome construction contract estimated operating lease lease rate paid reliably revenue constructiontype project lessee recognized expense lease generally recognized percentageof rate received lessor recognized income completion method based percentage cost respectively leased asset continues recog date compared total estimated contract cost nized lessor statement financial position expected loss construction contract im fixed asset mediately recognized expense cumulative work contract cost contract result inventory exceeds advance payment received construc tion contract recognized receivables raw material supply including merchandise amount due customer contract reported inventory average cost prin balance deduction advance payment received ciple finished good work progress reported negative obligation construction contract cost conversion cost includes direct cost recognized liability amount due allocated material customer appropriate portion production material han dling overhead general administrative expense fixed asset normal depreciation amortiza tion rate provided expense caused production consolidated financial statement note note financial statement provision pension similar obligation financial liability group mainly comprise loan bank trade payable finance lease payable pension provision similar obligation recog derivative financial instrument negative fair nized consolidated financial statement value sartorius group accordance actuarial principle ia employee benefit stipulates projected financial instrument initially recognized unit credit method method measurement fair value transaction cost directly attributable addition known pension life expectancy acquisition issue financial instrument expected cash value method take account future recognized determining carrying amount salary pension increase financial instrument measured fair value profit loss financial asset liabil actuarial gain loss recognized ities subsequently measured according cate comprehensive income directly equity pension gory assigned cash cash reserve according ia r standard equivalent availableforsale financial asset loan receivables financial liability measured amor tized cost financial asset liability classified provision held trading provision recognized liability third party incurred outflow resource cash cash equivalent probable amount obligation reasonably estimated amount recognized group considers highly liquid investment provision represents best estimate obliga less three month maturity date tion end reporting period provision acquisition cash cash equivalent main term maturity one year ly comprise check cash hand deposit bank discounted present value expenditure cash cash equivalent measured cost expected settle obligation end reporting period investment provision regularly reviewed adjusted fur ther information becomes available circumstance investment nonconsolidated subsidiary associ change provision warranty cost based ate security measured cost expected value reflect past experience active market exists share security fair value asset cannot reliably restructuring provision set connection measured program materially change scope business performed segment business unit man ner business conducted case loan receivables restructuring expense include termination benefit due termination employment lease financial asset classified loan receivables well compensation payment due agree measured amortized cost less impairment loss ments supplier dealer restructuring provi application effective interest method im sion recognized group detailed pairment loss trade receivables formal plan either commenced imple recognized using separate allowance account ment announced financial instrument financial instrument contract give rise financial asset one entity financial liabil ity equity instrument another entity financial asset mainly include cash cash equivalent availableforsale financial asset trade loan receivables derivative financial instrument positive fair value consolidated financial statement note note financial statement financial liability noncurrent asset disposal group held sale discontinued operation financial liability except derivative financial instrument measured amortized cost using according ifrs noncurrent asset disposal effective interest method group must classified held sale carrying amount recovered principally sale transaction rather continuing use derivative financial instrument case asset disposal group available immediate sale present condition sale derivative financial instrument foreign cur highly probable sale considered highly probable rency exchange contract interest rate swap con appropriate level management committed tract measured fair value derivative financial plan sell asset active program locate instrument classified held trading unless buyer complete plan already initi designated hedging instrument ated offer sell asset disposal group hedge accounting applied change fair value reasonable price made sale expected derivative financial instrument recognized recognized completed within twelve month either profit loss case hedge date classification unlikely comprehensive income significant change plan made plan withdrawn cash flow hedge noncurrent asset disposal group classified held sale measured lower effective portion change fair value carrying amount fair value less cost sell derivative instrument designated cash flow hedge asset longer depreciated amortized recognized comprehensive income ineffective portion recognized immediately component entity disclosed discontin financial result amount accumulated equity ued operation either disposed reclassified net income period classified held sale hedged item affect net income represents separate major line business geographical area operation statement cash flow part single coordinated plan dispose statement cash flow cash flow present separate major line business geographical area ed according allocation operating activity operation investing activity financing activity subsidiary acquired exclusively view resale instance cash flow operating activity determined using indirect method ie expens e without effect payment added profit critical accounting judgment key tax income without effect pay source estimation uncertainty ments subtracted cash flow financing activity composed primarily change equity preparation consolidated financial addition repayment loan statement management u estimate assump tions based best knowledge current future situation period however actual result may differ estimate estimate assumption therefore revised regular basis impact change immediately recog nized statement profit loss period consolidated financial statement note note financial statement addition group management exercise judgment intangible asset defining accounting treatment specific transac tions existing standard interpretation capitalization selfconstructed intangible asset explicitly treat accounting problem concerned includes certain level estimate assumption eg evaluation technical feasibility assumption estimate primarily concern fol development project expected market prospect lowing fact determination useful live business combination trade receivables accounting acquisition requires certain estimate allowance doubtful account involves signifi assumption made especially concerning cant management judgment review individual fair value intangible asset property receivables based individual customer creditworthi plant equipment acquired liability assumed ness current economic development well acquisition date well useful life analysis historical bad debt portfolio basis intangible asset property plant equipment acquired employee benefit provision pension measurement largely based projected cash obligation flow difference expected actual cash flow may material impact future obligation pension postemployment group result benefit determined accordance actuarial valuation valuation rely key assumption including discount rate expected salary increase impairment asset mortality rate discount rate assumption determined reference yield highquality impairment test conducted certain event lead fixedinterest corporate bond appropriate duration assumption asset might impaired currency end reporting period case carrying amount asset com pared recoverable amount higher due changing market economic condition net realizable value value use cal underlying key assumption may differ actual culation value use generally based dis development may lead significant change counted cash flow method use cash flow pension obligation postemployment benefit projection five year projection take obligation account past experience represent manage ments best estimate future sale revenue difference recognized full directly cost development cash flow planning equity period occur without af period extrapolated using individual growth rate fecting profit loss sensitivity analysis see key assumption management based section pension employee benefit provision determination value use include estimated growth rate weighted average cost capital tax rate estimate material impact respective value ultimately amount impairment carrying amount exceeds recoverable amount impairment loss recognized consolidated financial statement note note financial statement provision contingent liability operating segment contingent asset according ifrs operating segment identifi provision recognized legal constructive cation reportable operating segment based obligation exist respect third party management approach ie segment end reporting date determine defined analogously internal control amount obligation certain estimate porting structure entity therefore area sumptions applied including evaluation activity considered operating segment probability obligation occur business activity may result revenue expense amount cost incurred typically significant operating result regularly reviewed uncertainty involved determination entity chief operating decision maker execu provision related onerous contract warranty cost tive board sartorius ag discrete financial closure business location asset retirement obliga formation available internal reporting tions legal proceeding result classification intec division discontinued operation division called bioprocess solution lab product service con income tax sidered operating segment group operates various tax jurisdiction underlying ebitda key performance indicator therefore must determine tax position respec operating segment group ebitda corre tive local tax law tax authority view sponds earnings interest financial result complex subject different interpreta tax depreciation amortization underlying tions taxpayer local tax authority ebitda mean ebitda adjusted extraordinary item connection extraordinary item ex deferred tax asset recognized de penses income exceptional ductible temporary difference unused tax loss onetime nature accordingly distort sustaina extent probable future taxable ble profitability segment material profit available deductible impact net worth financial position earn temporary difference unused tax loss ings group example item restruc utilized future development uncertain turing expense large group project proceeds partly beyond management control assumption loss disposal sale transfer necessary estimate future taxable profit financial asset property plant equipment well period deferred tax asset provided recurrent nature recovered apart recognition measurement estimate revised period method reportable segment conform sufficient evidence revise assumption man general group accounting principle agement considers probable portion deferred tax asset cannot realized correspond intersegment receivables payable internal ing valuation allowance taken account transfer price set price corresponding would agreed upon external third party particular situation given framework condition essentially price calculated applying costplusmargin method resale price method combination two method method determining internal transfer price documented promptly continuously maintained volume inter segment receivables payable immaterial segment asset segment liability report ed regular basis chief operating decision maker therefore part segment report consolidated financial statement note note financial statement sale revenue underlying ebitda k bioprocess solution lab product service total continuing operation reconciliation profit tax depreciation amortization extraordinary effect earnings interest tax ebit financial result profit tax continuing operation depreciation amortization capital expenditure k bioprocess solution lab product service total continuing operation geographical information particular company location sale revenue reported according customer location noncurrent european region includes market western asset correspond property plant equipment eastern europe north american region well intangible asset group affiliate comprised u marketplace canadian allocated various region goodwill market japan china australia south korea india resulting reverse acquisition stedim among country allocated associated intangible asset regionally allocated asia pacific region market segment pri france marily consists latin america africa fiscal prior year none custom following applies regional key figure er accounted sale revenue regional allocation noncurrent asset refers sale revenue noncurrent asset k europe germany france north america usa asia pacific china market group consolidated financial statement note note financial statement scope consolidation ownership consolidated parent sartorius ag goettingen germany company x sartorius stedim biotech sa aubagne france along subsidiary x europe sartorius stedim belgium nv vilvoorde belgium x sartorius stedim nordic herlev denmark x distribo gmbh goettingen germany sartorius stedim biotech gmbh goettingen germany x sartorius stedim plastic gmbh goettingen germany x sartorius stedim system gmbh guxhagen germany x sartorius stedim uk ltd epsom uk x sartorius stedim lab ltd stonehouse uk x tap biosystems group ltd royston uk x tap esop management ltd royston uk x tap biosystems phc ltd royston uk tap biosystems ltd royston uk automation partnership cambridge ltd royston uk x sartorius stedim fmt sa aubagne france x sartorius stedim france sa aubagne france x sartorius stedim financière sa aubagne france sartorius stedim aseptics sa lourdes france x sartorius stedim ireland ltd dublin ireland x sartorius stedim italy spa florence italy x sartorius stedim netherlands bv rotterdam netherlands x sartorius stedim austria gmbh vienna austria x sartorius stedim poland sp z oo kostrzyn poland x ooo sartorius icr st petersburg russia sartorius stedim switzerland ag tagelswangen switzerland x sartorius stedim spain sa madrid spain x sartorius stedim hungaria kft budapest hungary north america sartorius stedim filter inc yauco puerto rico x sartorius stedim north america inc wilmington delaware usa x allpure technology llc new oxford pennsylvania usa x asia pacific sartorius stedim australia pty ltd dandenong south victoria australia x sartorius stedim biotech beijing co ltd beijing china x sartorius stedim shanghai trading co ltd shanghai china x sartorius stedim india pvt ltd bangalore india x sartorius stedim japan kk tokyo japan x sartorius korea biotech co ltd seoul south korea x sartorius stedim malaysia sdn bhd kuala lumpur malaysia x sartorius stedim singapore pte ltd singapore x market sartorius stedim bioprocess sarl mhamdia tunisia x consolidated financial statement note note financial statement ownership consolidated europe sartorius belgium nv vilvoorde belgium x sartorius nordic herlev denmark x sartorius weighing technology gmbh goettingen germany x sartorius corporate administration gmbh goettingen germany x si weendeverwaltungsgmbh goettingen germany x siv weende gmbh co kg goettingen germany x si grone verwaltungsgmbh goettingen germany x siv grone gmbh co kg goettingen germany x swt treuhand gmbh goettingen germany x sartorius lab holding gmbh goettingen germany x sartorius lab instrument gmbh co kg goettingen germany x sartorius uk ltd epsom uk x sartorius biohit liquid handling oy helsinki finland x sartorius france sa dourdan france x vl finance sa aubagne france x sartorius ireland ltd dublin ireland x sartorius italy srl florence italy x sartorius netherlands bv rotterdam netherlands x sartorius austria gmbh vienna austria x sartorius poland sp z oo kostrzyn poland x ooo sartogosm st petersburg russia ooo biohit st petersburg russia x sartorius spain sa madrid spain x sartorius hungaria kft budapest hungary sartorius intec belgium bvba vilvoorde belgium x sartorius mechatronics th gmbh hamburg germany x sartorius mechatronics cd gmbh co kg aachen germany including sartoriusverwaltungsgmbh x sartorius industrial scale gmbh co kg bovenden germany x sartorius industrial weighing verwaltungs gmbh bovenden germany x sartorius intec uk ltd epsom uk x sartorius intec france sa le ulis france x sartorius intec italy srl muggiò italy x sartorius intec netherlands bv rotterdam netherlands x sartorius intec austria gmbh vienna austria x sartorius intec poland sp z oo kostrzyn poland x sartorius mechatronics switzerland ag tagelswangen switzerland x sartorius intec spain sl madrid spain x north america sartorius north america inc wilmington delaware usa x sartorius corporation wilmington delaware usa x sartorius canada inc mississauga canada x consolidated financial statement note note financial statement ownership consolidated asia pacific sartorius australia pty ltd dandenong south victoria australia x denver instrument beijing co ltd beijing china x sartorius scientific instrument beijing co ltd beijing china x sartorius shanghai trading co ltd shanghai china x biohit biotech suzhou co ltd shanghai china x sartorius hong kong ltd kowloon hong kong x sartorius weighing india pvt ltd bangalore india x biohit biotech system india pvt ltd chennai india x sartorius japan kk tokyo japan x sartorius malaysia sdn bhd kuala lumpur malaysia x sartorius singapore pte ltd singapore x sartorius korea ltd seoul south korea x sartorius thailand co ltd bangkok thailand x sartorius industrial weighing equipment beijing co ltd beijing china x sartorius mechatronics india pvt ltd bangalore india x sartorius intec kk tokyo japan x sartorius mechatronics philippine inc makati city philippine market sartorius argentina sa buenos aire argentina sartorius brasil ltda são paulo brazil sartorius de méxico sa de cv naucalpan mexico company sartorius korea biotech sartorius thailand included scope consolidation due contractual agreement see section company marked nonconsolidated january difference resulting table included scope consoli initial consolidation deducted dation figure minor importance retaining earnings assessing actual net worth financial position profitability sartorius group sale revenue total asset nonconsolidated com statement cash flow panies taken whole approximately group figure associate joint venture statement cash flow show impact cash consolidated company identified x inflow outflow cash cash equivalent fully consolidated group cash flow classified operat ing investing financing activity according fiscal material change ia statement cash flow capital voting share right company listed respect prior year context cash equivalent asset converted cash within short term generally following company included first within three month amount considered time fiscal scope consolidation statement cash flow primarily includes cash hand bank balance similar item equal sartorius intec poland sp z oo amount reported statement financial sartorius poland sp z oo position sartorius stedim poland sp z oo well allpure technology llc acquired april company poland consolidated group financial statement due polish company minor importance consolidated consolidated financial statement note note financial statement group received grant related asset purchase price allocation business final connection purchase construction ized end following table compare production facility puerto rico amount final purchase price allocation preliminary million cash inflow reported allocation measured payment cash flow investing activity final purchase preliminary following noncash transaction concluded price purchase price allocation allocation reflected statement cash flow k k intangible asset addition fixed asset related financial property plant lease amounted k k equipment inventory trade receivables asset business acquisition cash cash equivalent deferred tax net acquisition tap biosystems group plc provision loan borrowing december sartorius acquired british com liability pany tap biosystems group plc company primari net asset acquired ly specializes design development small scale multiparallel fermentation system addition purchase price company array product cover automated cell goodwill culture system bioprocessing benchtop equipment biotech application acquisition sartorius stedim biotech intangible asset identified within scope extended current bioprocess solution portfolio purchase price allocation measured essentially fermentation business multiparallel mini comprised technology acquired customer bioreactors range milliliter milli relationship liter tap portfolio stand gain substantial market penetration based sartorius greater sale goodwill disclosed represents asset strength global reach well benefit separately identifiable recognized synergy related product sartorius generate economic benefit expansion group fluid management cell culture medium group portfolio strengthened position business relevant biopharmaceutical market named among benefit acquisition bring goodwill may amortized corre sponding effect taxable income purchase price paid cash acquisition related cost million included operating expense statement profit loss consolidated financial statement note note financial statement acquisition allpure technology llc goodwill disclosed represents asset separately identifiable recognized april sartorius subgroup generate economic benefit expansion sartorius stedim biotech acquired stake group portfolio strengthened position u startup allpure technology llc price relevant biopharmaceutical market u million purchase price paid cash named among benefit goodwill expected latter company based new oxford pennsylvania taxdeductible full usa operating market four year earned revenue around u million sartorius stedim biotech group elected employee allpure specializes singleuse recognize amount noncontrolling interest component biopharmaceutical application level prorated share net identifiable provides product complementary sar asset partial goodwill method torius group portfolio bioprocess solution segment reporting year company acquired earned sale revenue approximately million slight share allpure remaining former ly positive annual profit reason er also transferred sartorius material effect group financial statement latest exact time acquisition well since allpures initial consolidation may purchase price depend future business perfor mance entity purchased corresponding transaction cost million disclosed liability disclosed financial liability operating expense present value expected future payment million liability initially recognized retained earnings according ia subsequent measurement recognized profit loss financial result overall preliminary purchase price allocation follows preliminary purchase price allocation k intangible tangible asset inventory trade receivables asset cash cash equivalent provision liability net asset acquired purchase price goodwill noncontrolling interest consolidated financial statement note note statement profit loss note statement profit loss sale revenue functional cost sale revenue broken operating statement profit loss prepared according segment geographical market according function expense method also known customer location consists following cost sale expense allocated spective functional area production sale lab distribution research development well bioprocess product general administration total expense incurred solution service total k k k functional area material employee bene fit represented follows germany country raw material supply lab item consists following bioprocess product solution service total k k k k k germany country purchase consumed cost purchased service amount million earned affiliated company million addition com employee benefit expense pany earned sale revenue million discontinued operation million sum item broken follows approximately million earned providing service million k k wage salary social security expense retirement benefit pension consolidated financial statement note note statement profit loss operating income expense financial result k k k k currency translation gain interest similar income income decrease allowance bad debt affiliated company income release use income derivative provision liability financial instrument income grant financial income income financial income operating income interest similar expense extraordinary expense currency translation loss affiliated company allowance bad debt expense derivative financial instrument expense interest pension operating expense retirement benefit financial charge operating income financial expense expense item reported income grant discloses expense derivative financial instrument e grant expense essentially related research sentially include effect connection disso development project recognized lution hedging relationship consequence come soon sufficiently reliable indication refinancing see section necessary prerequisite met income fiscal includes income income tax cell culture medium business well income con nection service provided discontinued operation k k current income tax extraordinary item fiscal essential deferred tax ly incurred various strategic group project integration acquisition cost matter principle domestic income tax calculated estimated taxable profit fiscal income generated outside germany taxed particular rate valid cor responding country considering german average tax rate impact tax legislation expected tax rate group roughly following table describes difference tax expense expected income tax expense reported particular financial year consolidated financial statement note note statement profit loss earnings per share k k expected tax rate according ia earnings per share earnings per share class must determined separately expected tax expense case higher dividend entitlement cur difference group average income tax rate rently two euro cent preference share must effect loss taken account undiluted earnings per share interest carried forward basic eps calculated basis number temporary difference share outstanding period diluted earn deferred tax accrued ings per share diluted eps calculated taxfree income tax cause option conversion right credit exercised sartorius share regard share expense deductible subscription right granted executive board tax purpose member december change adjustment previous year computed result withholding similar tax treasury share may included calculating average number share outstanding effective tax rate ordinary share basis calculating basic earnings per ordinary share item effect loss interest carried net profit minority interest k forward temporary difference continuing deferred tax accrued include negative ef operation k fects due lack foreseeability future taxable discontinued profit well opposite positive effect operation k use interest loss carried forward weighted average number deferred tax asset yet recognized share outstanding basic earnings per ordinary share continuing operation discontinued operation preference share basis calculating basic earnings per preference share net profit minority interest k continuing operation k discontinued operation k weighted average number share outstanding basic earnings per preference share continuing operation discontinued operation consolidated financial statement note note statement financial position note statement financial position goodwill intangible asset integration business division bioprocess solution lab product goodwill service respective positioning total solu tions provider regard segment goodwill cashgenerating unit thus goodwill distributed k segment follows gross book value jan currency translation dec dec change scope consolidation k k acquisition bioprocess solution gross book value dec lab product service amortization impairment loss industrial technology jan currency translation amortization impairment loss amortization impairment loss dec impairment test conducted fiscal mea net book value dec sure recoverable amount basis value use particular cashgenerating unit cash gross book value jan flow forecast consider previous experience currency translation generally based current projection ex change scope consolidation acquisition ecutive board period three five year reclassification held sale bioprocess solution division calculation gross book value dec based average terminal growth rate amortization impairment loss fiscal year terminal growth rate jan derived market expectation forecast currency translation mediumterm growth rate high upper single amortization impairment loss digit range biopharmaceutical market targeted amortization impairment loss division major growth driver dec among others aging population increase net book value dec population improved access pharmaceutical market emergingmarket country well yearearlier figure adjusted account final currently ongoing paradigm shift towards utiliza purchase price allocation tap biosystems tion singleuse product manufacture biopharmaceuticals lab product service item reported goodwill amount division terminal growth rate used k k capitalized dif fiscal year ference asset resulting capital consolidation extent also cover asset deal discount rate cashgenerating unit corre crease fiscal refers acquisition spond weighted average cost capital wacc pure technology llc see section goodwill recognized follows atrributable intec reclassified accordance ifrs according ia goodwill may amortized scheduled basis rather must tax tax tax tax tested annually impairment bioprocess solution lab product service industrial technology consolidated financial statement note note statement financial position fiscal impairment test result recognition impairment loss even realistic change basic assumption upon mea surement value use based would result carrying amount cashgenerating unit exceeding value use upon classification intec division discontinued operation criteri testing reclassified goodwill impairment must applied according fair value less cost sell reporting date need recognize impairment loss based expected selling price intangible asset patent license technology capitalized similar customer development payment right brand name relationship cost account total k k k k k k gross book value jan currency translation change scope consolidation acquisition capital expenditure disposal transfer gross book value dec amortization impairment loss jan currency translation amortization impairment loss disposal transfer amortization impariment loss dec net book value dec consolidated financial statement note note statement financial position patent license technology capitalized similar customer development payment right brand name relationship cost account total k k k k k k gross book value jan currency translation change scope consolidation acquisition capital expenditure disposal transfer reclassification held sale gross book value dec amortization impairment loss jan currency translation amortization impairment loss disposal transfer reclassification held sale amortization impairment loss dec net book value dec brand name acquired stedim transaction fiscal development cost k book value k considered indef k recognized asset fig inite useful life foreseeable limit ures also include discontinued operation capi period expected generate net cash talized development cost essentially covered cost inflow company integration allocated project staff involved stedim brand sartorius stedim biotech rd effort raw material supply outside ser brand separate measurement relevant cash flow vice directly attributable overhead internally possible however recoverability generated intangible asset amortized according brand name intangible asset acquired straightline method useful life within scope business combination considered nexthigher level cash amortization intangible asset allocated generating unit cgu ie bioprocess solution corresponding function statement profit division loss capitalized development cost amortization disclosed research development cost brand name acquired conjunction biohit liquid handling business limited period fiscal impairment expense million useful life estimated ten year average recognized capitalized development cost million customer relationship obtained part acquisition stedim likewise constitute material intangible asset attributable intec division intangible asset book value customer reclassified according ifrs relationship amounted million million year ended december remaining period useful life eight year consolidated financial statement note note statement financial position property plant equipment factory office payment land building technical equipment account machinery construction improvement equipment equipment progress total k k k k k gross book value jan currency translation change scope consolidation capital expenditure disposal transfer gross book value dec depreciation impairment loss jan currency translation depreciation impairment loss disposal transfer depreciation impairment loss dec net book value dec factory office payment land building technical equipment account machinery construction improvement equipment equipment progress total k k k k k gross book value jan currency translation change scope consolidation grant related asset capital expenditure disposal transfer reclassification held sale gross book value dec depreciation impairment loss jan currency translation depreciation impairment loss disposal transfer reclassification held sale depreciation impairment loss dec net book value dec depreciation included statement profit capitalized property plant equipment include loss according use asset cost sale asset held finance lease amounting selling distribution expense research devel k k cost acquisition opment expense administrative expense asset total k k operating expense fiscal rental payment amounting year material impairment million million made loss plant property equipment recognized set leased operating lease consolidated financial statement note note statement financial position deferred tax deferred tax asset deferred tax liability dec dec dec dec k k k k intangible asset tangible asset inventory receivables current asset provision liability gross amount taxable loss carried forward tax nondistributed earnings subsidiary offset deferred tax asset deferred tax liability reporting date group unused tax loss deferred tax liability connection intangi amount carried forward million ble asset refer asset acquired business combina around million deducted future tax tions consequently mainly linked customer able profit deferred tax amount reported relationship approx million approx million loss concerning remaining loss company taxable temporary difference carried forward deferred tax amount recog million million respect nized lack foreseeability future investment subsidiary deferred tax liability taxable profit million million recognized temporary difference include deferred tax asset approximately million holding tax realization liability around million relate company reported expected within foreseeable future temporary loss year review earlier difference conjunction retained earnings porting year loss carried forward report subsidiary amount million ed asset assumed taxable profit million deferred tax liability measured would available future unused realization foreseeable planned tax loss deductible temporary difference retained earnings distributed offset would subject taxation rate ger many addition foreign withholding tax might addition group unused interest carry incurred determination tax effect would entail forward german company group unreasonable expense effort amount million million deferred tax asset considered carryforwards fiscal previous year tax effect reporting year today stance use yielded reporting derivative financial instru sufficiently probable remaining amount ments recognized outside statement profit carried forward loss according ia rule hedge accounting deferred tax asset recognition actuarial gain loss recognized comprehen sive income likewise amount current income tax incurred net investment foreign operation recognized comprehensive income deferred current income tax recognized directly equity disclosed follows table consolidated financial statement note note statement financial position trade receivables reported k k discernible risk covered allowance recog cash flow hedge nized based past experience actual credit actuarial gain loss loss please refer section concerning ex defined benefit obligation penses income resulting allowance net investment foreign reported statement profit loss operation book value trade receivables receiv total ables approximate receivables fair value due short term inventory within scope implementing factoring pro gram retained part risk essentially credit dec dec risk associated asset carrying k k amount continuing involvement stood raw material supply million end fiscal work progress million associated liability finished good million million total amount merchandise original asset million payment account million reporting year valuation allowance developed follows dec dec k k gross amount inventory k k writedowns valuation allowance net amount inventory beginning year increase fiscal year derecognition current trade receivables consumption recovery amount dec dec previously impaired k k currency translation difference trade receivables third party reclassification held sale amount due customer contract work valuation allowance end year receivables non consolidated affiliate trade receivables business area group carry long term construction contract limited extent customerspecific contract recognized application ia construction contract based percentage completion method reporting year contract revenue k earned k aggregate amount cost incurred profit loss recognized project progress reporting date k k project advance pay ments k k recorded consolidated financial statement note note statement financial position following table show maturity structure sartorius ag exercised authority granted receivables past due impaired annual shareholder meeting june repurchase treasury share amount k dec dec pursuant subsection german k k stock corporation law aktg according ia day treasury share deducted equity capital day reserve day day share held particular currency day future acquisition company october total reporting date ordinary share repurchased average price preference share average price corresponds portion trade receivables k past due capital stock fiscal treasury share reporting date k valuation purchased share deducted company allowance made material issued capital capital reserve change creditworthiness debtor could expected would pay amount outstanding trade receivables yet due reserve financial asset written indication impairment capital reserve asset capital reserve include amount generated previous year beyond nominal amount dec dec sartorius ag issued share within scope k k purchase treasury share see k derivative financial deducted capital reserve instrument miscellaneous fiscal capital reserve increased k financial asset due use share part sharebased pay financial asset ments see section detail provided remuneration report issued capital cash flow hedging reserve sartorius ag capital stock divided bearertype ordinary share nonvoting amount recognized comprehensive income preference share calculated par value part effective hedgeing relationship trans according company article asso ferred cash flow hedging reserve particular ciation preference share entitled dividend fluctuation fair value interest payment higher dividend payment currency hedge well respective tax effect ordinary share amount equal preference share calculated proportion issued capital ie two euro cent per share case pension reserve dividend entitlement shall least preference share calculated proportion issued actuarial gain loss defined benefit plan capital ie four euro cent per share share commitment including respective tax effect paid full included pension reserve consolidated financial statement note note statement financial position noncontrolling interest condensed statement profit loss comprehensive income sartorius stedim biotech subgroup headquartered aubagne france account majority non controlling interest sartorius group latter k k hold approximately capital share sale revenue voting right subgroup following sub profit tax sidiaries account noncontrolling interest income tax amount net profit period comprehensive income sartorius korea biotech based seoul south korea tax sartorius thailand located bangkok total comprehensive income share capital company consolidated due available call option exercised time comparable contractual arrangement condensed statement cash flow allpure technology llc new oxford usa k k k k net cash flow operating activity cumulative noncontrolling interest dec net cash flow investing activity acquisition sartorius stedim biotech net cash flow financing activity net increase decrease profit loss allocated cash cash equivalent noncontrolling interest cash cash equivalent sartorius stedim biotech beginning period net effect currency translation cash cash equivalent dividend paid non cash cash equivalent controlling interest end period sartorius stedim biotech pension employee benefit provision following summarized financial information refers sartorius stedim biotech group defined contribution plan company group defined condensed statement financial position contribution plan frequently form govern mentbacked retirement insurance country dec dec percentage company pay social security k k contribution national insurance contribution noncurrent asset oldage retirement benefit cannot reliably deter current asset mined fiscal amount million recognized defined contribution plan million remaining group company equity noncurrent liability current liability consolidated financial statement note note statement financial position defined benefit plan following parameter used french company pension provision similar obligation recognized consolidated financial statement sartorius group accordance actuarial prin discount rate ciples actuarial gain loss shown directly future salary increase comprehensive income according future pension increase vised ia r standard actuarial loss transferred pension reserve essentially resulted change discount rate totaled k k amount reported statement profit loss statement comprehensive income amount k k relates consist following particular net amount pension provision retirement pension plan germany provision based direct commitment defined bene k k fit pension plan commitment em service cost ployees earn benefit year service rendered net interest cost company pension benefit generally component defined funded asset substantial portion benefit cost recognized profit loss provision relate sartorius ag case return plan asset excl obligation measured pertain general pension interest plan allgemeine versorgungsordnung employ actuarial gain loss ee whose employment commenced prior january component defined one hand individual com benefit cost recognized mitments active former executive board mem comprehensive income bers executive exist form performance total defined benefit cost based postemployment benefit plan assumed discount factor reflect interest rate paid reporting date prime corpo statement profit loss current service rate industrial bond matching maturity cost disclosed according assignment em denominated relevant currency corpo ployees respective function rate bond available matching longterm maturity insufficiently available match net amount present value included con ing interest rate determined extrapolation solidated statement financial position arising group obligation respect defined benefit measurement postemployment benefit obliga plan follows tions german group company based following actuarial assumption dec dec k k present value obligation discount rate fair value plan asset future salary increase net liability future pension increase consolidated financial statement note note statement financial position defined benefit obligation plan asset k k k k present value plan asset jan obligation jan interest income current service cost return plan asset excl past service cost interest interest cost actuarial gain loss actuarial gain loss group contribution currency translation payment difference employee contribution retirement benefit paid currency translation reporting year difference employer contribution employer contribution employee contribution contribution plan contribution plan participant participant reclassification held reclassification held sale sale change change plan asset dec present value obligation dec composition plan asset actuarial gain loss defined benefit obligation allocated follows plan asset essentially consist insurance contract insurance company germany switzerland amount million held local bank k k security subsidiary south korea experience adjustment change demographic sensitivity analysis assumption change financial increase decrease actuarial assumption assumption would following impact defined total benefit obligation year ended december demographic assumption change life expectancy year year effect financial assumption change discount rate bps bps effect change future salary increase bps bps effect change future pension increase bps bps effect consolidated financial statement note note statement financial position present value defined benefit obligation maturity analysis year ended december undiscounted cash flow defined benefit demographic assumption obligation allocated maturity follows change life expectancy year year effect dec dec financial assumption k k change discount rate bps bps year effect year change future salary year increase bps bps year effect change future pension increase bps bps effect weighted average duration defined benefit obligation year year sensitivity analysis presented might fiscal payment million defined representative actual change defined benefit plan commitment expected benefit obligation unlikely change million cover contribution plan asset assumption would occur isolation one another payment retirement benefit furthermore present value defined benefit obligation calculated using method applied calculating defined benefit obligation liability recognized statement financial position projected unit credit method noncurrent provision payment employee early retirement plan total k k k balance jan currency translation consumption reversal utilization addition balance dec payment employee early retirement plan total k k k balance jan currency translation consumption reversal utilization addition reclassification held sale balance dec noncurrent provision comprise mainly provision employee anniversary bonus obligation partial retirement type early retirement plan arise mainly german group company consolidated financial statement note note statement financial position early retirement plan partial retirement plan noncurrent provision reported present permit employee work parttime value reporting date discount interest rate year reach actual retirement age employee early retirement plan provision accrued company anniversary according ia r treatment severance pay fiscal effect ments earned future period must recog compounding noncurrent provision including nized profit loss active employee effect change interest rate million respective remaining period service millon ia rule require actuarial gain loss well past service cost bonus company anniversary generally obligation recognized income granted employee accumulated seniori expense statement profit loss tie year cover additional special vacation well relatively small sum money noncurrent liability loan borrowing finance lease liability balance non balance non dec current dec current k k k k loan borrowing finance lease liability financing sartorius group consists various approximately million factoring program element largely renewed reporting volume million year benefit attractive market environ ment increase flexibility noncurrent liability major pillar financing syndicated credit line million concluded december dec dec maturity term five year new financing k k arrangement sartorius replaced two syndicated derivative financial credit line ahead schedule consolidated instrument financing within group liability total additional component company financing note loan schuldscheindarlehen placed volume million maturity derivative financial instrument represent fair five ten year value interest rate swap agreement addition several longterm loan totaling around noncurrent liability essentially include million available expand company liability payment remaining purchase price production capacity among project acquisition lonzas cell culture medium busi ness liability connection non beyond component company diverse controlling interest allpure see section working capital guaranteed credit line totaling consolidated financial statement note note statement financial position current provision warranty total k k k balance jan currency translation change scope consolidation consumption reversal utilization addition balance dec warranty total k k k balance jan currency translation change scope consolidation consumption reversal utilization addition reclassification held sale balance dec measuring provision recognizable obligation based past business trans action past event uncertain timing amount recognized provision recognized result legal constructive obligation respect third party provision essentially include pending loss onerous contract uncertain obligation concerning employee benefit consolidated financial statement note note statement financial position current liability financial obligation contingent asset liability trade payable financial obligation conjunction oper ating lease consist following dec dec k k dec dec payment received k k account order operating lease trade payable third due within one year party due within year payable participation due thereafter payable non consolidated subsidiary trade payable financial instrument financial risk financial liability general information dec dec k k section give overview impact finan cial instrument financial statement derivative financial instrument sartorius group provides additional information personnelrelated liability item contain financial instrument statement financial position financial liability derivative measured fair value determined according markingtomarket method recognized mathematical method used fair value based market data available liability time value derivative calculated reflect estimate market condition dec dec k k end year tax social security liability consolidated financial statement note note statement financial position class financial instrument following table compare carrying amount fair value category financial instrument reconcile item statement financial position carrying carrying amount fair value amount fair value category acc ia dec dec dec dec k k k k financial investment available sale financial asset loan receivables financial asset noncurrent trade receivables loan receivables receivables asset loan receivables derivative financial instrument held trading derivative financial instrument hedging instrument financial asset current cash cash equivalent loan receivables financial liability loan borrowing cost finance lease liability ifrs financial liability trade payable cost trade payable ifrs trade payable derivative financial instrument held trading derivative financial instrument hedging instrument financial liability financial liability cost financial liability ifrs financial liability aggregate carrying amount financial instrument ia category shown following table dec dec k k availableforsale asset loan receivables held trading asset financial liability cost held trading liability consolidated financial statement note note statement financial position fair value hierarchy net result financial instrument fair value financial instrument de net gain loss various category termined basis market information avail financial instrument presented following able reporting date allocated table one three level fair value hierarchy accordance ifrs k k level financial instrument calculated availableforsale asset basis price quoted active market identical loan receivables asset liability level financial instrument financial asset calculated basis input factor liability held trading derivable observable market data basis financial liability cost market price similar instrument level finan cial instrument calculated basis input factor cannot derived observable market net result availableforsale financial asset data essentially comprised dividend capital gain loss equity investment non equity investment measured acquisition consolidated subsidiary cost financial asset possible determine fair value reliably due absence active mar net result borrowing receivables primarily kets applies mainly share nonconsolidated includes effect currency translation change subsidiary assumed carrying amount valuation adjustment correspond fair value reporting date net result financial asset liability held financial instrument recognized fair trading primarily comprised change value reporting date exclusively derivative market value derivative financial instrument form forward contract interest rate interest income expense instrument swap measured basis quot ed exchange rate market yield curve taking net result liability measured acquisition cost counterparty risk account level mainly consists effect currency translation fair value disclosed financial liability total interest income expense financial recognized amortized cost especially liability asset liability recognized fair bank related note loan schuldschein value profit loss follows darlehen measured basis market interest rate curve according zero coupon method taking current indicative credit spread k k account level interest income interest expense allpure liability required disclosed amount present value expected purchase price payment noncontrolling interest company present value derived expected allpure sale revenue exercise date riskadjusted discount rate presented fair value remaining financial asset liability disclosed approximate carrying amount account predominantly short term maturity consolidated financial statement note note statement financial position capital management management exchange rate risk sartorius group capital managed order group exposed currency risk approximate maximize earnings company stakeholder ly onethird sale revenue generated u dol optimizing ratio equity liability lars currency linked u dollar ensure group company operate lesser extent foreign currency premise goingconcern principle time sartorius global manufacturing network enables company offset lion share sale reve financial liability described section nues received foreign currency within group regarded managed capital furthermore cost likewise incurred foreign currency cash cash equivalent well equity capital portion sale revenue foreign currency main settled cost ie net currency exposure resulting currency translation goal financial risk management hedged large extent derivative financial struments hedging strategy generally provides treasury management unit group cen hedging remaining net currency exposure trally focused sartorius corporate administration year ahead hedging measure regularly reviewed gmbh centralized treasury management unit adapt expected exchange rate fluctuation performs service company sartorius group coordinate access national interna using forward contract concluded end tional financial market addition treasury reporting date secure right simultaneous management unit monitor control financial risk ly create obligation sell established foreign essentially entail currency interest rate currency amount exercise date specific liquidity risk exchange rate euro independently exchange rate actually valid date profit sartorius group strives minimize impact loss resulting difference current currency interest rate risk using derivative finan previously established exchange rate gener cial instrument hedging transaction con ally measured income expense state trolling carried different staff member ment profit loss moreover group internal auditing department regularly monitor use financial instru addition structured hedge socalled target profit ments trading derivative financial instrument forward used optimize hedging transaction done hedging purpose transaction secure right create obligation swap agreed amount foreign currency corresponding euro amount fixed exchange rate several target date long profit resulting exchange transaction exceed contractually defined limit reporting date company forward contract total volume u million million hedge risk fluctuation eur usd exchange rate furthermore japanese yen total volume million million hedged forward exchange transaction million form target profit forward end reporting date consolidated financial statement note note statement financial position december fair value currency volume maturity k forward contract usd q usd q usd q usd q usd forward contract jpy q jpy q jpy q jpy q jpy december fair value currency volume maturity k forward contract usd q usd q usd q usd q usd q usd forward contract jpy q jpy q jpy target profit forward jpy q jpy q jpy derivative financial instrument measured annual profit tax would time acquisition cost fair value subse million million currently quent reporting date change value disclosed figure vice versa u dollar would derivative financial instrument recognized appreciated euro resulting statement profit loss reporting date impact annual profit tax would derivative financial instrument serve hedge million million im cash flow risk qualified hedging rela pact equity million million tionship exists based criterion ia impact include effect group inter valuation adjustment portion determined company loan partially compensated effective hedge recognized compre effect currency reserve translation hensive income ineffective portion gain loss recognized financial result change swiss franc chf would primari ly affected measurement liability recorded fiscal amount k chf resulting acquisition lonza cell recognized comprehensive income culture medium business increase de ineffective portion k recognized crease chf rate would effect result period amount k million million respectively classified reporting year equity measurement statement profit loss k disclosed operating income expense concerning exchange rate u dollar euro following sensitivity provide estimated impact u dollar would depreciated euro equity would million higher million actually reported consolidated financial statement note note statement financial position interest risk management ing relationship meet requirement cash hedge accounting according requirement refinancing arrangement implemented ia valuation adjustment portion december entire sartorius group determined effective recognized financed exclusively sartorius ag u comprehensive income ineffective portion internal group loan ensure financing gain loss recognized financial result group company hedging relationship dissolved due placement former syndicated loan amount loan predominantly taken million reclassified reporting year variable interest rate sartorius group exposed comprehensive income statement interest rate risk control interest rate risk profit loss earlier year amount group concluded interest rate hedge form million recorded comprehensive interest swap cover part loan income standing variable interest rate result group receives particular variable interest rate following table provides overview inter valid market pay fixed interest rate est hedging contract available reporting date interest hedge transaction concluded serve hedge interest rate risk effective hedg hedged volume hedged volume hedged fair value fair value dec dec end term interest rate dec dec instrument k k k k swap sept mar forward swap aug mar reporting date december swap million amount mil volume variable interest loan around lion would recorded annual profit million hedging volume next five effect comprehensive income year million million approxi conjunction market valuation financial mately half twothirds company exposure struments used hedging effective hedging interest rate risk hedged debt relationship exist million million v hedging volume million million decrease base interest rate used measure sensitivity declining interest financial instrument held reporting rate condition corresponding impact date sensitivity analysis yield following result profit tax would million market interest rate would per million previous year additionally centage point higher would impact impact million compre million resulting variable interest hensive income loan million opposite effect would yielded valuation interest rate consolidated financial statement note note statement financial position liquidity risk management following table show liquidity analysis financial liability excluding derivative form contractually agreed undiscounted cash flow based condition reporting date carrying amount cash flow dec dec year year year k k k k k loan borrowing finance lease trade payable liability excluding derivative financial liability carrying amount cash flow dec dec year year year k k k k k loan borrowing finance lease trade payable liability excluding derivative financial liability carrying amount cash flow derivative shown follows carrying amount cash flow dec dec year year year k k k k k interest rate swap derivative carrying amount cash flow dec dec year year year k k k k k gross fulfilment forward contract payment obligation payment claim net fulfilment interest rate swap derivative group control liquidity risk maintaining credit line additional facility bank selling ceivables within scope factoring program continuously tracking forecasted actual cash flow managing maturity profile financial asset liability consolidated financial statement note note statement financial position credit line credit line credit line credit line used unused k dec year year year interest rate dec dec syndicated credit line variable note loan variable schuldscheindarlehen fixed variable bilateral credit line fixed total credit line credit line credit line used unused k dec year year year interest rate dec dec syndicated credit line variable note loan variable schuldscheindarlehen fixed variable bilateral credit line fixed total explained section group essentially sharebased payment financed syndicated loan note loan schuldscheindarlehen agreement within sartorius group sharebased payment group required comply standard financial exist form socalled phantom stock unit key ratio covenant context ratio sartorius ag stock option plan sartorius net debt underlying ebitda may greater stedim biotech sa respectively fiscal group achieved ratio net debt underlying socalled phantom stock virtual option ebitda compared ratio share sartorius ag specifically company include company discontinued operation based phantom stock plan credit member ex current information available company ecutive board gec beginning every year considers unlikely would comply phantom stock unit valued agreed mone covenant tary sum phantom stock option may exer cised earlier four year sum credited certain condition risk associated spect performance sartorius ag share financial instrument met executive board member exercise option number phantom stock unit granted evalu reporting date sartorius group ated current stock exchange price amount exposed significant risk volatility paid capped time grant price share price vested portion sharebased pay detail please refer remuneration ments linked directly price development port fair value phantom stock unit sartorius stock measured using blackscholes model disclosed follows significant risk financial instrument discernible consolidated financial statement note note statement financial position fair value number yearend fair value phantom yearend stock unit dec dec paid component longterm incentive effect k k k tranche tranche tranche tranche tranche fiscal expense relating granting share granted price class share valuation phantom stock unit k grant date ordinary share preference k prior year phantom stock unit share amount k due exercisable reporting date phan sharebased payment arrangement expected dividend tom stock unit granted reporting year included measurement unit fair value k grant date share considering agreed condition amount attributable member executive board resulting december spread detail phantom stock unit please refer employee benefit expense full vesting remuneration report integral part period plan fiscal amount k group management report accordingly recognized employee benefit expense resulting grant share resolution supervisory board december detail please refer remuneration report dr kreuzburg reappointed member executive board chairman ceo stock option plan staff sartorius term november november stedim biotech group relate share sartorius due dr kreuzburgs excellent performance stedim biotech sa various stock option plan developing company since start tenure outstanding exercisble reporting date executive board november shown follows company wished continue successful coopera tion despite alternative offer dec dec made new remuneration agreement pro outstanding vides ordinary share prefer beginning period ence share company shall transferred granted period supplementary compensation component dr forfeited period kreuzburg sharebased payment subject exercised period rule ifrs deemed granted expired period upon resolution approved supervisory outstanding end board december remuneration com period ponent included total remuneration exercisable end fair value grant date share respec period tive fair value derived number consolidated financial statement note note statement financial position various stock option plan summarized follows number number date share number option general number option subject annual initial subscribed number granted target number shareholder date number director total share perfor benefi meeting board share director number subscrip subscribed exercisable mance ciaries authorized granted executive benefi tion price fiscal dec dec valid plan approval subscribed executive concerned ciaries option june july june sept june nov total number number date share number option general number option subject annual initial subscribed number granted target number shareholder date number director total share perfor benefi meeting board share director number subscrip subscribed exercisable mance ciaries authorized granted executive benefi tion price fiscal dec dec valid plan approval subscribed executive concerned ciaries option june july june sept june nov total sartorius stedim biotech share purchase option disclosure discontinued operation allocated employee director subgroup plan inactive since result comprehensive strategic analysis new stock option issued since company business area executive board sarto time option exercised reporting year rius ag already decided review various based average share price option industrial technology division date exercise share option still outstand included possibility selling business ing reporting date statement fi necessary initial action taken spin nancial position exercisable november division separate legal entity december latest fair value service per sartorius signed contract sell entity formed measured reference fair value japanese company minebea ltd partner option date allocation using bino development bank japan reason mialtype mathematic model fair value thus intec division reported discontinued operation measured recognized employee benefit ex consolidated financial statement pense spread full vesting period plan need record impairment loss based meas provided stock option entitlement actual urement intec disposal group lower ly acquired carrying amount fair value less cost sell cash received exercise option sartorius stedim biotech share disclosed cash cash equivalent offsetting item non controlling interest reported equity consolidated financial statement note note statement financial position asset liability intec division financial asset allocated loan reporting date december shown receivables category financial liability follows financial liability cost dec deferred tax asset discontinued operation k relate primarily temporary difference carry noncurrent asset ing amount intangible asset goodwill goodwill intangible asset pension provision reported consist defined property plant equipment benefit obligation k plan asset financial asset amount k please see section infor asset mation measurement parameter deferred tax asset earnings attributable shareholder current asset sartorius ag discontinued operation inventory follows trade receivables financial asset k k current tax asset asset cash cash equivalent sale revenue expense asset classified held sale operating income expense earnings interest noncurrent liability tax ebit pension provision financial result provision profit tax deferred tax liability income tax profit tax current liability discontinued operation provision trade payable financial liability transaction date close reporting date current tax liability subsequent measurement fair value less cost sell liability yield impairment loss liability associated asset classified held sale consolidated financial statement note disclosure disclosure consolidated financial statement prepared number employee goingconcern basis table show average workforce employed exemption option provided subsection fiscal year german commercial code hgb applied annual financial statement reported sartorius lab holding gmbh sartorius weighing technology bioprocess solution gmbh sartorius corporate administration gmbh lab product service based goettingen germany year ended continuing operation december industrial technology total exemption option provided b german commercial code hgb used annual financial statement reported sartorius mechatronics cd gmbh co kg aachen germany siv weende gmbh co kg goettingen auditor fee germany siv grone gmbh co kg goettingen germany sartorius lab instrument gmbh co kg fiscal following fee goettingen germany sartorius industrial scale curred group auditor deloitte gmbh co kg goettingen germany year touche gmbh ended december k k material event reporting date audit certification sale industrial technology divsion verification service japanese minebea co ltd partner tax consultation service development bank japan inc completed service february become economically effec tive january cash proceeds resulting transaction total approximately million certification verification service include audit review fee k k declaration according subsec firsthalf financial report pursuant w german commercial code hgb german security trading act wphg declaration prescribed german stock corporation law aktg submitted december made available share holder sartorius ag company website wwwsartoriuscom member supervisory board executive board member supervisory board executive board listed end section consolidated financial statement note disclosure related company person total remuneration executive board supervisory board member shown following group company included consolidated table financial statement carry business activity transaction related party relationship defined ia particular concern transaction k k nonconsolidated subsidiary associate total remuneration generally concluded according customary executive board market term detail transaction completed fixed remuneration reporting year balance outstanding fringe benefit reporting date provided relevant total section note financial statement annually paid variable remuneration specifically section variable remuneration multi year component according ia related person consolidated net result year responsible planning management control phantom stock plan year reporting entity particular person include share granted member executive board super total visory board sartorius ag particular total remuneration person include member executive board supervisory board sartorius ag reporting year total remuneration supervi partial payment multiyear variable remuneration sory board member k k executive board member executive board k k remuneration former managing director mem bers executive board surviving de k k pendent k k pension balance jan fiscal year obligation former managing director partial payment deducted member executive board surviving partial payment effected dependent totaled k k balance dec detail remuneration please refer remu fiscal year neration report integral part com bined group management report beyond supervisory board remuneration employee repre sentatives employee within sartorius k k group receive compensation related remuneration supervisory service supervisory board board member total remuneration fixed remuneration compensation committee work meeting attendance fee remuneration sartorius weighing technology gmbh goettingen total remuneration sartorius stedim biotech subgroup remuneration sartorius stedim biotech gmbh goettingen remuneration sartorius stedim biotech sa aubagne consolidated financial statement note disclosure proposal appropriation profit supervisory board executive board submit proposal annual shareholder meeting appropriate retained profit reported sartorius ag year ended december follows payment dividend per ordinary share payment dividend per preference share unappropriated profit carried forward goettingen february sartorius aktiengesellschaft executive board consolida ted financiall statement note declaration executive board declaration executtive board declare best know wledge tthe consolidatedd financial staatements fiscal p sent truee fair vieew acctual net worrth p financial sittuation profitability group accordance acccounting staandards used preparing hese statement also certify tthe b progress group business including busin e performancee situuation represented acccu rately thee group manaagement report materrial respect andd present important opportunitties risk f groupss future deveelopment duriing fiscal yeear goettingen february sartorius akktiengesellschaaft executivve board dr joachim kreuzburg jörg pfirrmaann reinhard voogt consolidated financial statement note independent auditor report independent auditor report audited consolidated yearend financial state audit cover assessment annual financial ments consist consolidated statement statement company included consoli profit loss along statement compre dated financial statement definition scope hensive income statement financial position consolidation accounting consolidation statement cash flow statement change principle applied significant estimate made equity note financial statement well executive board well evaluation management report integrated group overall presentation consolidated yearend management report sartorius aktieng financial statement group management esellschaft germany prepared fiscal year port believe audit provides reasonable january december preparation basis opinion consolidated financial statement group management report according international audit result objection financial reporting standard ifrs applied eu according commercial according assessment based information rule additionally applied conformance obtained audit consolidated finan subsection german commercial code cial statement sartorius aktiengesellschaft hgb responsibility executive board goettingen conform ifrs parent corporation sartorius aktiengesellschaft applied eu commercial rule responsibility express opinion con additionally applied compliance sub solidated financial statement group man section hgb present fairly material agement report based audit respect net worth financial position earn ings group group management report conducted audit accordance hgb consistent consolidated financial statement taking account principle proper auditing provides overall true fair view established german institute independent group situation accurately present oppor auditor institut der wirtschaftsprüfer prin tunities risk future development ciples require plan perform audit obtain reasonable assurance misrep hanover germany february resentations infraction material impact presentation net worth financial posi deloitte touche gmbh tion earnings consolidated financial state ments consideration accounting principle applied group management report determining audit focus information busi ness activity economic legal background group well expectation possible error henning scharpenberg dr christian meyer taken account within scope audit auditor auditor effectiveness accountingrelated internal control system well evidence supporting amount disclosure made consolidated financial statement group management port predominantly examined test basis consolidated financial statement note executive board supervisory board executive board supervisory board fiscal executive board supervisory board dr rer pol joachim kreuzburg prof dr dres hc arnold picot diplingenieur graduate engineer ceo diplkaufmann graduate business administration chairman corporate strategy operation legal affair university professor compliance corporate communication chairman born april executive director institute information resident hanover germany organization management faculty economics member since november ludwig maximilian university munich germany sprecher spokesman may resident gauting germany november chairman since november manfred zaffke appointed november diplvolkswirt graduate political economist vice chairman jörg pfirrmann first authorized representative german diplökonom graduate economist metalworker union ig metall southern executive labor relation lower saxonyharz region northeim germany finance human resource general administration resident osterode harz germany born november resident noertenhardenberg germany dr dirk basting member since july diplchemiker graduate chemical engineer appointed july resident fort lauderdale florida usa reinhard vogt annette becker industriekaufmann industrial business manager personalfachkauffrau hr specialist marketing sale service chairwoman employee council born august sartorius corporate administration gmbh resident dransfeld germany goettingen germany member since july chairwoman group employee council appointed july sartorius ag goettingen germany resident goettingen germany uwe bretthauer diplingenieur graduate engineer chairman employee council sartorius lab instrument gmbh co kg goettingen germany resident goettingen germany michael dohrmann feinmechaniker precision engineer chairman employee council sartorius stedim biotech gmbh goettingen germany resident reinhausen germany dr lothar kappich diplökonom graduate economist managing director ece projektmanagement gmbh co kg hamburg germany information required pursuant sec resident hamburg germany german commercial code hgb consolidated financial statement note executive board supervisory board committee supervisory board petra kirchhoff executive task committee diplvolkswirtin graduate political economist prof dr dres hc arnold picot chairman vice president corporate communication manfred zaffke since march investor relation gerduwe boguslawski february sartorius corporate administration gmbh uwe bretthauer goettingen germany prof dr gerd krieger resident goettingen germany audit committee karoline kleinschmidt prof dr klaus rüdiger trützschler chairman diplsozialwirtin graduate social economist manfred zaffke since march secretary german metalworker union ig metall gerduwe boguslawski february district management lower saxony uwe bretthauer saxonyanhalt hanover germany prof dr dres hc arnold picot resident hanover germany conciliation committee prof dr gerd krieger prof dr dres hc arnold picot chairman rechtsanwalt lawyer manfred zaffke since march honorary professor heinrichheine university gerduwe boguslawski february duesseldorf uwe bretthauer resident duesseldorf germany prof dr gerd krieger prof dr thomas sheper nomination committee diplchemiker graduate chemical engineer prof dr gerd krieger university professor head institute prof dr dres hc arnold picot technical chemistry dr lothar kappich leibnitz university hanover germany resident hanover germany prof dr klaus rüdiger trützschler diplwirtschaftsmathematiker graduate business mathematician diplmathematiker graduate mathematician resident essen germany gerduwe boguslawski diplsozialwirt graduate social manager vice chairman february german metalworker union ig metall south ern lower saxonyharz region northeim germany resident hoeckelheim germany information required pursuant sec german commercial code hgb consolidated financial statement note executive board supervisory board position held member executive board december dr rer pol joachim kreuzburg jörg pfirrmann présidentdirecteur général ceo board director sartorius stedim biotech sa france sartorius ireland ltd ireland supervisory board sartorius stedim ireland ltd ireland sartorius stedim biotech gmbh germany sartorius corporation usa vice chairman sartorius canada inc canada board director sartorius stedim nordic denmark sartorius north america inc usa sartorius nordic denmark sartorius stedim north america inc usa sartorius uk ltd uk sartorius stedim filter inc puerto rico sartorius stedim uk ltd uk sartorius japan kk japan sartorius shanghai trading co ltd china sartorius stedim japan kk japan sartorius stedim shanghai trading co ltd china denver instrument beijing co ltd china sartorius stedim biotech beijing co ltd china sartorius scientific instrument beijing co ltd china management committee sartorius hong kong ltd china sartorius france sa france sartorius stedim lab ltd uk comité exécutif executive committee comité exécutif executive committee sartorius stedim france sa france sartorius stedim fmt sa france consiglio di amministrazione supervisory board board management carl zeiss ag germany sartorius italy srl italy regionalbeirat regional advisory board sartorius stedim italy spa italy commerzbank ag hamburg germany consejo de administración board director beirat advisory board sartorius spain sa spain otto bock holding gmbh co kg germany unternehmerbeirat employer advisory board wirtschaftsbeirat economic advisory board gothaer versicherungsbank vvag germany norddeutsche landesbank germany reinhard vogt conseil dadministration board director sartorius stedim biotech sa france board director tap biosystems group ltd uk sartorius north america inc usa sartorius stedim north america inc usa denver instrument beijing co ltd china sartorius scientific instrument beijing co ltd china sartorius shanghai trading co ltd china sartorius stedim shanghai trading co ltd china sartorius stedim malaysia sdn bhd malaysia sartorius japan kk japan sartorius stedim japan kk japan sartorius hong kong ltd china sartorius korea ltd south korea sartorius australia pty ltd australia sartorius stedim australia pty ltd australia verwaltungsrat administrative board information required pursuant sec sartorius stedim switzerland ag switzerland german commercial code hgb position held within group chairman external position held member executive board december consolidated financial statement note executive board supervisory board position held member supervisory board december prof dr dres hc arnold picot dr lothar kappich conseil dadministration board director none sartorius stedim biotech sa france supervisory board petra kirchhoff sartorius stedim biotech gmbh supervisory board germany chairman awo goettingen ggmbh takkt ag germany wissenschaftliches institut für infrastruktur und karoline kleinschmidt kommunikationsdienste gmbh scientific institute none communication service wikconsult gmbh germany prof dr gerd krieger supervisory board manfred zaffke arag lebensversicherungsag germany supervisory board arag krankenversicherungsag germany terex mhps gmbh germany gmh guss gmbh germany prof dr thomas scheper vice chairman none dr dirk basting prof dr klaus rüdiger trützschler none supervisory board deutsche bank ag germany annette becker wuppermann ag germany chairman none zwiesel kristallglas ag germany chairman verwaltungsrat administrative board uwe bretthauer wilh werhahn kg germany none michael dohrmann none information required pursuant sec german commercial code hgb position held within group external position held member supervisory board december executive board supervisory board supplementary information supplementary information glossary glossary industrial productspecific term bag singleuse membrane filter plastic disposable bag used bioreactors storing liquid thin film foil made polymer porous culture medium intermediate product biopharma structure film suitable filtration application ceuticals monoclonal antibody bioreactor synthetic antibody used particular treatment englishspeaking country bioreactor vessel used cancer hiv autoimmune disease cultivating animal human cell culture medium non englishspeaking country term bioreactor also used pat process analytical technology synonymously term fermentor denote system strategy design analysis control manufacturing used multiply microorganism either case vessel process according quality characteristic interme used obtain cell part one metabolite diate finished product defined analyzed monitored using critical process parameter identified capsule readytouse filter unit consisting filter housing hose pharmerging market connector incorporated filter cartridge according ims health egypt argentina brazil china disposable india indonesia mexico pakistan poland romania russia used synonymously singleuse south africa thailand turkey ukraine venezuela vietnam downstream processing purification collective term various step follow fermentation important step downstream processing cell cultivation upstream processing production biopharmaceuticals example separation purification recombinant protein concentration protein manufactured using genetically modified organism used production therapeutic protein insulin fda food drug administration vaccine u regulatory agency responsible ensuring safety efficacy human veterinary pharmaceutical biological scaleup product medical device food transfer scale increase size used denote progres sion process increase range lab scale pilot fermentation scale process scale retaining technology technical process used produce transform intra material construction geometry throughout extracellular substance help microorganism singleuse reusable product fluid management technology disposable product ie onetime usage reusable product technology system transportation storage designed repeated use biological liquid sterile filter sterilizinggrade filter mechatronics membrane filter whose pore size usually smaller interdisciplinary field combine mechanical electrical product processspecific validation test required electronic engineering intelligent control technology com confirm filter type selected delivers sterile filtrate puter science technology interact compensate distorting effect material property ambient upstream processing condition may accuracy measured result manufacture biopharmaceuticals designates vari ous step take place seeding propagating cell membrane chromatography produce active pharmaceutical ingredient selective separation mixture substance adsorption specifically modified membrane membrane adsorbers validation flowing system documented verification system device process reproducibly deliver desired result supplementary information glossary business economic term amortization fixed asset amortization relates exclusively potential reduction sum intangible asset property plant equipment value goodwill allocation purchase price financial asset intangible asset acquired carried accordance ifrs free float cash flow proportion public company share freely available flow fund financial resource earned investing public definition least daytoday business activity amount cash earned paying expense tax word cash balance goodwill inflow outflow fund difference price paid company business net asset form intangible asset compliance observance applicable law code relevant rule holding company regulation parent company exists purpose owning controlling interest share several legally independent dax mdax sdax tecdax subsidiary subordinate parent company within german stock index transaction service provider organizational hierarchy holding company conduct marketplace organizer deutsche börse ag business exclusively subsidiary insurance ia director officer liability insurance cover super international accounting standard internationally recognized visory executive board member managerial employee accounting principle dvfa sg ifrs method commission society investment profes international financial reporting standard internationally sionals germany dfva ev also commonly referred recognized accounting principle german association financial analysis asset man agement schmalenbachgesellschaft sg one market capitalization leading scientific society area business administration total number share outstanding class issued financial reporting company multiplied corresponding share price ebitda prime standard earnings interest tax depreciation amortization market segment frankfurt stock exchange high context amortization refers exclusively purchase internationally accepted transparency requirement seg price allocation ppa intangible asset acquired according ment intended meet need company seeking ifrs attract attention international investor ebitda margin supply chain management ratio ebitda earnings interest tax depreciation setup coordination integrated flow material amortization sale revenue information finance supply chain entire valueadded process equity ratio ratio equity balance sheet total treasury short mediumterm liquidity management erp stand enterprise resource planning itbased resource underlying planning system adjusted eliminate extraordinary item see definition extraordinary item exceptional onetime expense income restructuring cost nonoperating expense supplementary information index index e acquisition ff f earnings f f f ff ff f ff address ff annual financial statement f ff ff earnings per share f earnings reserve annual shareholder meeting cover ff ebit f f ebitda f amortization f ff f ff f appropriation profit employee f ff asset f f ff ff f f ff employee benefit expense f f auditor ff f equity ff ff ff f ff b executive board f ff ff ff balance sheet cover f f f f f ff ff bioprocess solution ff ff ff f f f ff business development f f f financial asset f f c capital expenditure ff financial instrument f f cash flow f ff financing cash flow statement financial result f f compliance f f f f consolidated finacial statement f ff fixed asset ff forecast report corporate governance ff foreign exchange foreign exchange rate currency f f f foreign subsidiary ff ff ff currency translation f ff f g f f group company ff f f group executive committee f group financial statement depreciation ff f f f group management report ff distribution ff ff h hedging f ff dividend cover f f f impairment f ff impairment loss ff industrial technology f f intangible asset ff interest income inventory f f f investment f ff f investor relation cover supplementary information index index l lab product service ff f sale distribution ff f sale revenue cover f ff ff ff liability f f f f ff ff ff f ff ff f f sartorius stedim biotech f f ff macroeconomic environment ff security marketing segment report market capitalization f f shareholder structure shareholding n share index f net debt ff share cover f ff f ff f ff net profit f f f f f ff singleuse technology statement profit loss p f pension provision stedim transaction phantom stock phantom stock unit f supervisory board ff f f ff position held f ff procurement supply chain management production f f ff f sustainability report ff f ff product f ff f f tax f ff ff ff f f f ff f f profit ff ff trading volume ff f ff f ff ff treasury f f ff property plant equipment ff u provision f ff f unqualified audit certificate f f ff w r working capital ratio net debt ebitda cover receivables f f f f f ff f region f remuneration executive board research development f f reserve restructuring result ff f ff retained profit f f risk management system ff ff risk opportunity report supplementary information local presence worldwide local presence worldwide america mississauga canada bohemia ny usa wilmington de usa new oxford pa usa mexico city mexico yauco puerto rico são paulo brazil buenos aire argentina sale production production sale supplementary information local presence worldwide europe africa dublin ireland kajaani finland royston uk helsinki finland stonehouse uk st petersburg russia epsom uk moscow russia vilvoorde belgium goettingen germany paris france guxhagen germany aubagne france poznan poland lourdes france budapest hungary florence italy vienna austria milan italy tagelswangen switzerland madrid spain mohamdia tunisia barcelona spain asia paciﬁc beijing china suzhou china shanghai china hong kong china seoul south korea tokyo japan hanoi vietnam bangkok thailand bangalore india kuala lumpur malaysia singapore singapore melbourne australia supplementary information address address europe germany belgium sartorius ag sartorius stedim plastic gmbh sartorius stedim belgium nv weender landstrasse karlarnoldstr leuvensesteenweg b goettingen goettingen vilvoorde phone phone phone fax fax fax infosartoriuscom infosartoriusstedimcom lindreymensartoriuscom sartorius stedim biotech gmbh sartorius stedim system gmbh sartorius belgium nv augustspindlerstr robertboschstraße leuvensesteenweg b goettingen guxhagen vilvoorde phone phone phone fax fax fax infosartoriusstedimcom infosartoriusstedimcom infobelgiumsartoriuscom sartorius lab holding gmbh sartorius corporate administration gmbh denmark weender landstrasse weender landstrasse goettingen goettingen sartorius stedim nordic phone phone lyskaer fax fax herlev infosartoriuscom infosartoriuscom phone fax sartorius weighing technology gmbh austria infodksartoriusstedimcom weender landstrasse goettingen sartorius stedim austria gmbh sartorius nordic phone modecenterstr lyskaer fax vienna herlev infosartoriuscom phone phone fax fax sartorius lab instrument gmbh co kg separationaustriasartoriuscom infodksartoriuscom weender landstrasse goettingen sartorius austria gmbh finland phone modecenterstr fax vienna sartorius biohit liquid handling oy infosartoriuscom phone laippatie fax helsinki infoaustriasartoriuscom phone fax lhinfofinlandsartoriuscom supplementary information address france hungary netherlands sartorius stedim biotech sa sartorius stedim hungary kft sartorius stedim netherlands bv zone industrielle le paluds kagyló u westblaak avenue de jouques c budakeszi kg rotterdam aubagne cedex phone phone phone fax fax fax ssbsartoriushu officenlsartoriuscom infosartoriusstedimcom sartorius hungary kft sartorius netherlands sartorius stedim fmt sa kagyló u westblaak zone industrielle le paluds budakeszi kg rotterdam avenue de jouques c phone phone aubagne cedex fax fax phone mechatronikasartoriushu officenlsartoriuscom fax infosartoriusstedimcom ireland poland sartorius stedim france sa sartorius stedim ireland ltd sartorius stedim poland sp zoo zone industrielle le paluds unit business centre ul wrzesinska avenue de jouques c stadium business park kostrzyn aubagne cedex ballycoolin road phone phone dublin fax fax phone biuroplsartoriuscom infobiotechfrancesartoriusstedimcom fax infoirelandsartoriusstedimcom sartorius poland sp zoo sartorius stedim aseptics sa ul wrzesinska zone industrielle de saux rue ampère sartorius ireland ltd kostrzyn lourdes unit business centre phone phone stadium business park fax fax ballycoolin road infoplsartoriuscom infosartoriusstedimcom dublin phone sartorius france sa fax rue antoine laurent de lavoisier infoirelandsartoriuscom zone dactivité de la gaudrée dourdan italy phone fax sartorius stedim italy spa commercialfrancebiohitcom via dellantella antella bagno ripoli florence phone fax infoitalysartoriuscom sartorius italy srl viale alfonso casati muggió monza e brianza phone fax infoitalysartoriuscom supplementary information address russia spain uk ooo sartogosm sartorius stedim spain sa sartorius stedim uk ltd uliza rasstannaya dom korp lit polígon le guixeres carrer marcus porcius longmead business centre st petersburg edifici bcin blenheim road phone badalona barcelona epsom surrey kt qq fax phone phone infosartogosmru fax fax biotech_spainsartoriusstedimcom uksartoriussartoriusstedimcom ooo sartorius icr uliza rasstannaya dom korp lit sartorius spain sa sartorius stedim lab ltd st petersburg avda de la industria unit phone edificio payma stonedale road fax alcobendas madrid stonehouse gloucestershire gl rq russiasartoriuscom phone phone fax fax ooo biohit spainweighingsartoriuscom alanjohnsonsartoriusstedimcom uralskaya str letter b room h st petersburg switzerland sartorius uk ltd phone longmead business centre fax sartorius stedim switzerland ag blenheim road russiasartoriuscom ringstrasse epsom surrey kt qq tagelswangen phone ooo biohit phone fax petrovskorazumovsky proyezd building fax uksartoriussartoriuscom moscow biotechswitzerlandsartoriusstedimcom phone automation partnership cambridge ltd fax york way russiasartoriuscom royston hertfordshire sg wy phone fax infotapbiosystemscom supplementary information address north america latin america africa canada argentina tunisia sartorius canada inc sartorius argentina sa sartorius stedim bioprocess sarl dunwin drive unit int avalos km route de zaghouan mississauga ontario l l x becs munro mhamdia bourbiâa phone buenos aire bp ben arous fax phone phone salescanadasartoriuscom fax fax sartoriusargsartoriuscom infosartoriusstedimcom puerto rico brazil sartorius stedim filter inc carretera int sartorius brasil ltda barriada arturo lluveras avenida senador vergueiro po box yauco puerto rico são bernardo campo phone cep spbrasil fax phone marcoslopezsartoriuscom fax sartoriusbrsartoriuscom usa mexico sartorius stedim north america inc orville drive sartorius de méxico sa de cv bohemia new york circuito circunvalación poniente phone ciudad satélite fax estado de méxico phone infosartoriusstedimcom fax sartorius corporation sartoriusmxsartomexcom orville drive bohemia new york phone fax infosartoriuscom allpure technology inc progress avenue new oxford pa phone fax salesallpureinccom supplementary information address asia pacific china japan sartorius scientific instrument sartorius stedim shanghai trading co ltd sartorius stedim japan kk beijing co ltd rd floor north wing tower th floor daiwa shinagawa north bldg yu road tianzhu airport jinke road kitashinagawa shinagawaku industrial park zone b pudong district shanghai tokyo shun yi district beijing telefon phone phone fax fax fax infocnsartoriuscom infosartoriuscojp infocnsartoriuscom sartorius shanghai trading co ltd sartorius japan kk sartorius hong kong ltd rd floor north wing tower th floor daiwa shinagawa north bldg unit lu plaza jinke road kitashinagawa shinagawaku wing yip street pudong district shanghai tokyo kwun tong kowloon hong kong telefon phone phone fax fax fax infocnsartoriuscom infosartoriuscojp enquiryhongkongsartoriuscom india malaysia sartorius stedim biotech beijing co ltd yu road tianzhu airport sartorius stedim india pvt ltd sartorius stedim malaysia sdn bhd industrial park zone b jakkasandra lot leb enterprise shun yi district beijing kunigal road technology park malaysia phone nelamangala bangalore bukit jalil fax phone kuala lumpur enquirycnsartoriusstedimcom fax phone biotechindiasartoriuscom fax biohit biotech suzhou co ltd ehtansartoriuscommy block west jinzhi rd sartorius weighing india pvt ltd suzhou city jiangsu province jakkasandra sartorius malaysia sdn bhd phone kunigal road lot leb enterprise fax nelamangala bangalore technology park malaysia infochinabiohitcom phone bukit jalil fax kuala lumpur denver instrument beijing co ltd swilpssartoriuscom phone yu road tianzhu airport fax industrial park zone b ehtansartoriuscommy shun yi district beijing phone fax infocnsartoriuscom supplementary information address singapore thailand australia sartorius stedim singapore pte ltd sartorius thailand co ltd sartorius stedim australia pty science park road rama ix road ltd unit rodeo drive capricorn huaykwang dandenong south melbourne singapore science park ii bangkok victoria singapore phone phone phone fax fax fax enquirythailandsartoriuscom infoaustraliasartoriusstedimcom chooleepangsartoriusstedimcom vietnam sartorius australia pty ltd sartorius singapore pte ltd unit rodeo drive science park road sartorius representative office dandenong south melbourne capricorn unit c th floor tower big building victoria phone singapore science park ii pham hung street fax singapore dinh tu liem hanoi infoaustraliasartoriusstedimcom phone phone fax fax enquirysingaporesartoriuscom sartoriusvnhnvnnvn south korea sartorius korea biotech co ltd th floor solid space pangyoyeokro bundanggu seongnamsi gyeonggido phone fax infosartoriuscokr sartorius korea ltd th floor solid space pangyoyeokro bundanggu seongnamsi gyeonggido phone fax infosartoriuscokr address please visit website internet wwwsartoriuscom supplementary information leerseite leerseite financial schedule annual shareholder meeting goettingen germany april payment dividend april publication firstquarter figure april publication firsthalf figure july publication ninemonth figure october german equity forum frankfurt main germany november publication preliminary figure fiscal january annual press conference goettingen germany march annual shareholder meeting goettingen germany april publication firstquarter figure april subject approval annual shareholder meeting contact petra kirchhoff andreas theisen vice president director corporate communication ir investor relation phone phone petrakirchhoffsartoriuscom andreastheisensartoriuscom publication published financial reporting system firesys sartorius ag michael konrad gmbh corporate communication frankfurt main germany goettingen germany photography editorial deadline peter ginter february lohmar germany published february translation original germanlanguage annual report order intake sale revenue underlying ebitda ebita million million sartorius ag sartorius group annual report weender landstrasse goettingen germany phone fax infosartoriuscom wwwsartoriuscom order intake ebitda sartorius group sale revenue ebita annual report key figure figure given million according ifrs unless otherwise specified order intake sale revenue earnings order intake sale revenue underlying ebitda underlying ebitda sale revenue underlying ebita underlying ebita sale revenue net profit noncontrolling interest underlying net profit noncontrolling interest research development cost financial data per share earnings per share underlying per ordinary share per preference share dividend sartorius ag printed germany publication oge order per ordinary share per preference share balance sheet balance sheet total equity equity ratio gearing financials capital expenditure excluding financial asset goodwill capital expenditure sale depreciation amortization net cash flow operating activity net debt ratio net debt underlying ebitda total number employee december fiscal sartorius group adopted slight change reporting structure result change relate item amortization tax since shown functional expense change cost allocation impact group net profit ensure comparability business figure previous year restated accordingly excluding noncash amortization excluding effect fair value adjustment hedging instrument well excluding noncash interest expense share price warrant amount suggested supervisory board executive board sartorius ag excluding amortization financial asset goodwill excluding biohit liquid handling excluding tap biosystems